Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3026725	s-e2	nmol/l (nmol/l)	5946	8441	3.15%
3026725	s-e2	— (—)	1746	2097	100.00%	Distribution not available
3026725	s-estradioli	nmol/l (nmol/l)	7	8	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

L02BA Anti-estrogens

532

862

6.61

316.24

1.5

1.3

0.27

0.37

nmol/l

2.26

377

600

Malignant neoplasm of breast, HER-positive

866

1170

7.69

307.65

1.4

1.3

0.24

0.34

nmol/l

3.46

532

811

Malignant neoplasm of breast

1073

1648

4.87

307.65

1.3

1.4

0.26

0.38

nmol/l

5.64

665

1230

Female infertility, cervigal, vaginal, other or unspecified origin

1657

1273

9.66

307.65

1.6

1.3

0.68

0.34

nmol/l

16.05

1454

903

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

1079

1530

4.79

307.65

1.3

0.27

0.41

nmol/l

6.66

671

1169

Female infertility

1817

1319

9.40

307.65

1.6

1.3

0.64

0.34

nmol/l

14.00

1584

941

Exclusions for E4_PCOS_BROAD

688

1061

7.03

307.65

1.8

1.4

0.28

0.42

nmol/l

3.79

504

839

Medicines for HER+ breast cancer

1012

1388

7.52

307.65

1.6

1.3

0.31

0.37

nmol/l

0.75

654

996

Noninflammatory disorders of female genital tract

1257

1508

4.35

307.65

1.6

1.3

0.48

0.32

nmol/l

4.84

1054

1099

Malignant neoplasm of breast, HER2-negative

1017

1592

4.86

307.65

1.4

1.3

0.25

0.37

nmol/l

5.50

626

1170

Hypopituitarism

325

272

13.40

307.65

2.0

1.4

0.24

0.36

nmol/l

2.45

239

217

Disorders of other endocrine glands

1195

2806

4.37

307.65

1.8

1.4

0.34

0.42

nmol/l

1.42

940

2212

Medical treatment for female infertility

1483

2783

6.08

307.65

1.8

1.3

0.75

0.38

nmol/l

14.38

1308

2156

Female infertility, associated with anovulation

555

613

10.42

307.65

2.1

1.3

0.59

0.36

nmol/l

2.26

477

469

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

1078

1528

4.79

307.65

1.3

0.27

0.41

nmol/l

6.70

670

1167

L02BG Aromatase inhibitors

673

947

7.47

307.65

1.7

1.3

0.31

0.33

nmol/l

0.15

401

653

Amenorrhoea

545

458

14.09

307.65

2.0

1.4

0.22

0.34

nmol/l

3.19

439

347

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

880

998

7.54

307.65

1.4

1.2

0.24

0.37

nmol/l

4.26

542

723

Malignant neoplasm

1502

3128

2.90

268.84

1.4

0.28

0.41

nmol/l

8.06

1020

2487

Malignant neoplasm, wide definition for exclusion

1548

3312

2.81

262.27

1.5

1.4

0.28

0.42

nmol/l

9.13

1065

2663

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

1548

3312

2.81

262.25

1.5

1.4

0.28

0.42

nmol/l

9.13

1065

2663

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

1546

3311

2.81

261.48

1.5

1.4

0.28

0.42

nmol/l

9.10

1064

2663

Polycystic ovarian syndrome, broad definition

629

1645

4.22

215.82

2.0

1.4

0.58

0.52

nmol/l

0.34

548

1373

Any event in cancer register

1595

4051

2.37

193.72

1.5

1.4

0.30

0.45

nmol/l

10.80

1108

3305

Benign neoplasm: Pituitary gland, craniopharyngeal duct

220

227

10.79

193.61

1.9

1.5

0.31

0.38

nmol/l

0.88

158

195

Benign neoplasm: Pituitary gland, craniopharyngeal duct

220

278

8.79

165.48

1.9

1.5

0.31

0.35

nmol/l

0.43

158

223

Hypothyroidism and >3 levothyroxin purchases

795

1466

3.21

165.30

1.7

1.4

0.48

0.53

nmol/l

0.50

659

1260

Hypothyroidism, levothyroxine purchases

795

1466

3.21

165.30

1.7

1.4

0.48

0.53

nmol/l

0.50

659

1260

Ovarian dysfunction

425

1025

4.62

163.28

1.9

1.4

0.47

0.55

nmol/l

0.41

361

868

Hypothyroidism (congenital or acquired)

794

1473

3.19

163.15

1.7

1.4

0.48

0.53

nmol/l

0.49

656

1265

Endometriosis

715

1295

3.37

162.46

1.4

1.3

0.54

0.33

nmol/l

6.14

592

918

Genitourinary diseases

838

1356

3.14

162.35

1.6

1.4

0.39

0.26

nmol/l

2.79

681

1044

Irregular menses

1299

4641

2.34

162.04

1.6

1.4

0.32

0.48

nmol/l

10.66

1047

3640

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

661

2114

3.22

161.92

1.8

1.4

0.30

0.43

nmol/l

4.41

491

1626

Exclusions for E4_PCOS_CONSORTIUM

1535

4517

2.17

153.36

1.6

1.4

0.34

0.46

nmol/l

5.30

1169

3581

Benign neoplasm of other and unspecified endocrine glands

253

436

6.05

140.68

1.9

1.4

0.33

0.39

nmol/l

0.56

182

359

Endocrine, nutritional and metabolic diseases

1554

3829

2.09

135.10

1.6

1.4

0.40

0.41

nmol/l

0.15

1243

3081

Testicular dysfunction

21.51

129.29

1.8

1.6

0.12

nmol/l

0.15

Neoplasms

1489

3915

2.07

127.12

1.6

1.5

0.38

0.46

nmol/l

2.31

1188

3298

Hyperfunction of pituitary gland

227

395

6.35

127.03

1.5

1.3

0.30

0.47

nmol/l

2.30

169

321

Procreative management

703

2211

2.76

125.58

1.7

1.5

0.70

0.31

nmol/l

7.60

595

1663

Polycystic ovarian syndrome, consortium definition

1550

4747

2.01

125.09

1.7

1.4

0.36

0.47

nmol/l

3.79

1249

3708

Endometriosis of ovary

360

940

3.95

120.36

1.5

1.3

0.60

0.32

nmol/l

5.46

308

650

Excessive, frequent and irregular menstruation

715

1450

2.80

117.97

1.4

1.3

0.39

0.32

nmol/l

1.80

584

1047

Disorders of the thyroid gland

1507

5087

1.96

117.22

1.6

1.4

0.44

0.42

nmol/l

0.38

1191

4044

Hypothyroidism, other/unspecified

1461

4972

1.97

114.60

1.6

1.4

0.45

0.42

nmol/l

0.41

1157

3947

Testicular hypofunction

20.80

113.07

1.8

1.6

0.12

0.13

nmol/l

0.26

Hypothyreosis and Thyroxine purchase for inclusion criteria

1489

5128

1.94

112.74

1.6

1.4

0.45

0.42

nmol/l

0.38

1175

4050

Endometriosis diagnosis and infertility diagnosis occurring together

421

1296

3.48

112.21

1.5

1.4

0.69

0.48

nmol/l

2.72

369

1031

Ovarian cyst

654

1367

2.82

111.08

1.5

1.3

0.46

0.33

nmol/l

2.36

522

979

Benign neoplasm of other and unspecified endocrine glands

253

545

4.83

109.61

1.9

1.4

0.33

0.36

nmol/l

0.25

182

419

Recurrent or chronic depression

776

2300

2.48

109.57

1.5

1.4

0.41

0.46

nmol/l

0.45

607

1829

Endometriosis of pelvic peritoneum

359

1013

3.62

105.29

1.4

1.3

0.55

0.33

nmol/l

4.58

301

715

Unspecified/other endometriosis

266

626

4.46

103.52

1.4

1.3

0.57

0.36

nmol/l

2.73

227

466

Complications associated with artificial fertilization

106

12.52

101.40

2.1

1.3

1.90

0.29

nmol/l

5.10

101

Anxiety disorders, excluding more controls

1284

4421

1.95

98.73

1.5

1.4

0.37

0.43

nmol/l

1.07

1009

3477

Pain and other conditions associated with female genital organs and menstrual cycle

422

1325

3.14

98.60

1.4

1.3

0.45

0.32

nmol/l

1.42

357

969

Neurotic, stress-related and somatoform disorders

1420

5454

1.87

98.41

1.5

1.4

0.38

0.42

nmol/l

0.60

1128

4286

Anxiety disorders

1423

5456

1.87

98.15

1.5

1.4

0.38

0.42

nmol/l

0.61

1130

4288

Hyperprolactinaemia

180

324

6.24

97.78

1.5

1.3

0.31

0.49

nmol/l

2.12

139

268

Depression

1446

5483

1.84

93.62

1.5

1.4

0.39

0.41

nmol/l

0.21

1134

4342

Mood disorders

1477

5505

1.78

85.77

1.5

1.4

0.39

0.41

nmol/l

0.21

1152

4357

Mood [affective] disorders

1474

5507

1.78

85.34

1.5

1.4

0.39

0.41

nmol/l

0.22

1149

4359

Polycystic ovarian syndrome

281

804

3.83

84.97

1.9

1.4

0.58

nmol/l

0.00

248

686

Other antidepressants

1418

4101

1.82

84.25

1.5

0.33

0.44

nmol/l

3.87

1091

3310

Anxiety (asthma-related co-morbidities)

1121

4721

1.90

82.58

1.5

1.4

0.41

0.43

nmol/l

0.34

915

3754

Hypothyroidism, strict autoimmune

1164

4130

1.89

81.63

1.5

1.4

0.48

0.43

nmol/l

0.49

921

3311

Primary ovarian failure

125

190

7.75

81.20

1.8

1.3

0.23

0.49

nmol/l

2.26

156

Female infertility, tubal origin

163

314

5.53

81.16

1.6

1.3

0.74

0.31

nmol/l

3.68

149

223

Mood disorders, excluding more controls

1315

4459

1.81

79.80

1.5

1.4

0.37

0.43

nmol/l

1.00

1018

3509

All anxiety disorders

1145

5091

1.84

76.21

1.5

1.4

0.40

0.43

nmol/l

0.37

938

4051

Used for control exclusion in common control thyroid runs

1514

4475

1.73

75.43

1.6

1.4

0.39

0.41

nmol/l

0.30

1194

3615

Depression medications

681

1525

2.28

72.99

1.5

1.4

0.38

0.52

nmol/l

1.92

530

1307

Gender identity disorders

129

9.10

72.53

2.2

1.7

0.26

0.36

nmol/l

0.95

114

Oligomenorrhoea

111

173

6.84

68.83

1.7

1.5

0.26

0.27

nmol/l

0.11

134

Polyp of the female genital tract

446

1007

2.62

66.66

1.5

1.3

0.46

0.32

nmol/l

3.06

348

685

Endometriosis of rectovaginal septum and vagina

150

331

4.70

63.25

1.6

1.4

0.54

0.31

nmol/l

3.05

124

247

Personal history of malignant neoplasm

103

169

6.51

60.81

1.7

1.5

0.29

0.33

nmol/l

0.20

131

Other menopausal disorders

386

842

2.69

60.47

1.3

0.30

0.29

nmol/l

0.17

281

561

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

293

899

2.89

59.47

1.6

1.3

0.23

0.32

nmol/l

2.33

203

687

Behavioural syndromes associated with physiological disturbances and physical factors

652

3349

1.99

56.82

1.7

1.5

0.35

0.45

nmol/l

1.70

532

2733

Benign neoplasms

1189

4004

1.70

56.77

1.5

1.4

0.41

0.46

nmol/l

0.85

968

3367

GASTRO-related operations

1312

4001

1.66

56.27

1.5

1.4

0.41

0.43

nmol/l

0.18

1045

3246

Any gastric operation

1312

4001

1.66

56.27

1.5

1.4

0.41

0.43

nmol/l

0.18

1045

3246

Ovarian hyperstimulation (induction)

100

177

6.48

55.77

2.2

1.3

1.98

0.32

nmol/l

4.88

145

Any reimbursement code in KELA

1132

3325

1.72

55.64

1.5

0.36

0.48

nmol/l

3.75

873

2805

Dysplasia of cervi uteri

380

1228

2.44

52.89

1.5

1.3

0.49

0.34

nmol/l

2.47

310

875

Use of cabergoline

9.00

52.02

1.6

0.37

0.39

nmol/l

0.09

KRA_PSY_EATING, excluding more controls

311

1247

2.61

50.72

1.7

1.5

0.26

0.48

nmol/l

8.71

250

1062

Depression or dysthymia

804

2474

1.83

50.17

1.5

1.4

0.34

0.44

nmol/l

1.73

619

1962

Hypothyroidism, strict autoimmune, 3 medication purchases required

1176

4978

1.63

49.76

1.5

1.4

0.47

0.43

nmol/l

0.46

930

3916

Headache

955

4759

1.69

49.05

1.5

1.4

0.33

0.46

nmol/l

6.05

749

3815

Hypertrophy of breast in women and men

368

1615

2.33

48.69

1.4

0.31

0.40

nmol/l

0.91

286

1211

Selective serotonin reuptake inhibitors

1250

4124

1.61

48.02

1.5

0.34

0.44

nmol/l

2.79

957

3328

Habitual aborter

130

6.59

46.77

1.6

1.4

0.76

0.35

nmol/l

1.33

108

Adrenocortical insufficiency

150

5.99

46.57

1.8

1.4

0.33

0.38

nmol/l

0.32

124

Other anxiety disorders

849

4467

1.71

45.18

1.5

0.39

0.45

nmol/l

0.86

709

3618

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

215

722

2.90

44.81

1.3

0.35

0.39

nmol/l

0.36

142

534

Primary_lymphoid and hematopoietic malignant neoplasms

176

551

3.23

44.75

1.7

1.4

0.30

nmol/l

0.00

146

423

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

132

344

3.90

44.53

1.7

1.4

0.26

0.31

nmol/l

0.48

110

278

General symptoms and signs

1480

4914

1.52

44.17

1.5

1.4

0.30

0.45

nmol/l

11.71

1131

3946

Other disorders of adrenal gland

101

219

4.84

43.85

1.7

1.4

0.31

0.41

nmol/l

0.59

175

Anorexia (incl.atypical)

204

723

2.97

42.78

1.8

1.5

0.25

0.47

nmol/l

3.97

160

610

Medical observation and evaluation for suspected diseases and conditions

921

2843

1.67

41.17

1.6

1.4

0.34

0.42

nmol/l

1.35

726

2266

Menorrhagia

435

1144

2.13

41.10

1.4

1.3

0.36

0.33

nmol/l

0.58

335

796

Eating disorder

312

1382

2.36

41.09

1.7

1.6

0.26

0.49

nmol/l

9.12

251

1170

Endometriosis ASRM stages 3,4

436

2189

2.03

40.93

1.5

1.4

0.59

0.48

nmol/l

1.42

370

1708

Eating disorders

320

1458

2.27

39.18

1.7

1.5

0.26

0.49

nmol/l

7.28

255

1235

Endometriosis of intestine

6.96

38.63

1.5

1.4

0.58

0.29

nmol/l

1.69

Hodgkin lymphoma

111

6.27

38.01

1.7

1.5

0.39

0.38

nmol/l

0.04

101

Psychiatric diseases

1322

4452

1.50

36.86

1.5

1.4

0.38

0.42

nmol/l

0.80

1010

3502

Other diseases of hard tissues of teeth

795

3673

1.63

34.64

1.5

0.44

0.40

nmol/l

0.33

625

2908

Deep endometriosis

207

825

2.59

34.31

1.6

1.4

0.56

0.47

nmol/l

0.85

177

680

Any mental disorder

1313

4485

1.47

34.16

1.5

1.4

0.37

0.43

nmol/l

1.02

1003

3529

Pain in joint

740

2987

1.65

33.64

1.5

0.32

0.42

nmol/l

2.65

560

2407

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

198

4.41

33.60

3.1

1.4

0.16

0.34

nmol/l

3.86

156

Primary_lymphoid and hematopoietic malignant neoplasms

176

661

2.69

32.43

1.7

1.4

0.30

0.27

nmol/l

0.20

146

496

Adenomyosis (Endometriosis of uterus)

152

541

2.86

31.19

1.5

1.3

0.50

0.32

nmol/l

1.37

123

368

Hodgkin lymphoma, hilmo

134

5.18

31.09

1.7

1.5

0.39

0.34

nmol/l

0.23

109

Benign neoplasms

1294

5048

1.44

30.53

1.5

1.4

0.40

0.43

nmol/l

0.34

1037

4067

Anaemias

373

1272

1.97

30.39

1.5

1.4

0.39

0.55

nmol/l

2.79

305

1089

Diabetes insipidus

10.21

29.69

2.6

1.4

0.25

0.30

nmol/l

0.28

Supervision of high-risk pregnancy

531

1857

1.77

29.44

1.5

1.4

0.51

0.34

nmol/l

2.20

430

1393

Lymphoid leukaemia

101

5.57

28.72

1.8

1.5

0.22

0.31

nmol/l

0.84

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

6.72

28.70

2.0

1.4

0.23

0.37

nmol/l

0.99

Other diseases of blood and blood-forming organs, wide

218

973

2.27

27.77

1.5

1.4

0.25

0.35

nmol/l

2.65

145

745

Fever of other and unknown origin

592

3376

1.64

27.66

1.5

0.29

0.43

nmol/l

7.42

445

2696

Agranulocytosis

136

488

2.84

27.61

1.4

0.27

0.37

nmol/l

1.28

374

Episodal and paroxysmal disorders

1427

5293

1.39

27.14

1.5

0.35

0.43

nmol/l

2.10

1114

4252

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

129

453

2.87

27.08

1.6

1.3

0.18

0.26

nmol/l

2.16

346

Acromegaly and pituitary gigantism

13.07

26.95

2.0

1.3

0.36

0.35

nmol/l

0.03

Ovarian dysfunction, other/unspecified

9.04

26.80

1.6

1.3

0.25

0.53

nmol/l

1.41

Migraine, single triptan purchase ok & required. ICD-code if available is included

1117

5313

1.43

26.71

1.4

1.5

0.47

0.40

nmol/l

0.92

870

4198

Triptan medication for migraine, single purchase ok

1117

5313

1.43

26.71

1.4

1.5

0.47

0.40

nmol/l

0.92

870

4198

Complications of procedures, not elsewhere classified

858

4986

1.50

26.69

1.4

0.35

0.42

nmol/l

1.85

646

3898

Carcinoma in situ of breast, intraductal

244

3.64

26.64

1.2

1.3

0.44

0.33

nmol/l

0.57

178

Drug-induced neutropenia

287

3.36

25.34

1.4

1.5

0.28

0.31

nmol/l

0.18

212

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

138

513

2.67

25.13

2.4

1.3

0.21

0.43

nmol/l

4.54

382

Dental caries 2

1047

5805

1.43

25.07

1.5

0.55

0.39

nmol/l

2.74

848

4568

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1259

5182

1.39

24.89

1.6

1.4

0.35

0.41

nmol/l

1.14

1010

4074

Cystitis

1158

5082

1.40

24.09

1.5

1.4

0.42

0.43

nmol/l

0.06

916

4005

Hypertrichosis

273

3.48

23.76

1.6

1.4

0.41

0.49

nmol/l

0.26

232

Endometriosis ASRM stages 1,2

364

2065

1.80

23.75

1.4

0.55

0.48

nmol/l

0.72

304

1613

Hirsutism in women

244

3.66

23.71

1.5

1.4

0.42

0.49

nmol/l

0.20

209

Rare circulating lymphoid malignancy

5.54

23.69

2.0

1.4

0.23

0.33

nmol/l

0.72

First line medication for Crohn's disease

1361

5470

1.36

23.57

1.5

1.4

0.33

0.43

nmol/l

5.40

1020

4410

Complications of medical and surgical care

717

4547

1.51

23.46

1.4

0.36

0.40

nmol/l

1.03

540

3505

Neurological diseases

1239

4528

1.39

23.22

1.5

0.37

0.44

nmol/l

1.53

982

3651

Abdominal and pelvic pain

1150

4156

1.40

22.78

1.4

1.5

0.41

0.39

nmol/l

0.18

893

3304

Other noninflammatory disorders of vulva and perineum

118

437

2.75

22.65

1.4

0.36

0.32

nmol/l

0.44

311

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

574

3677

1.57

22.60

1.4

0.37

0.40

nmol/l

0.48

431

2834

Malaise and fatigue

441

2203

1.68

22.53

1.5

1.4

0.28

0.45

nmol/l

7.53

330

1736

Lymphoid leukaemia

125

4.49

22.50

1.8

1.6

0.22

0.29

nmol/l

0.66

Other eating disorders

163

714

2.38

22.38

1.7

1.5

0.25

0.47

nmol/l

5.30

136

608

Any operation in hilmo

4.73

22.31

1.6

1.2

0.32

0.27

nmol/l

0.23

Family history of malignant neoplasm

190

885

2.20

22.14

1.4

0.36

0.44

nmol/l

0.83

145

685

Parasetamol

1109

4072

1.40

22.02

1.5

0.42

0.41

nmol/l

0.06

866

3339

Deposits [accretions] on teeth

321

3.02

22.00

1.6

0.25

0.33

nmol/l

0.84

249

Malignant neoplasm of breast, HER-negative

151

637

2.39

21.95

1.3

0.31

0.37

nmol/l

0.49

449

Opioids

1290

5002

1.36

21.92

1.5

1.4

0.39

0.43

nmol/l

0.75

1005

4020

Autoimmune diseases

1336

5062

1.35

21.89

1.5

1.4

0.42

0.40

nmol/l

0.33

1059

4044

Dental caries 2, only avohilmo

1025

5839

1.39

21.55

1.5

0.56

0.39

nmol/l

2.90

831

4598

Migraine

823

4884

1.45

21.45

1.4

1.5

0.38

0.45

nmol/l

1.18

656

3928

Leiomyoma of uterus

572

2053

1.58

21.37

1.3

0.44

0.46

nmol/l

0.18

427

1641

Nonorganic sleeping disorders, excluding more controls

274

1477

1.88

21.06

1.8

1.4

0.42

0.45

nmol/l

0.14

230

1198

Symptoms and signs involving the digestive system and abdomen

1138

4156

1.38

20.81

1.4

1.5

0.41

0.39

nmol/l

0.23

883

3304

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

528

3405

1.56

20.56

1.4

0.38

0.41

nmol/l

0.39

397

2601

Dental caries 2 and operation codes

1010

5842

1.38

20.29

1.4

1.5

0.56

0.39

nmol/l

2.82

818

4603

Chronic diseases of tonsils and adenoids

1030

4735

1.38

20.23

1.5

1.4

0.40

0.41

nmol/l

0.06

838

3732

Dermatitis and eczema

1217

5957

1.35

20.11

1.5

1.4

0.36

0.41

nmol/l

1.62

943

4731

Secondary and unspecified malignant neoplasm of lymph nodes

230

3.32

20.09

1.7

1.5

0.31

0.28

nmol/l

0.29

183

Persons encountering health services in other circumstances, wide

1329

5187

1.33

20.00

1.6

1.4

0.35

0.41

nmol/l

1.25

1043

4079

Persons encountering health services in circumstances related to reproduction

622

2802

1.51

19.90

1.5

0.38

0.28

nmol/l

1.36

490

2109

Examination and observation for other reasons

688

2835

1.48

19.62

1.4

0.47

0.42

nmol/l

0.45

532

2260

Endocrine disorders, other/unspecified

100

4.72

19.16

1.6

1.3

0.38

0.40

nmol/l

0.09

Drug-induced adrenocortical insufficiency

5.49

19.15

1.5

1.4

0.38

0.28

nmol/l

0.53

Complications of surgical and medical care, not elsewhere classified

1006

5295

1.37

18.90

1.4

0.36

0.42

nmol/l

1.30

755

4162

248

3.27

18.88

1.4

1.5

0.47

0.50

nmol/l

0.08

210

Acute lymphocytic leukaemia, excluding all cancers (controls excluding all cancers)

7.16

18.86

1.7

1.5

0.26

0.43

nmol/l

0.77

Acute lymphocytic leukaemia, helper endpoint

7.16

18.86

1.7

1.5

0.26

0.43

nmol/l

0.77

Sleep disorders

306

1770

1.75

18.65

1.7

1.5

0.43

0.45

nmol/l

0.07

258

1423

Acute upper respiratory infections

1166

5477

1.34

18.63

1.4

0.35

0.42

nmol/l

2.66

889

4338

Symptoms and signs involving the circulatory and respiratory systems

1353

5174

1.32

18.41

1.5

0.37

0.43

nmol/l

1.68

1038

4170

Other endocrine disorders

301

2.89

18.28

1.7

1.4

0.31

0.39

nmol/l

0.66

242

Acute lymphocytic leukaemia

6.86

18.14

1.7

1.5

0.26

0.37

nmol/l

0.45

Pregnancy examination and test

436

1712

1.62

18.03

1.6

1.5

0.63

0.35

nmol/l

4.91

366

1316

Routine general health check-up of defined subpopulation

196

3.44

17.53

1.8

1.5

0.39

0.38

nmol/l

0.03

152

General examination and investigation of persons without complaint and reported diagnosis

760

2843

1.43

17.52

1.5

1.4

0.35

0.42

nmol/l

0.91

582

2266

Secondary uncertain malignant neoplasm

314

2.77

17.01

1.7

1.5

0.29

0.26

nmol/l

0.32

248

Benzodiazepine use

1067

5719

1.33

16.95

1.5

1.4

0.36

0.42

nmol/l

1.13

809

4532

Postprocedural endocrine and metabolic disorders, not elsewhere classified

176

885

2.02

16.80

1.7

1.4

0.32

0.41

nmol/l

1.20

138

682

Other metabolic disorders

183

935

1.99

16.68

1.7

1.4

0.32

0.40

nmol/l

1.25

143

718

Other reaction to severe stress, and adjustment disorders

559

3832

1.47

16.53

1.5

1.4

0.37

0.45

nmol/l

1.94

446

3063

Disorders of adult personality and behaviour

455

2996

1.54

16.45

1.6

1.5

0.34

0.43

nmol/l

0.98

360

2420

Sleep disorders (combined)

966

4714

1.35

16.38

1.5

1.4

0.33

0.40

nmol/l

1.33

738

3654

Use of hypnotics and sedatives

1084

4736

1.33

16.28

1.5

1.4

0.33

0.43

nmol/l

3.99

834

3696

Other diseases of urinary system

1217

5265

1.31

16.07

1.5

1.4

0.42

nmol/l

0.04

955

4165

Cushing syndrome

6.07

15.61

3.2

1.4

0.23

0.44

nmol/l

0.99

Impotence

5.42

15.43

2.7

1.3

0.13

0.12

nmol/l

0.27

Benign neoplasm of ovary

133

622

2.16

15.34

1.8

1.3

0.47

0.43

nmol/l

0.16

469

Pain (limb, back, neck, head abdominally)

827

3023

1.38

15.23

1.5

0.41

0.42

nmol/l

0.13

646

2436

Hypothyroidism, drug reimbursement

205

793

1.87

14.78

1.5

1.4

0.33

0.54

nmol/l

3.24

159

682

Other noninflammatory disorders of uterus, except cervix

150

494

2.09

14.76

1.3

1.4

0.27

0.25

nmol/l

0.17

116

309

Carcinoma in situ of breast, intraductal

345

2.57

14.74

1.2

1.4

0.44

0.29

nmol/l

0.86

232

Other noninflammatory disorders of vagina

339

2.58

14.74

1.9

1.3

0.40

0.29

nmol/l

0.90

246

Other special examinations and investigations of persons without complaint or reported diagnosis

773

2844

1.38

14.62

1.5

1.4

0.38

0.42

nmol/l

0.41

603

2266

Dental caries

260

1526

1.70

14.54

1.5

0.35

0.41

nmol/l

0.29

210

1214

Other abnormal products of conception

726

3550

1.38

13.96

1.5

1.4

0.56

0.45

nmol/l

1.86

592

2828

Postmenopausal bleeding

197

579

1.88

13.84

1.3

0.19

0.23

nmol/l

0.81

135

345

Conjunctivitis

910

6048

1.32

13.80

1.5

1.4

0.42

0.41

nmol/l

0.09

748

4751

Certain infectious and parasitic diseases

1219

4780

1.28

13.79

1.5

1.4

0.35

0.43

nmol/l

2.67

921

3836

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

821

5045

1.34

13.58

1.5

1.4

0.49

0.45

nmol/l

0.50

652

3953

Neurological diseases, wide definition

568

1993

1.44

13.55

1.5

0.41

0.45

nmol/l

0.28

450

1638

Nonorganic sleeping disorders

274

1682

1.65

13.54

1.8

1.5

0.42

0.44

nmol/l

0.06

230

1347

In situ neoplasms

281

1649

1.64

13.53

1.3

1.4

0.42

0.47

nmol/l

0.48

203

1336

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

542

1883

1.45

13.52

1.5

0.37

0.45

nmol/l

1.09

426

1536

Disorders of conjunctiva

949

6110

1.31

13.48

1.5

1.4

0.42

0.41

nmol/l

0.08

775

4803

189

1050

1.83

13.42

1.8

1.4

0.40

0.44

nmol/l

0.23

148

829

Symptoms and signs involving the nervous and musculoskeletal systems

517

3634

1.43

13.35

1.4

1.5

0.36

0.40

nmol/l

0.54

383

2821

Triptan medication for migraine, min. 3 purchases

904

5467

1.31

13.19

1.4

0.43

0.44

nmol/l

0.15

714

4332

Abnormalities of heart beat

343

2209

1.55

13.18

1.5

0.31

0.42

nmol/l

3.13

272

1757

Sleep apnoea, including avohilmo

843

4130

1.33

13.12

1.5

1.4

0.28

0.38

nmol/l

3.23

625

3147

Other disorders of lacrimal gland

312

1993

1.58

12.99

1.4

0.30

0.38

nmol/l

1.59

224

1505

Other other unspecified disorders of the circulatory system

109

3.75

12.98

1.4

1.3

0.21

0.27

nmol/l

0.22

Other symptoms and signs involving the digestive system and abdomen

171

930

1.86

12.96

1.8

1.5

0.33

0.39

nmol/l

0.45

140

712

Codeine

1136

4896

1.28

12.96

1.5

1.4

0.39

0.44

nmol/l

0.89

887

3926

Diabetes, insulin treatment (Kela reimbursement)

518

4456

0.71

12.89

1.4

0.26

0.37

nmol/l

4.18

377

3411

Disorders of puberty, all

161

3.27

12.74

2.0

1.6

0.34

0.32

nmol/l

0.05

136

Other abnormal uterine and vaginal bleeding

174

669

1.87

12.72

1.3

1.4

0.34

0.32

nmol/l

0.22

129

450

Nausea and vomiting

253

1518

1.65

12.71

1.5

0.40

0.39

nmol/l

0.06

190

1214

Diseases of male genital organs

201

559

1.82

12.68

1.7

1.5

0.12

0.13

nmol/l

0.69

162

464

Melanocytic naevi

298

1895

1.59

12.68

1.5

0.39

0.47

nmol/l

0.77

242

1541

Non-selective monoamine reuptake inhibitors

263

1582

1.62

12.33

1.5

1.4

0.33

0.37

nmol/l

0.36

191

1192

Disorders of puberty

119

3.62

12.29

1.9

1.4

0.32

0.37

nmol/l

0.24

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

390

2444

1.48

12.26

1.5

1.4

0.25

0.34

nmol/l

3.31

290

1822

Other headache syndromes

507

3624

1.41

12.05

1.4

0.32

0.43

nmol/l

3.05

370

2851

Pain, not elsewhere classified

289

1848

1.58

12.03

1.5

1.4

0.39

0.49

nmol/l

0.91

222

1477

Persons encountering health services in other circumstances

420

2903

1.46

11.97

1.5

1.4

0.31

0.43

nmol/l

3.21

339

2302

Personality disorders, excluding more controls

367

2478

1.49

11.91

1.5

1.4

0.36

0.48

nmol/l

1.02

287

2021

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

516

4372

0.72

11.88

1.4

0.26

0.37

nmol/l

4.13

375

3341

Dentinal caries

218

1299

1.68

11.84

1.5

0.27

0.41

nmol/l

2.93

176

1023

Oxycodone

191

1065

1.74

11.81

1.5

1.4

0.22

0.31

nmol/l

2.13

127

774

Irritable bowel syndrome

329

2183

1.52

11.62

1.5

1.4

0.37

0.44

nmol/l

1.19

266

1697

Antihypertensive medication - note that there are other indications

1070

4626

1.27

11.61

1.5

0.39

0.46

nmol/l

1.53

869

3769

Torsion of ovary, ovarian pedicle and fallopian tube

109

3.59

11.52

1.3

1.4

0.48

0.24

nmol/l

1.95

Postmenopausal atrophic vaginitis

183

623

1.78

11.13

1.3

1.4

0.23

0.25

nmol/l

0.24

124

380

Special screening examination for infectious and parasitic diseases

438

2301

1.43

11.10

1.7

1.4

0.44

0.47

nmol/l

0.38

389

1888

Coxibs

306

1051

1.56

10.98

1.6

1.5

0.31

0.42

nmol/l

1.95

254

879

Other symptoms and signs involving the nervous and musculoskeletal systems

409

2864

1.44

10.95

1.4

1.5

0.38

0.42

nmol/l

0.34

296

2235

Male infertility

3.62

10.92

1.6

1.4

0.12

nmol/l

0.01

Spontaneous abortion

730

3798

1.32

10.70

1.5

1.4

0.54

0.44

nmol/l

1.31

570

3003

Benign leiomyoma with endometriosis

109

545

2.02

10.69

1.3

0.59

0.40

nmol/l

0.89

408

Other diseases of upper respiratory tract

1150

4823

1.25

10.60

1.5

1.4

0.41

nmol/l

0.05

893

3801

Temporomandibular joint disorders

217

1340

1.64

10.58

1.4

1.5

0.35

0.45

nmol/l

1.29

165

1074

Symptoms and signs involving the skin and subcutaneous tissue

660

4992

1.32

10.58

1.4

1.5

0.36

0.42

nmol/l

0.53

513

3877

Intestinal infectious diseases

978

6065

1.26

10.46

1.5

1.4

0.38

0.41

nmol/l

0.39

777

4821

Allergic conjunctivitis

722

5479

1.30

10.45

1.5

1.4

0.44

0.43

nmol/l

0.12

595

4284

Asthma (mode)

892

3840

1.28

10.36

1.5

1.4

0.41

0.42

nmol/l

0.04

686

3067

Other disorders of fluid, electrolyte and acid-base balance

158

866

1.77

10.34

1.7

1.4

0.26

0.31

nmol/l

0.54

121

631

Cerebral cysts

375

2.23

10.28

1.4

1.5

0.33

0.38

nmol/l

0.50

313

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

128

3.16

10.16

1.3

1.5

0.36

0.34

nmol/l

0.05

103

Dental caries 2 and operation codes, only avohilmo

813

3934

1.29

10.11

1.4

1.5

0.55

0.38

nmol/l

2.59

643

3107

Uterine polyps

397

2.17

10.04

1.4

0.50

0.26

nmol/l

1.74

258

Inflammatory diseases of prostate (prostatitis)

161

2.87

9.99

1.5

1.4

0.10

0.12

nmol/l

0.79

136

Codeine or tramadol medication

1233

5579

1.23

9.98

1.5

1.4

0.38

0.42

nmol/l

0.82

960

4430

Acetic acid derivatives and related substances

300

1026

1.53

9.97

1.5

0.46

0.43

nmol/l

0.22

248

858

Symptoms and signs concerning food and fluid intake

411

2.14

9.95

1.7

1.5

0.23

0.41

nmol/l

2.88

330

Benign neoplasm: Cerebral meninges

224

2.57

9.94

1.4

1.3

0.28

0.30

nmol/l

0.10

176

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

694

5270

1.30

9.94

1.5

1.4

0.45

0.43

nmol/l

0.15

574

4120

Other soft tissue disorders, not elsewhere classified

1038

5156

1.25

9.94

1.4

1.5

0.40

0.43

nmol/l

0.36

784

4185

Emotional disorders starting during childhood or adolecense, excluding more controls

101

497

2.04

9.92

1.4

1.5

0.28

0.44

nmol/l

2.41

421

Benign neoplasm of meninges

243

2.49

9.83

1.4

1.3

0.27

0.29

nmol/l

0.07

192

Generalized anxiety disorder

263

1731

1.54

9.83

1.4

1.5

0.37

0.44

nmol/l

0.65

225

1427

Asthma, including avohilmo

1256

5989

1.22

9.81

1.4

1.5

0.40

0.41

nmol/l

0.10

977

4760

Polyuria

138

768

1.81

9.81

1.5

1.4

0.24

0.34

nmol/l

1.99

114

604

Panic disorder

256

1678

1.54

9.75

1.6

1.5

0.32

0.45

nmol/l

2.57

204

1381

L01XE Protein kinase inhibitors

137

3.03

9.71

1.5

1.4

0.20

0.29

nmol/l

0.70

101

Disorders of lacrimal system

350

2441

1.44

9.66

1.4

0.32

0.40

nmol/l

1.23

258

1838

Benign neoplasm: Colon

205

967

1.63

9.64

1.4

1.3

0.33

0.32

nmol/l

0.06

151

739

Hyperkinetic disorders, excluding more controls

184

1088

1.67

9.64

1.6

1.5

0.28

0.46

nmol/l

4.43

158

937

Malignant neoplasm of ovary

165

2.84

9.64

3.8

1.4

0.15

0.31

nmol/l

2.45

122

Dentofacial anomalies [including malocclusion]

365

2545

1.43

9.54

1.4

1.5

0.37

0.43

nmol/l

0.70

276

2017

Disorders of tooth development and eruption

437

2.07

9.39

1.6

0.35

0.45

nmol/l

0.70

350

Hyperhidrosis

232

2.53

9.39

1.6

1.5

0.31

0.49

nmol/l

1.32

198

Excessive attrition of teeth

469

1850

1.38

9.31

1.5

1.4

0.52

0.43

nmol/l

0.60

376

1477

Other septicaemia

197

1202

1.61

9.29

1.5

1.4

0.23

0.35

nmol/l

3.56

156

911

Insomnia

211

1342

1.59

9.19

1.8

1.5

0.37

0.42

nmol/l

0.39

178

1067

Other dorsopathies, not elsewhere classified

1195

5180

1.22

9.12

1.5

0.36

0.43

nmol/l

1.46

924

4168

Benign neoplasm of colon, rectum, anus and anal canal

253

1182

1.53

9.12

1.5

1.3

0.32

0.33

nmol/l

0.09

186

914

Asthma, excluding more controls

892

3787

1.26

9.10

1.5

1.4

0.42

nmol/l

0.03

685

3026

Asthma

894

3822

1.26

9.08

1.5

1.4

0.42

nmol/l

0.02

687

3056

Soft tissue disorders

1224

5238

1.22

9.07

1.4

1.5

0.39

0.42

nmol/l

0.51

930

4253

Other complications of surgical and medical care, not elsewhere classified

102

532

1.94

8.98

1.4

1.5

0.41

0.35

nmol/l

0.13

423

Other functional intestinal disorders

361

2444

1.41

8.92

1.6

1.5

0.38

0.39

nmol/l

0.07

288

1860

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

347

2.16

8.72

1.7

1.4

0.25

0.39

nmol/l

1.54

286

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

449

3257

1.36

8.66

1.4

0.30

0.37

nmol/l

2.29

343

2511

Abnormal findings in secretions and smears from cervix uteri vagina vulva

780

4881

1.26

8.62

1.5

1.4

0.51

0.46

nmol/l

0.57

621

3823

Sleep apnoea

714

3800

1.28

8.61

1.5

1.4

0.29

0.36

nmol/l

1.67

522

2857

Diseases of the eye and adnexa

1127

4642

1.22

8.51

1.5

0.42

nmol/l

0.04

888

3724

Temporomandibular joint disorders, including avohilmo

622

4838

1.29

8.50

1.5

0.44

nmol/l

0.01

488

3878

Hypo-osmolality and hyponatraemia

389

2.06

8.47

1.7

1.5

0.25

0.26

nmol/l

0.12

283

Secondary polycythaemia

3.82

8.39

1.4

1.5

0.24

0.30

nmol/l

0.36

Malignant neoplasm of mesothelium and soft tissue

3.42

8.37

1.3

1.5

0.28

0.32

nmol/l

0.12

Disorders of parathyroid gland

100

524

1.89

8.31

1.5

1.4

0.31

0.27

nmol/l

0.37

375

Bronchitis

1111

6038

1.21

8.12

1.5

1.4

0.34

0.42

nmol/l

3.16

865

4789

Acute upper respiratory infections of multiple and unspecified sites

859

5212

1.24

8.07

1.5

1.4

0.32

0.44

nmol/l

3.99

672

4154

Chronic rhinitis, nasopharyngitis and pharyngitis

317

2249

1.42

8.07

1.5

0.35

0.40

nmol/l

0.59

255

1740

Congenital malformations, deformations and chromosomal abnormalities

751

5763

1.25

8.07

1.5

0.40

0.42

nmol/l

0.27

618

4590

Parodontitis or/and operation codes

402

3221

0.74

7.89

1.4

0.43

0.40

nmol/l

0.13

290

2502

Gastrointestinal diseases

906

3682

1.24

7.88

1.5

0.39

0.44

nmol/l

0.52

724

2953

Bacterial infection, other or unspecified

298

1888

1.43

7.87

1.5

1.4

0.25

0.36

nmol/l

3.29

211

1438

Certain disorders involving the immune mechanism

157

968

1.63

7.82

1.6

1.4

0.28

0.35

nmol/l

0.61

123

725

Direct fill therapy

132

779

1.71

7.79

1.5

0.26

0.36

nmol/l

1.63

106

612

Fenamates

181

768

1.60

7.79

1.5

0.33

0.46

nmol/l

2.00

150

634

Diseases of oral cavity, salivary glands and jaws

891

3708

1.24

7.74

1.4

1.5

0.37

0.40

nmol/l

0.62

699

2934

Abnormal results of function studies

412

1.99

7.74

1.7

1.5

0.26

0.33

nmol/l

0.55

323

Septicaemia

218

1393

1.51

7.73

1.4

0.23

0.37

nmol/l

4.49

169

1055

Factors influencing health status and contact with health services

255

859

1.49

7.68

1.5

1.4

0.28

0.27

nmol/l

0.09

209

674

Thyroiditis, ILD-related definition

153

945

1.64

7.64

1.6

1.5

0.44

nmol/l

0.01

121

751

Other specific joint derangements/joint disorders

914

5020

1.23

7.61

1.4

1.5

0.33

0.44

nmol/l

4.37

705

4039

Dorsopathies

1218

5212

1.20

7.58

1.5

0.38

0.43

nmol/l

0.97

950

4195

Persons encountering health services for examination and investigation

715

2844

1.26

7.55

1.5

1.4

0.39

0.42

nmol/l

0.30

577

2266

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

249

2.26

7.53

1.8

1.4

0.24

0.27

nmol/l

0.22

199

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

314

2.11

7.51

1.5

1.3

0.18

0.25

nmol/l

1.37

240

ILD differential diagnosis

937

3840

1.23

7.50

1.5

1.4

0.44

0.42

nmol/l

0.18

719

3067

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

225

2.33

7.48

1.9

1.5

0.22

0.36

nmol/l

2.04

190

Other congenital malformations

127

752

1.71

7.47

1.7

1.5

0.57

0.43

nmol/l

0.36

103

604

COPD differential diagnosis

937

3842

1.23

7.46

1.5

1.4

0.43

0.42

nmol/l

0.17

719

3069

Excluding asthma or asthma-COPD overlap

941

3862

1.22

7.43

1.5

1.4

0.44

0.42

nmol/l

0.18

721

3088

Hard cardiovascular diseases

202

1942

0.67

7.41

1.4

0.19

0.28

nmol/l

4.16

141

1407

Asthma (only as main-diagnosis)

785

3822

1.24

7.41

1.4

0.43

0.42

nmol/l

0.08

599

3056

Obsessive-compulsive disorder

125

742

1.72

7.35

1.6

1.5

0.46

nmol/l

0.02

104

624

Non-follicular lymphoma, hilmo, excluding all cancers

155

2.60

7.27

1.9

1.4

0.19

0.30

nmol/l

1.35

122

Hyperparathyroidism

423

1.93

7.23

1.5

1.3

0.33

0.25

nmol/l

0.62

297

Visual disturbances and blindness

411

3096

1.33

7.22

1.6

1.5

0.38

0.39

nmol/l

0.15

312

2405

Tramadol

699

3597

1.25

7.18

1.5

1.4

0.33

0.41

nmol/l

1.72

530

2804

Monoamine oxidase A inhibitors

494

1.86

7.16

1.3

1.4

0.40

0.38

nmol/l

0.06

379

Somatoform disorder

185

1214

1.54

7.12

1.5

0.29

0.44

nmol/l

3.30

138

952

Oedema, not elsewhere classified

207

1382

1.50

7.09

1.4

0.35

0.42

nmol/l

0.85

155

1067

Asthma (only as main-diagnosis), excluding more controls

784

3787

1.24

7.09

1.4

0.43

0.42

nmol/l

0.06

598

3026

Diseases of the skin and subcutaneous tissue

1124

4721

1.20

7.09

1.5

1.4

0.38

0.43

nmol/l

0.89

873

3759

Tonsillectomy and adenotomy

915

5271

1.21

7.05

1.5

0.44

0.43

nmol/l

0.03

763

4212

Benign neoplasm: Colon, unspecified

424

1.91

6.99

1.4

1.3

0.31

0.24

nmol/l

0.47

315

Brain meningioma, excluding all cancers (controls excluding all cancers)

124

2.77

6.97

1.3

0.22

0.34

nmol/l

1.14

malignant neoplasm of female genital organs

477

1.86

6.96

2.6

1.3

0.22

0.31

nmol/l

1.28

335

Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)

4.65

6.96

2.0

1.7

0.14

0.15

nmol/l

0.11

Other/unspecified dorsalgia

350

2579

1.36

6.92

1.5

0.33

0.42

nmol/l

1.95

256

2019

Other general symptoms and signs

309

2.08

6.91

1.6

1.4

0.24

0.46

nmol/l

2.85

253

Other obstetric conditions, not elsewhere classified

797

4236

1.23

6.91

1.4

1.5

0.64

0.45

nmol/l

2.84

662

3457

Deviated nasal septum

200

1340

1.50

6.91

1.4

0.23

0.34

nmol/l

3.48

161

1038

Other pulmonary diagnosis

934

3862

1.21

6.89

1.5

1.4

0.44

0.42

nmol/l

0.18

716

3088

Melanocytic naevi of trunk

110

641

1.73

6.87

1.4

0.43

0.47

nmol/l

0.15

532

Other CVD

415

1.91

6.86

1.3

1.5

0.25

nmol/l

0.03

319

Hypoplasia of dental enamel , including avohilmo

252

2.22

6.84

1.7

0.25

0.31

nmol/l

0.43

214

Postprocedural disorders of nervous system

123

742

1.68

6.83

1.3

1.5

0.42

0.45

nmol/l

0.20

102

606

Enlarged lymph nodes

137

849

1.63

6.75

1.4

0.26

0.46

nmol/l

4.12

113

660

Bulimia nervosa (incl. atypical)

508

1.84

6.75

1.4

1.5

0.28

0.53

nmol/l

3.46

432

Benign neoplasm: Sigmoid colon

321

2.03

6.75

1.4

1.3

0.30

0.25

nmol/l

0.41

240

TMD related operations

200

1351

1.49

6.74

1.4

1.5

0.30

0.43

nmol/l

2.32

150

1047

Visual disturbances

390

2948

1.33

6.74

1.6

1.5

0.38

0.40

nmol/l

0.13

293

2296

Disorders of skin appendages

529

4163

1.28

6.72

1.5

0.39

0.42

nmol/l

0.40

437

3304

Malignant neoplasm of testis

4.78

6.72

2.1

1.6

0.14

0.15

nmol/l

0.20

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

783

4164

1.23

6.72

1.4

1.5

0.64

0.45

nmol/l

2.69

653

3413

Molar incisor enamel hypoplasia

266

2.16

6.64

1.7

1.6

0.25

0.33

nmol/l

0.75

226

Haemorrhage from respiratory passages

168

1014

1.54

6.63

1.5

0.21

0.34

nmol/l

3.72

130

784

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

163

2.48

6.61

2.0

1.5

0.22

0.35

nmol/l

1.72

140

Disorders of mineral metabolism

304

2.06

6.61

1.2

1.5

0.30

0.29

nmol/l

0.03

232

Obesity related asthma

263

1875

1.41

6.60

1.6

1.4

0.36

nmol/l

0.02

191

1424

Specific personality disorders

330

2447

1.36

6.57

1.5

0.36

0.45

nmol/l

0.58

260

1982

Pain associated with micturition

101

583

1.75

6.54

1.4

1.5

0.30

0.39

nmol/l

0.93

457

Chromosomal abnormalities, not elsewhere classified

177

2.44

6.52

2.1

1.4

0.31

0.39

nmol/l

0.59

143

Abnormal findings on diagnostic imaging of central nervous system

273

2.13

6.51

1.3

1.5

0.29

0.35

nmol/l

0.43

221

Other nutritional deficiencies

721

5763

1.23

6.50

1.5

1.4

0.38

0.43

nmol/l

0.78

575

4547

Cluster headache, wide

254

2.17

6.47

1.4

0.24

0.37

nmol/l

1.99

207

Misadventures to patients during surgical and medical care

112

668

1.69

6.44

1.5

1.4

0.30

0.40

nmol/l

1.20

526

Diseases of the respiratory system

778

3186

1.23

6.39

1.5

1.4

0.45

0.43

nmol/l

0.20

587

2544

Explicit Sepsis

273

1887

1.39

6.38

1.4

1.5

0.26

0.40

nmol/l

4.99

211

1481

In situ neoplasms

281

2039

1.38

6.37

1.3

1.5

0.42

0.44

nmol/l

0.18

203

1574

Benign neoplasm of breast

102

595

1.73

6.37

1.4

0.31

0.48

nmol/l

2.46

475

Wide developmental disorders, excluding more controls

208

2.28

6.37

1.7

1.4

0.25

0.38

nmol/l

1.20

173

Preparation and fitting of bite rail to mouth

161

1053

1.54

6.36

1.3

1.4

0.26

0.39

nmol/l

3.81

124

811

Dorsalgia

1121

5146

1.18

6.32

1.4

1.5

0.34

0.43

nmol/l

3.12

844

4137

Psychotic depression

337

1.98

6.32

1.5

0.44

0.50

nmol/l

0.19

288

Dissociative [conversion] disorders

382

1.93

6.24

1.3

1.5

0.56

0.47

nmol/l

0.11

321

Benign neoplasm of brain and other parts of central nervous system

231

2.19

6.23

1.7

1.5

0.26

0.35

nmol/l

1.01

192

Autism spe, excluding more controls

175

2.40

6.22

1.8

1.5

0.26

0.39

nmol/l

1.11

148

Personality disorders

367

2788

1.33

6.21

1.5

0.36

0.44

nmol/l

0.62

287

2256

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

355

2441

1.34

6.21

1.5

1.6

0.30

0.44

nmol/l

5.01

294

2075

Other joint disorders

1125

5089

1.18

6.20

1.5

0.35

0.44

nmol/l

2.97

892

4091

Cardiovascular diseases

1027

4720

1.19

6.18

1.5

0.44

0.45

nmol/l

0.05

810

3866

Polyneuropathies and other disorders of the peripheral nervous system

101

592

1.71

6.18

1.7

1.4

0.28

0.27

nmol/l

0.12

443

1179

5309

1.18

6.17

1.5

1.4

0.34

0.43

nmol/l

3.66

897

4210

Cluster headache, strict

246

2.16

6.16

1.4

0.25

0.37

nmol/l

1.80

203

Post-traumatic stress disorder

162

1074

1.53

6.10

1.5

0.32

0.49

nmol/l

3.69

128

898

Other disorders of optic [2nd] nerve and visual pathways

314

2.00

6.10

1.7

1.4

0.27

0.36

nmol/l

0.70

251

Malignant melanoma, excluding all cancers (controls excluding all cancers)

390

1.88

6.09

1.3

0.27

0.30

nmol/l

0.27

308

Other maternal disorders predominantly related to pregnancy

873

4584

1.20

6.06

1.4

0.49

0.41

nmol/l

0.92

686

3567

Congenital malformations and deformations of the musculoskeletal system

129

811

1.60

5.98

1.5

0.31

0.43

nmol/l

1.45

112

656

Sleep disorders, other/unspecified

257

2.11

5.92

1.9

1.5

0.61

0.35

nmol/l

0.30

211

Disorders of ocular muscles, binocular movement, accommodation and refraction

528

4190

1.25

5.91

1.4

1.5

0.37

0.41

nmol/l

0.49

409

3340

Unspecified misadventure during surgical and medical care

217

2.19

5.90

1.4

0.35

0.31

nmol/l

0.19

171

Diarrhoea and gastroenteritis of presumed infectious origin

715

5361

1.22

5.89

1.5

0.37

0.42

nmol/l

0.90

561

4287

Persons with potential health hazards related to communicable diseases

568

4554

1.24

5.84

1.4

1.5

0.34

0.46

nmol/l

4.50

419

3740

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

3.03

5.81

1.4

1.5

0.17

0.40

nmol/l

2.33

Disturbances of skin sensation

316

2375

1.34

5.79

1.4

1.5

0.31

0.45

nmol/l

4.24

244

1883

Disorders of refraction and accommodation

313

2341

1.34

5.78

1.4

1.5

0.36

0.40

nmol/l

0.40

253

1862

Parodontitis

468

4348

0.79

5.75

1.5

1.4

0.39

0.37

nmol/l

0.15

330

3326

Benign neoplasm of colon, rectum, anus and anal canal

260

1707

1.38

5.74

1.5

1.4

0.31

0.28

nmol/l

0.30

192

1226

Other and unspecified polyneuropathies, also in other diseases

456

1.78

5.74

1.4

0.30

0.26

nmol/l

0.21

342

Parodontitis or operation codes

469

4349

0.79

5.71

1.5

1.4

0.39

0.37

nmol/l

0.15

330

3328

Fibromyalgia

126

802

1.59

5.69

1.3

1.4

0.33

0.41

nmol/l

0.77

641

Chronic periodontitis, including avohilmo

466

4341

0.79

5.68

1.5

1.4

0.39

0.37

nmol/l

0.14

329

3319

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

274

2.03

5.68

1.7

1.4

0.26

0.42

nmol/l

1.60

229

Benign neoplasm: Colon

208

1433

1.42

5.66

1.4

0.32

0.27

nmol/l

0.40

153

1020

Short stature, not elsewhere classified

147

2.42

5.64

1.9

1.4

0.26

0.39

nmol/l

1.00

123

Inflammatory diseases of female pelvic organs

845

5353

1.19

5.64

1.4

0.44

0.45

nmol/l

0.14

664

4207

Other disorders of male genital organs

3.42

5.59

1.9

1.4

0.13

0.12

nmol/l

0.08

Myalgia

249

1815

1.38

5.58

1.5

0.33

0.44

nmol/l

1.81

178

1453

Other sleep disorders

550

1.70

5.58

1.6

1.5

0.41

0.38

nmol/l

0.12

441

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

122

2.58

5.57

1.3

1.4

0.85

0.27

nmol/l

1.18

Non-follicular lymphoma

177

2.27

5.55

1.9

1.5

0.19

0.27

nmol/l

0.91

134

Oter anti-inflammatory and antirheumatic agents, non-steroids

116

393

1.64

5.51

1.6

1.4

0.29

0.46

nmol/l

1.40

310

Mouth breathing

270

1995

1.36

5.50

1.5

1.4

0.30

0.34

nmol/l

0.44

209

1502

Correction of physiology of bite - demanding therapy visit

592

1.68

5.49

1.4

1.5

0.33

0.43

nmol/l

0.81

470

Contact with and exposure to communicable diseases

510

4099

1.25

5.39

1.4

1.5

0.34

0.46

nmol/l

3.85

371

3380

Cervical disc disorders

223

1608

1.39

5.33

1.5

1.4

0.27

0.34

nmol/l

1.74

168

1188

Disorders of calcium metabolism

207

2.15

5.30

1.2

1.5

0.34

0.28

nmol/l

0.29

161

Benign neoplasm of ovary

133

871

1.54

5.28

1.8

1.4

0.47

0.37

nmol/l

0.47

619

Implicit viral Sepsis

117

744

1.58

5.28

1.4

1.5

0.23

0.34

nmol/l

2.78

599

Emotional disorders and disorders of social functioning with onset specific to childhood

107

661

1.63

5.25

1.4

1.6

0.27

0.40

nmol/l

2.06

557

Erosion of teeth, including avohilmo

234

1649

1.38

5.24

1.4

0.37

0.45

nmol/l

0.84

179

1323

Migraine with aura

361

2808

1.29

5.22

1.5

0.40

0.47

nmol/l

0.66

308

2283

Abnormal findings on diagnostic imaging of other body structures

538

1.68

5.22

1.9

1.4

0.26

0.34

nmol/l

0.83

416

Transplanted organ and tissue status

354

1.85

5.19

1.6

1.5

0.23

0.28

nmol/l

0.79

269

Atopic dermatitis

755

5413

1.19

5.17

1.5

1.4

0.40

0.44

nmol/l

0.73

608

4342

Viral Sepsis

117

748

1.57

5.17

1.4

1.5

0.23

0.34

nmol/l

2.78

602

Erosion of teeth

2.79

5.16

1.6

1.4

0.22

0.30

nmol/l

0.77

Hypoparathyroidism

109

2.60

5.15

1.6

1.4

0.36

nmol/l

0.02

Benign neoplasm: Rectum, anus and anal canal

369

1.82

5.14

1.4

1.3

0.27

0.26

nmol/l

0.05

279

Bipolar affective disorders

238

1749

1.37

5.13

1.5

0.35

0.46

nmol/l

1.57

195

1419

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

158

2.29

5.11

1.4

0.22

0.25

nmol/l

0.18

125

Benign neoplasm: Rectum

320

1.88

5.09

1.4

1.3

0.28

0.24

nmol/l

0.18

243

Arthropathies

1157

5095

1.16

5.09

1.5

0.35

0.44

nmol/l

3.56

925

4095

Osteoporosis

552

1.65

5.07

2.0

1.4

0.22

0.26

nmol/l

0.40

371

Other epidermal thickening

172

2.24

5.06

1.5

0.22

0.36

nmol/l

1.78

137

Benign neoplasm: Transverse colon

159

2.28

5.04

1.1

1.4

0.22

0.28

nmol/l

0.54

126

Influenza and pneumonia

802

6222

0.85

5.04

1.5

1.4

0.36

0.41

nmol/l

0.92

605

4941

Diabetes medication

741

5354

0.84

5.04

1.5

1.4

0.43

0.41

nmol/l

0.16

566

4167

Gingivitis and periodontal diseases

849

3706

1.19

5.00

1.4

1.5

0.41

0.40

nmol/l

0.08

661

2933

Propionic acid derivatives

310

1176

1.33

4.99

1.6

1.5

0.37

0.40

nmol/l

0.23

255

983

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

309

1.89

4.98

1.7

1.4

0.25

0.41

nmol/l

1.64

257

Benign neoplasm of other and ill-defined parts of digestive system

470

1.71

4.95

1.5

1.4

0.27

0.36

nmol/l

0.58

366

Benign lipomatous neoplasm

152

1038

1.47

4.94

1.4

1.3

0.44

0.37

nmol/l

0.20

106

809

Covid-19 confirmed case

255

1906

1.34

4.91

1.5

0.29

0.43

nmol/l

4.01

193

1529

Low back pain

756

4911

1.19

4.90

1.4

1.5

0.34

0.44

nmol/l

2.16

566

3943

Enterocolitis due to Clostridium difficile

325

1.86

4.89

1.6

1.5

0.23

0.32

nmol/l

1.28

254

Other symptoms and signs involving cognitive functions and awareness

218

1490

1.38

4.88

1.6

1.4

0.29

0.34

nmol/l

0.73

170

1110

Diabetes mellitus

767

5410

0.84

4.88

1.6

1.4

0.42

0.41

nmol/l

0.08

589

4216

Other diseases of blood and blood-forming organs

221

2.05

4.87

1.6

1.5

0.24

0.29

nmol/l

0.45

169

Melanocytic naevi

298

2282

1.31

4.86

1.5

0.39

0.44

nmol/l

0.37

242

1787

Benign neoplasm: Cerebral meninges

305

1.88

4.83

1.4

0.28

0.27

nmol/l

0.04

217

TMD related pain

314

1.89

4.82

1.4

0.28

0.38

nmol/l

0.85

255

Other diseases of intestines

1141

5769

1.15

4.80

1.5

0.37

0.42

nmol/l

0.69

898

4570

Mycoses

205

1489

1.38

4.76

1.5

0.35

0.42

nmol/l

1.02

152

1164

Diabetes, varying definitions

758

5344

0.85

4.74

1.6

1.4

0.42

0.41

nmol/l

0.10

583

4156

Major coronary heart disease event

123

1230

0.67

4.73

1.2

1.4

0.20

0.21

nmol/l

0.17

868

Type 2 diabetes, wide definition

294

2493

0.77

4.72

1.5

1.4

0.22

0.33

nmol/l

4.37

214

1837

Migraine without aura

332

2594

1.29

4.71

1.4

1.5

0.41

0.46

nmol/l

0.30

263

2093

Cerebrovascular diseases

195

1925

0.72

4.71

1.4

0.26

0.29

nmol/l

0.24

148

1402

Migraine with aura and triptan purchases

254

1915

1.34

4.70

1.5

0.44

0.45

nmol/l

0.06

215

1552

Benign neoplasm of bone and articular cartilage

418

1.74

4.70

1.5

1.4

0.34

0.39

nmol/l

0.34

348

Lower back pain or/and sciatica

1002

6014

1.16

4.67

1.4

1.5

0.33

0.42

nmol/l

2.73

746

4802

Disorders of thyroid, IBD co-morbidities

257

1406

1.34

4.66

1.4

0.41

0.46

nmol/l

0.55

197

1141

Hypertrophy of breast

214

1574

1.37

4.65

1.3

1.4

0.45

0.41

nmol/l

0.16

163

1179

Haemorrhoids and perianal venous thrombosis

149

1027

1.45

4.62

1.4

0.44

0.36

nmol/l

0.36

111

771

Benign neoplasm: Ascending colon

212

2.04

4.61

1.6

1.3

0.30

0.26

nmol/l

0.18

158

Obesity and other hyperalimentation

667

5560

1.19

4.58

1.5

1.4

0.37

0.44

nmol/l

1.04

531

4372

Abnormal weight loss

318

1.84

4.58

1.7

1.6

0.28

0.31

nmol/l

0.32

253

Diseases of liver

204

1490

1.37

4.58

1.4

0.21

0.34

nmol/l

5.41

151

1115

Benign neoplasm of meninges

334

1.81

4.52

1.4

0.27

0.26

nmol/l

0.05

240

Sequelae of external causes of morbidity and mortality

158

1108

1.43

4.51

1.5

1.4

0.32

0.37

nmol/l

0.47

118

850

Emotional disorders starting during childhood or adolescence

101

644

1.58

4.51

1.4

1.6

0.28

0.39

nmol/l

1.59

542

Benign neoplasm: Adrenal gland

161

2.19

4.49

1.6

1.3

0.34

0.28

nmol/l

0.34

127

Contraceptive management

424

2396

1.25

4.49

1.3

1.5

0.43

0.30

nmol/l

1.11

324

1795

Benign paroxysmal vertigo

171

1218

1.41

4.48

1.3

1.4

0.31

0.37

nmol/l

0.66

128

894

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

470

1.67

4.46

1.6

1.5

0.28

0.40

nmol/l

1.42

373

Personal history of other diseases and conditions

177

1267

1.40

4.45

1.4

1.5

0.49

0.48

nmol/l

0.02

145

1031

Crossbite

536

1.61

4.43

1.4

1.5

0.27

0.29

nmol/l

0.16

432

Dysphagia

134

914

1.47

4.43

1.3

1.4

0.49

0.34

nmol/l

0.58

689

Varicose veins

234

2343

0.75

4.40

1.4

0.44

0.32

nmol/l

0.50

163

1651

Obesity

663

5551

1.19

4.39

1.5

1.4

0.37

0.44

nmol/l

1.05

528

4368

Autism spe

204

2.06

4.38

1.8

1.6

0.26

0.36

nmol/l

1.05

171

Constipation

650

3915

1.19

4.36

1.5

1.4

0.35

0.36

nmol/l

0.12

484

2964

Diseases of salivary glands

160

1134

1.42

4.34

1.4

1.5

0.38

0.42

nmol/l

0.27

117

865

Benign neoplasm: Caecum

157

2.18

4.33

1.2

1.3

0.23

0.30

nmol/l

0.55

122

Salpingitis and oophoritis

169

1211

1.40

4.32

1.4

0.47

0.37

nmol/l

0.60

122

881

Immunodeficiencies

282

1.87

4.30

1.7

1.5

0.22

0.39

nmol/l

1.71

222

Oxicams

169

678

1.42

4.29

1.4

1.5

0.38

0.46

nmol/l

0.47

122

556

Malignant neoplasm of retroperitoneum and peritoneum, excluding all cancers (controls excluding all cancers)

3.93

4.27

1.2

1.3

0.62

0.38

nmol/l

—

Female genital prolapse

201

845

1.38

4.26

1.3

0.37

0.32

nmol/l

0.66

149

561

Polyarthropathies

452

3679

0.82

4.24

1.5

1.4

0.31

0.43

nmol/l

3.39

331

2880

Other and unspecified anaemias

184

1295

1.38

4.24

1.6

1.4

0.28

0.34

nmol/l

1.11

148

961

Other anaemias

187

1317

1.37

4.22

1.6

1.4

0.27

0.35

nmol/l

1.39

150

976

Hypokalaemia

401

1.71

4.22

1.5

0.31

0.33

nmol/l

0.10

304

Follow-up examination after treatment for conditions other than malignant neoplasms

487

2618

1.22

4.22

1.4

0.36

0.45

nmol/l

1.82

383

2074

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

327

1.78

4.20

1.4

1.3

0.24

0.28

nmol/l

0.31

264

Melanocytic naevi, other sites/unspecified

403

1.70

4.17

1.3

1.5

0.49

0.44

nmol/l

0.17

345

Follow-up examination after treatment for malignant neoplasms

256

1.88

4.15

1.4

1.5

0.18

0.26

nmol/l

1.03

188

Dermatographic urticaria

559

1.59

4.14

1.4

0.39

0.44

nmol/l

0.16

451

Anti-inflammatory and antirheumatic products, non-steroids

302

1176

1.29

4.11

1.5

0.38

0.40

nmol/l

0.16

248

983

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

141

2.21

4.11

1.4

0.19

0.26

nmol/l

0.64

115

Weight loss

397

1.70

4.11

1.6

1.5

0.26

0.34

nmol/l

1.08

316

Spondylosis

294

1969

1.28

4.10

1.3

1.4

0.29

0.30

nmol/l

0.10

204

1431

Other skin changes

102

670

1.53

4.09

1.4

1.5

0.35

0.36

nmol/l

0.02

518

Other benign neoplasms of skin

197

1432

1.35

4.07

1.5

1.4

0.37

0.41

nmol/l

0.39

147

1132

Abrasion of teeth

255

1436

1.31

4.06

1.5

1.4

0.38

0.42

nmol/l

0.31

193

1130

L04AD Calcineurin inhibitors

537

1.59

4.06

1.6

1.5

0.24

0.36

nmol/l

1.48

412

Visual field defects

309

1.79

4.06

2.0

1.5

0.25

0.31

nmol/l

0.73

242

Other medical care

241

1798

1.31

4.04

1.6

1.4

0.38

0.36

nmol/l

0.11

160

1379

Obesity, other/unspecified

376

3038

1.24

4.04

1.5

1.4

0.42

0.44

nmol/l

0.15

308

2381

Retinal breaks without detachment

506

1.61

4.04

1.5

1.4

0.31

0.27

nmol/l

0.32

358

COPD/asthma/ILD related infections

1136

5004

1.14

4.04

1.5

1.4

0.36

0.43

nmol/l

2.08

853

3993

COPD/asthma related infections

1136

5004

1.14

4.04

1.5

1.4

0.36

0.43

nmol/l

2.08

853

3993

Autism

211

1.98

4.02

1.8

1.6

0.26

0.37

nmol/l

1.23

177

Other and unspecified drugs and medicaments

438

1.66

4.02

1.6

1.5

0.27

0.39

nmol/l

1.36

346

Syncope and collapse

283

1956

1.29

4.01

1.4

1.5

0.34

0.43

nmol/l

1.28

209

1559

Parodontitis and operation codes

447

4215

0.82

4.00

1.4

0.40

0.36

nmol/l

0.20

319

3211

Other degenerative diseases of the nervous system

915

0.63

3.97

1.4

0.38

0.42

nmol/l

0.13

725

Radiculopathy

595

1.55

3.96

1.3

1.4

0.28

0.33

nmol/l

0.61

445

Benign neoplasm of other and unspecified female genital organs

184

2.03

3.95

1.8

1.3

0.45

0.38

nmol/l

0.25

152

Benign neoplasm: Skin of eyelid, including canthus

409

1.67

3.94

1.4

1.3

0.58

0.32

nmol/l

1.05

319

Malignant neoplasm of eye, brain and central nervous system

144

2.18

3.94

1.9

1.5

0.21

0.32

nmol/l

1.18

113

Care involving use of rehabilitation procedures

492

3885

1.20

3.93

1.5

1.4

0.29

0.37

nmol/l

3.11

386

2973

Sciatica+with lumbago

427

3327

1.22

3.92

1.5

1.4

0.37

0.40

nmol/l

0.20

306

2575

Migraine without aura and triptan purchases

273

2137

1.29

3.91

1.4

1.5

0.43

0.45

nmol/l

0.10

215

1726

Cerebral palsy and other paralytic syndromes

574

1.56

3.90

1.5

0.26

0.38

nmol/l

1.61

456

Paracetamol of NSAID medication

217

815

1.35

3.90

1.5

1.6

0.35

0.37

nmol/l

0.21

175

697

Cramp and spasm

241

1.89

3.90

1.3

1.5

0.23

0.34

nmol/l

1.32

189

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

359

2900

1.24

3.89

1.4

0.43

0.49

nmol/l

0.61

277

2354

Stroke, including SAH

135

1410

0.71

3.87

1.5

1.4

0.18

0.27

nmol/l

3.18

102

1014

0.00

3.85

0.0

1.5

—

0.19

—

Asthma, hospital admissions , main diagnosis only

803

6238

1.15

3.83

1.4

1.5

0.42

0.40

nmol/l

0.20

615

4946

Asthma-related infections

498

4092

1.20

3.83

1.5

0.35

0.39

nmol/l

0.49

379

3209

Asthma, hospital admission 2, infections

498

4092

1.20

3.83

1.5

0.35

0.39

nmol/l

0.49

379

3209

Anisometropia and aniseikonia

146

2.15

3.83

1.5

1.6

0.33

0.32

nmol/l

0.02

117

Candidiasis

123

853

1.45

3.82

1.5

0.40

0.45

nmol/l

0.35

691

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

491

1.60

3.80

1.3

0.55

0.37

nmol/l

0.30

396

Other noninfective disorders of lymphatic vessels and lymph nodes

140

2.17

3.79

1.6

1.4

0.25

0.35

nmol/l

0.68

114

All pneumoniae

733

5857

0.86

3.77

1.5

1.4

0.36

0.40

nmol/l

0.69

548

4621

Other diseases of liver

124

864

1.44

3.75

1.5

1.4

0.22

0.34

nmol/l

2.92

646

Major coronary heart disease event excluding revascularizations

104

1055

0.68

3.73

1.2

1.4

0.18

0.20

nmol/l

0.17

734

Anankastic personality disorder

304

1.77

3.72

1.6

1.4

0.22

0.48

nmol/l

4.15

255

Other extrapyramidal and movement disorders in other diseases

129

907

1.43

3.71

1.4

0.25

0.36

nmol/l

1.95

103

684

Hernia of abdominal wall, postoperative

661

1.50

3.71

1.6

1.4

0.31

0.40

nmol/l

0.60

517

Asthma (diagnoses ohter than nonallergic)

829

6178

1.15

3.71

1.5

1.4

0.40

0.41

nmol/l

0.02

631

4900

Statin medication

530

3529

0.84

3.66

1.3

1.4

0.26

0.39

nmol/l

6.43

378

2700

Injury of muscle and tendon at shoulder and upper arm level

148

1069

1.39

3.65

1.4

0.23

0.27

nmol/l

0.40

112

783

Ischemic heart diseases

216

1765

0.76

3.64

1.4

0.21

0.25

nmol/l

1.18

142

1251

Pain in limb

766

4801

1.16

3.63

1.4

1.5

0.37

0.43

nmol/l

0.97

578

3877

Other disorders starting during childhood or adolecense, excluding more controls

427

1.62

3.63

1.6

1.4

0.22

0.46

nmol/l

4.21

353

Congenital malformations of breast

213

1.94

3.62

1.7

1.5

0.91

0.39

nmol/l

0.45

180

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

435

1.62

3.62

1.4

0.33

0.35

nmol/l

0.10

340

Type 2 diabetes

681

4697

0.86

3.61

1.6

1.4

0.42

0.40

nmol/l

0.13

521

3620

420

3448

1.21

3.61

1.5

0.34

0.40

nmol/l

1.01

321

2738

Viral infections characterized by skin and mucous membrane lesions

336

2717

1.24

3.60

1.5

0.35

0.40

nmol/l

0.69

271

2139

Other and unspecified dermatitis

422

3495

1.21

3.60

1.5

1.4

0.33

0.41

nmol/l

1.28

324

2696

Other disorders of skin and subcutaneous tissue

454

3464

1.20

3.59

1.5

1.4

0.27

0.38

nmol/l

4.41

343

2629

Abnormalities of breathing

985

5157

1.14

3.58

1.4

1.5

0.33

0.43

nmol/l

3.90

743

4158

Complications following infusion, transfusion and therapeutic injection

3.10

3.55

1.2

1.5

0.35

0.28

nmol/l

—

Type 2 diabetes, strict (exclude DM1)

600

4195

0.85

3.55

1.6

1.4

0.43

0.39

nmol/l

0.26

457

3191

Melanocytic naevi of trunk

110

759

1.46

3.54

1.4

1.5

0.43

nmol/l

0.03

608

Malignant neoplasm of other and unspecified female genital organs, excluding all cancers (controls excluding all cancers)

3.08

3.54

1.4

1.5

0.12

0.30

nmol/l

—

Hyperkinetic disorders

184

1369

1.34

3.53

1.6

0.28

0.47

nmol/l

4.74

158

1157

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

111

2.25

3.52

1.4

1.3

0.21

0.18

nmol/l

0.19

Malignant neoplasm of cervix uteri, excluding all cancers (controls excluding all cancers)

145

2.10

3.51

1.3

1.4

0.34

0.41

nmol/l

0.22

127

Gastro-oesophageal reflux disease

493

3673

1.19

3.50

1.5

1.4

0.34

0.37

nmol/l

0.24

385

2769

Disturbance of activity and attention

174

1287

1.35

3.48

1.6

0.29

0.48

nmol/l

4.89

149

1089

Type 2 diabetes, definitions combined

600

4186

0.85

3.48

1.6

1.4

0.43

0.39

nmol/l

0.25

457

3183

Haemangioma and lymphangioma, any site

401

1.63

3.48

1.4

0.24

0.40

nmol/l

1.95

331

External causes of morbidity and mortality

828

3614

1.15

3.48

1.4

0.40

0.47

nmol/l

1.02

636

2920

Wide developmental disorders

266

1.80

3.48

1.7

1.6

0.25

0.37

nmol/l

1.20

219

Implicit fungal Sepsis

106

2.29

3.47

1.4

0.36

0.38

nmol/l

0.04

Haemangioma, any site

363

1.66

3.46

1.4

0.22

0.35

nmol/l

2.44

298

Benign neoplasm of brain and other parts of central nervous system

288

1.75

3.45

1.7

1.5

0.26

0.32

nmol/l

0.69

222

Phlebitis and thrombophlebitis (not including DVT)

149

1090

1.37

3.44

1.2

1.4

0.31

0.38

nmol/l

0.82

828

Paralytic ileus and intestinal obstruction

115

804

1.43

3.43

1.2

1.4

0.24

0.32

nmol/l

1.02

589

Antenatal screening

427

1992

1.21

3.43

1.4

1.5

0.50

0.33

nmol/l

1.57

339

1505

Pneumonias (Asthma/COPD co-morbidities)

729

5804

0.87

3.42

1.5

1.4

0.36

0.40

nmol/l

0.66

545

4578

Hypermobility syndrome

611

1.51

3.42

1.4

1.5

0.38

0.46

nmol/l

0.62

498

Diseases of the ear and mastoid process

1267

5744

1.12

3.41

1.5

0.37

0.42

nmol/l

0.99

988

4564

Aplastic and other anaemias

201

1458

1.31

3.40

1.6

1.4

0.27

0.36

nmol/l

1.79

163

1078

Correction of physiology of bite - very demanding therapy visit

239

1.83

3.39

1.5

0.33

0.42

nmol/l

0.39

196

Social phobias

126

901

1.41

3.38

1.6

1.5

0.35

0.46

nmol/l

0.60

103

749

6-mercaptopurine

210

1.89

3.38

1.8

1.5

0.42

0.41

nmol/l

0.03

175

154

2.05

3.38

1.2

1.6

0.61

0.33

nmol/l

0.69

119

Diseases of tongue

253

1.79

3.38

1.2

1.6

0.38

0.34

nmol/l

0.07

187

Gestational diabetes (for exclusion)

755

4661

1.15

3.36

1.5

1.4

0.61

0.45

nmol/l

2.00

615

3743

Hyperplasia of prostate

260

1.60

3.36

1.7

1.3

0.13

0.12

nmol/l

0.53

219

Oral lichen ruber planus wide, hypothyreosis or thyroxin

168

1.98

3.34

1.5

0.20

0.26

nmol/l

0.67

123

Other and unspecified epidermal thickening

121

2.18

3.34

1.6

1.5

0.23

0.34

nmol/l

1.01

Nonhereditary hypogammaglobulinemia

2.99

3.33

1.5

1.4

0.29

nmol/l

—

Small fibre neuropathy

2.57

3.31

1.4

1.5

0.17

0.35

nmol/l

1.15

Ischaemic heart disease, wide definition

204

1653

0.77

3.29

1.4

0.20

0.24

nmol/l

0.95

138

1161

Varicella [chickenpox]

219

1.84

3.28

1.8

1.5

0.47

0.30

nmol/l

0.41

181

Intestinal stricture

137

998

1.38

3.25

1.2

1.4

0.25

0.32

nmol/l

0.87

732

Stroke, excluding SAH

119

1233

0.72

3.25

1.5

1.4

0.16

0.26

nmol/l

4.95

893

Benign neoplasm: Peripheral nerves and autonomic nervous system

3.21

3.23

1.9

1.2

0.15

0.36

nmol/l

—

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

190

987

1.32

3.22

1.3

0.27

0.30

nmol/l

0.44

143

743

Type 2 diabetes, definitions combined, including avohilmo

625

4283

0.86

3.22

1.6

1.4

0.42

0.39

nmol/l

0.18

474

3270

Benign neoplasm of mouth and pharynx

340

1.66

3.21

1.3

1.4

0.47

0.31

nmol/l

0.66

284

Autoimmune diseases related-to ILD

777

6000

1.14

3.19

1.5

1.4

0.37

0.41

nmol/l

0.88

598

4738

Nonalcoholic fatty liver disease

450

1.57

3.19

1.3

1.5

0.23

0.30

nmol/l

0.74

335

Restless leg syndrome

546

1.51

3.19

1.5

1.4

0.29

0.39

nmol/l

1.04

422

Sequelae with surgical and medical care as external cause

111

784

1.42

3.18

1.4

0.32

0.34

nmol/l

0.16

602

Abnormal findings on examination of blood, without diagnosis

227

1668

1.28

3.17

1.4

0.27

0.35

nmol/l

1.98

177

1299

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

695

5595

0.87

3.17

1.5

1.4

0.36

0.40

nmol/l

0.58

521

4398

Cluster headache, wide,, including avohilmo

381

1.62

3.16

1.4

0.24

0.36

nmol/l

2.46

312

Other or unspecified ileus, impaction or obstruction

458

1.55

3.16

1.3

1.5

0.29

0.26

nmol/l

0.23

343

Diabetic nephropathy, excluding more controls

463

0.52

3.16

1.6

0.21

0.42

nmol/l

2.25

365

Attention to artificial openings

2.37

3.16

1.2

1.5

0.19

0.33

nmol/l

1.11

Benign neoplasm: Brain, supratentorial

2.51

3.15

1.9

1.5

0.24

0.41

nmol/l

1.03

Thyroiditis

484

1.54

3.15

1.4

0.39

0.41

nmol/l

0.15

387

Other external causes of accidental injury

974

4328

1.13

3.14

1.5

1.4

0.37

0.45

nmol/l

1.72

755

3450

Venous thromboembolism

273

2130

1.25

3.14

1.4

0.36

0.34

nmol/l

0.13

189

1591

Drug-induced polyneuropathy

4.61

3.14

4.6

1.3

0.18

0.12

nmol/l

—

Fungal Sepsis

111

2.18

3.13

1.4

0.36

0.37

nmol/l

0.01

Benign neoplasm: Sigmoid colon

412

1.58

3.13

1.4

0.30

0.23

nmol/l

0.60

303

Unspecified haematuria

166

1071

1.33

3.13

1.3

1.4

0.41

0.32

nmol/l

0.28

127

824

Benign neoplasm: Colon, unspecified

540

1.50

3.12

1.4

0.31

0.23

nmol/l

0.52

378

Chronic sinusitis

378

3146

1.20

3.11

1.5

1.4

0.33

0.40

nmol/l

1.00

290

2425

Urticaria and erythema

381

3176

1.20

3.11

1.5

0.51

0.41

nmol/l

0.60

289

2495

Haemolytic anaemias

125

2.10

3.09

1.6

1.4

0.28

0.34

nmol/l

0.39

102

Missing teeth due to accident, extraction or parodontitis

406

1.58

3.09

1.3

1.5

0.36

0.32

nmol/l

0.14

301

Phobic anxiety disorders

192

1486

1.30

3.08

1.6

1.5

0.40

0.43

nmol/l

0.15

157

1225

Hypermetropia

407

1.59

3.07

1.7

1.5

0.29

0.39

nmol/l

0.57

317

Osteopathies and chondropathies

366

2883

1.21

3.07

1.7

1.4

0.27

0.39

nmol/l

4.27

280

2192

Obstructed labour due to maternal pelvic abnormality

1128

0.67

3.06

1.2

1.4

0.41

0.34

nmol/l

0.15

787

Oesophageal varices

2.60

3.05

1.1

1.7

0.29

0.22

nmol/l

0.30

Unspecified mental disorder

397

3330

1.20

3.03

1.5

0.36

0.42

nmol/l

0.75

304

2640

Other hearing loss

655

1.44

3.02

1.4

0.22

0.29

nmol/l

1.09

489

Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)

2.90

3.02

1.8

1.2

0.10

0.26

nmol/l

—

Continuous positive airway pressure

552

1.46

3.01

1.4

1.3

0.17

0.28

nmol/l

2.21

393

Ectopic pregnancy

221

1747

1.27

3.01

1.4

0.54

0.46

nmol/l

0.41

177

1344

Other noninfective gastroenteritis and colitis

195

1515

1.29

3.01

1.5

0.29

0.40

nmol/l

2.89

141

1184

Brain meningioma

168

1.92

3.00

1.3

1.4

0.22

0.30

nmol/l

0.70

125

Cluster headache, strict, including avohilmo

371

1.61

3.00

1.4

0.24

0.36

nmol/l

2.27

306

Pneumothorax

175

1.90

3.00

1.3

1.5

0.38

0.29

nmol/l

0.38

140

Other disorders of bladder

339

1.63

2.99

1.5

1.4

0.36

0.31

nmol/l

0.15

268

Complications of other internal prosthetic devices, implants and grafts

120

2.10

2.99

1.3

1.5

0.48

0.33

nmol/l

0.28

Dermatitis

486

4152

1.17

2.98

1.5

1.4

0.32

0.40

nmol/l

1.70

366

3224

Melanocytic naevi of scalp and neck

134

2.05

2.98

1.9

1.6

0.33

0.38

nmol/l

0.24

122

GI-bleeding

130

954

1.37

2.98

1.3

1.5

0.27

0.30

nmol/l

0.29

101

738

Gingival hyperplasia

127

2.07

2.98

1.5

1.6

0.22

0.28

nmol/l

0.85

Neuralgia and neuritis, unspecified

264

1.72

2.97

1.5

0.50

0.40

nmol/l

0.22

211

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

841

5339

1.13

2.96

1.5

1.4

0.35

0.40

nmol/l

0.82

651

4149

Thyrotoxicosis, other and/or unspecified

173

1329

1.31

2.94

1.5

1.4

0.44

0.43

nmol/l

0.05

129

1026

Other and unspecified mental retardation

2.36

2.94

1.3

1.5

0.30

0.35

nmol/l

0.16

Diseases of the musculoskeletal system and connective tissue

765

3371

1.14

2.93

1.5

0.40

0.47

nmol/l

0.87

609

2770

Zoster [herpes zoster]

589

1.47

2.93

1.5

1.4

0.29

0.33

nmol/l

0.50

452

Outcome of delivery

336

1718

1.22

2.92

1.6

1.4

0.58

0.35

nmol/l

2.38

297

1307

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

138

700

1.36

2.92

1.3

0.27

0.25

nmol/l

0.32

105

513

Redundant prepuce, phimosis and paraphimosis

402

1.56

2.91

1.4

1.6

0.12

0.14

nmol/l

0.53

334

Astigmatism

381

1.59

2.91

1.6

1.5

0.25

0.41

nmol/l

1.82

306

Maternal care for known or suspected fetal abnormality and damage

339

2506

1.21

2.91

1.6

1.5

0.63

0.49

nmol/l

0.94

291

2023

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

132

667

1.37

2.91

1.3

0.26

0.25

nmol/l

0.14

102

489

Diaphragmatic hernia

168

1287

1.31

2.90

1.5

1.4

0.29

0.31

nmol/l

0.21

133

922

Abnormal involuntary movements

624

1.45

2.89

1.3

1.5

0.36

0.37

nmol/l

0.03

493

Nontoxic multinodular goitre

106

757

1.41

2.89

1.2

1.4

0.29

0.38

nmol/l

1.00

549

Amblyopia ex anopsia

259

1.72

2.89

1.4

1.6

0.31

0.33

nmol/l

0.11

211

Malignant neoplasm of endocrine gland

367

1.59

2.87

1.7

1.4

0.24

0.33

nmol/l

1.27

277

Asthma-related pneumonia

211

1666

1.27

2.86

1.4

1.5

0.35

0.38

nmol/l

0.27

157

1289

Asthma, hospital admissions 3, pneumonia

212

1675

1.27

2.85

1.4

1.5

0.35

0.38

nmol/l

0.31

158

1296

Asthma-related pneumonia or sepsis

212

1675

1.27

2.85

1.4

1.5

0.35

0.38

nmol/l

0.31

158

1296

Other (not insulin) diabetes medications

619

4279

0.87

2.85

1.6

1.4

0.42

0.39

nmol/l

0.22

474

3276

Other coagulation defects

496

1.50

2.84

1.7

1.4

0.63

0.45

nmol/l

0.26

396

ILD medications: prednisolone, methylprednisolone, prednisone

1106

5629

1.11

2.83

1.5

1.4

0.34

0.43

nmol/l

4.11

850

4473

Other specified and unspecified personality disorders

105

753

1.41

2.83

1.3

1.5

0.31

0.45

nmol/l

1.46

611

Hernia

559

4371

0.87

2.82

1.5

1.4

0.27

0.38

nmol/l

5.46

436

3344

Oral lichen ruber planus, hypothyreosis or thyroxin

2.69

2.81

1.3

1.5

0.16

0.26

nmol/l

—

Benign neoplasm: Transverse colon

201

1.80

2.81

1.1

1.5

0.22

0.26

nmol/l

0.38

149

Insulin medication

269

2815

0.82

2.80

1.3

1.5

0.37

0.38

nmol/l

0.04

205

2203

Noninfective enteritis and colitis

395

3334

1.19

2.80

1.4

1.5

0.34

0.40

nmol/l

1.00

306

2620

Malignant neoplasm of urinary organs

151

1.93

2.79

1.4

1.5

0.25

0.19

nmol/l

0.50

118

Other systemic involvement of connective tissue (FG)

198

1549

1.27

2.79

1.4

0.35

0.42

nmol/l

0.74

152

1185

Emotionally unstable personality disorder

198

1563

1.28

2.78

1.5

0.43

0.46

nmol/l

0.11

158

1283

Biguanides

576

4082

0.87

2.78

1.6

1.4

0.42

0.38

nmol/l

0.26

441

3104

Persistent mood disorders

164

1262

1.30

2.77

1.4

0.34

0.42

nmol/l

0.74

131

988

Disorders of breast

547

4399

1.16

2.77

1.5

1.4

0.39

0.43

nmol/l

0.50

405

3365

Benign leiomyoma with endometriosis

109

790

1.39

2.75

1.3

1.4

0.59

0.35

nmol/l

1.31

552

Voice disturbances

196

1545

1.27

2.75

1.4

0.41

0.38

nmol/l

0.14

146

1160

Scar conditions and fibrosis of skin

263

1.69

2.75

1.3

1.4

0.42

0.34

nmol/l

0.18

205

Other systemic involvement of connective tissue

200

1581

1.27

2.74

1.4

1.5

0.35

0.42

nmol/l

0.70

153

1212

Cervicobrachial syndrome

183

1431

1.28

2.74

1.3

1.4

0.31

0.38

nmol/l

0.62

139

1096

Diseases of middle ear and mastoid

696

5029

1.14

2.72

1.5

0.37

0.45

nmol/l

1.51

566

4118

Balanced rearrangements and structural markers, not elsewhere classified

3.29

2.70

1.9

1.6

0.46

0.50

nmol/l

—

Asthma, unspecified (mode)

465

3160

1.17

2.70

1.5

1.4

0.33

0.39

nmol/l

1.64

342

2484

Localized swelling, mass and lump of skin and subcutaneous tissue

222

1780

1.25

2.70

1.4

0.42

0.39

nmol/l

0.06

174

1360

TMD muscular pain linked with fibromyalgia

2.40

2.70

1.1

1.4

0.41

0.37

nmol/l

0.10

Angina pectoris

105

976

0.73

2.70

1.2

1.4

0.18

0.20

nmol/l

0.37

671

Malignant neoplasm of kidney, except renal pelvis

139

1.95

2.69

1.4

1.5

0.20

0.19

nmol/l

0.09

108

Asthma, unspecified (mode), excluding more controls

465

3132

1.17

2.68

1.5

1.4

0.33

0.40

nmol/l

1.73

342

2460

Dizziness and giddiness

567

4008

1.15

2.67

1.4

0.29

0.39

nmol/l

4.42

424

3092

Seborrhoeic keratosis

609

1.43

2.67

1.5

1.4

0.23

0.25

nmol/l

0.30

427

Other neurological diseases

405

2763

1.18

2.67

1.3

1.4

0.32

0.37

nmol/l

0.81

312

2098

Bacterial Sepsis

180

1251

1.28

2.67

1.6

1.4

0.25

0.32

nmol/l

1.45

135

949

Use of pramipexole

104

752

1.39

2.66

1.5

1.4

0.22

0.31

nmol/l

1.66

553

Pruritus

669

1.41

2.66

1.4

1.5

0.29

0.45

nmol/l

2.49

539

Iron deficiency anaemia secondary to blood loss (chronic)

578

1.44

2.63

1.3

1.5

0.40

0.36

nmol/l

0.15

447

Presbycusis

2.20

2.60

1.3

0.11

0.12

nmol/l

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

196

1557

1.26

2.60

1.3

1.5

0.29

0.38

nmol/l

1.38

157

1211

Benign neoplasm: Skin of other and unspecified parts of face

329

1.59

2.59

1.6

1.4

0.22

0.40

nmol/l

2.28

274

Anomalies of dental arch relationship, including avohilmo

236

1719

1.24

2.59

1.4

1.5

0.45

0.39

nmol/l

0.28

181

1370

Melanocytic naevi of other and unspecified parts of face

322

1.60

2.58

1.5

1.4

0.34

0.39

nmol/l

0.37

272

Tinnitus

140

1066

1.32

2.58

1.4

0.32

0.36

nmol/l

0.27

111

785

Noninfectious colitis NAS

106

775

1.37

2.57

1.5

0.30

0.40

nmol/l

1.38

614

Heterophoria

641

1.42

2.56

1.4

1.5

0.32

0.45

nmol/l

0.61

504

Kela-code for severe mental illness

330

2771

1.19

2.56

1.5

0.35

0.41

nmol/l

0.72

249

2196

Appendectomy

666

5676

1.13

2.55

1.6

1.4

0.45

0.42

nmol/l

0.31

537

4450

Leiomyoma of uterus

625

3119

1.14

2.55

1.3

1.4

0.42

0.40

nmol/l

0.22

454

2300

Disorders of vestibular function (Vertigo)

258

2102

1.22

2.55

1.4

0.29

0.36

nmol/l

1.48

188

1545

Coagulation defects, purpura and other haemorrhagic conditions

152

1174

1.30

2.54

1.8

1.5

0.47

0.41

nmol/l

0.15

116

936

Cough

304

2432

1.20

2.53

1.5

0.32

0.37

nmol/l

0.48

212

1903

Skin changes due to chronic exposure to nonionizing radiation

527

1.44

2.52

1.2

1.4

0.22

0.18

nmol/l

0.33

361

Extrapyramidal and movement disorders

175

1377

1.27

2.52

1.4

0.27

0.36

nmol/l

1.99

143

1017

Pneumonia, organism unspecified

604

4960

0.88

2.50

1.5

0.36

0.39

nmol/l

0.49

452

3889

Inguinal hernia

224

1862

0.81

2.49

1.3

1.5

0.21

0.35

nmol/l

4.94

181

1479

Implicit bacterial Sepsis

137

957

1.31

2.49

1.6

1.4

0.26

0.30

nmol/l

0.48

104

722

Myocardial infarction

788

0.70

2.49

1.1

1.4

0.18

nmol/l

0.02

551

Other diseases of the digestive system

127

959

1.33

2.48

1.4

1.5

0.27

0.30

nmol/l

0.33

738

Acute otitis externa, noninfective

2.42

2.48

1.2

1.4

0.22

0.43

nmol/l

—

Retinal detachments and breaks

135

1030

1.31

2.46

1.4

0.27

0.29

nmol/l

0.14

102

726

Urolithiasis

153

1188

1.29

2.45

1.3

1.4

0.28

0.34

nmol/l

0.66

120

916

Palmar fascial fibromatosis [Dupuytren]

248

1.66

2.45

1.1

1.5

0.19

0.20

nmol/l

0.16

195

Other and unspecified local infections of skin and subcutaneous tissue

447

1.48

2.45

1.3

1.5

0.30

0.40

nmol/l

0.69

348

ILD medications

1160

5800

1.10

2.43

1.5

1.4

0.34

0.42

nmol/l

3.65

899

4618

Benign neoplasm of eye and adnexa

288

1.60

2.42

1.5

1.4

0.64

0.31

nmol/l

0.86

241

Symptoms and signs involving the urinary system

465

3111

1.16

2.41

1.5

1.4

0.33

0.38

nmol/l

0.40

373

2376

Fall on same level

1008

6209

0.91

2.41

1.5

1.4

0.31

0.42

nmol/l

5.64

767

4952

Tongue abnormality

212

1.71

2.40

1.2

1.4

0.22

0.29

nmol/l

0.67

157

Speech and linguistic disorders, excluding more controls

619

1.39

2.39

1.8

1.5

0.33

0.47

nmol/l

1.00

520

Maternal care related to the fetus and amniotic cavity and possible delivery problems

717

3757

1.13

2.39

1.4

0.47

0.41

nmol/l

0.67

556

2930

Xerosis cutis

2.79

2.39

1.1

1.5

0.16

0.28

nmol/l

—

Myocardial infarction, strict

708

0.69

2.38

1.1

1.4

0.15

0.18

nmol/l

0.87

505

Symptoms and signs involving speech and voice

220

1791

1.23

2.38

1.4

0.39

nmol/l

0.00

163

1346

Other disorders of teeth and supporting structures

133

1021

1.31

2.35

1.6

1.5

0.48

0.41

nmol/l

0.17

781

Ulcer of vagina/vulva

184

1.77

2.34

1.3

1.5

0.46

0.40

nmol/l

0.21

154

659

1.37

2.34

1.2

1.4

0.22

0.20

nmol/l

0.21

456

Systemic connective tissue disorders

245

2021

1.22

2.33

1.5

1.4

0.36

0.40

nmol/l

0.40

189

1534

Senile cataract

144

1149

0.78

2.33

1.3

1.4

0.15

0.22

nmol/l

2.67

102

787

Vocal cord dysfunction

121

852

1.32

2.32

1.4

0.32

0.41

nmol/l

1.02

662

Other local infections of skin and subcutaneous tissue

461

1.46

2.31

1.3

1.5

0.30

0.39

nmol/l

0.60

361

Benign neoplasm: Ascending colon

268

1.61

2.31

1.6

1.5

0.30

0.23

nmol/l

0.39

197

Epilepsy

216

1756

1.23

2.31

1.5

1.4

0.33

0.40

nmol/l

0.91

167

1401

Brachial plexus disorders

107

800

1.35

2.30

1.4

0.41

0.42

nmol/l

0.06

621

Disorders of optic nerve and visual pathways

646

1.39

2.30

1.7

1.5

0.44

0.40

nmol/l

0.15

521

Sequelae of other external causes

238

1.65

2.29

1.5

1.4

0.29

0.31

nmol/l

0.08

184

Benign neoplasm: Brain, unspecified

3.57

2.29

1.6

1.5

0.17

0.43

nmol/l

—

Disorders of psychological development

149

1080

1.29

2.29

1.8

1.6

0.30

0.40

nmol/l

1.21

128

895

Deforming dorsopathies

220

1800

1.23

2.28

1.5

0.38

0.39

nmol/l

0.04

176

1406

Schizophrenia or delusion, excluding more controls

251

2064

1.21

2.28

1.5

1.4

0.31

0.43

nmol/l

2.42

185

1645

Benign neoplasm: Caecum

200

1.71

2.28

1.2

1.4

0.23

0.27

nmol/l

0.32

149

Diabetic nephropathy

490

0.58

2.27

1.6

0.21

0.43

nmol/l

2.48

392

Calculus of kidney and ureter

144

1123

1.29

2.26

1.2

1.4

0.29

0.34

nmol/l

0.50

114

866

Other diseases of gallbladder

127

1.90

2.26

1.3

1.4

0.17

0.25

nmol/l

1.04

Immunodeficiency with predominantly antibody defects

149

1.84

2.26

1.9

1.5

0.22

0.38

nmol/l

1.76

119

Iron deficiency

256

1.63

2.25

1.7

1.5

0.55

0.47

nmol/l

0.14

219

Ehlers-Danlos syndrome

107

2.02

2.25

1.6

1.5

0.27

0.39

nmol/l

1.08

Vasomotor and allergic rhinitis

434

3717

1.15

2.24

1.5

0.36

0.41

nmol/l

0.42

353

2949

Abnormal findings on diagnostic imaging of lung

168

1301

1.26

2.24

1.3

1.4

0.22

0.28

nmol/l

1.06

119

938

Disorders of lipoprotein metabolism and other lipidaemias

303

2257

0.84

2.24

1.4

0.22

0.28

nmol/l

1.08

218

1625

Other problems related to primary support group, including family circumstances

167

1297

1.26

2.24

1.4

1.5

0.30

0.43

nmol/l

1.13

134

1057

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

137

724

1.30

2.23

1.3

0.27

0.25

nmol/l

0.27

104

531

Dislocation, sprain and strain of joints and ligaments of head

319

1.55

2.23

1.4

0.26

0.44

nmol/l

1.89

257

Ganglion

209

1707

1.23

2.22

1.3

1.5

0.33

0.43

nmol/l

1.80

164

1362

Infections of the skin and subcutaneous tissue

487

4250

1.14

2.22

1.4

1.5

0.35

0.40

nmol/l

0.63

391

3353

Other salmonella infections

157

1.80

2.22

1.5

1.4

0.53

0.31

nmol/l

0.34

123

Chronic lower respiratory diseases

1211

6009

1.09

2.21

1.5

0.40

0.41

nmol/l

0.06

937

4781

Undetermined asthma

727

1.35

2.20

1.4

0.30

0.36

nmol/l

0.53

565

Actinic keratosis

473

1.43

2.20

1.1

1.4

0.16

0.15

nmol/l

0.11

322

Ischaemic Stroke, excluding all haemorrhages

112

1112

0.76

2.19

1.6

1.4

0.16

0.23

nmol/l

3.84

805

Pure hypercholesterolaemia

221

1802

0.82

2.19

1.4

0.20

0.27

nmol/l

2.50

160

1294

Other chronic obstructive pulmonary disease, including avohilmo

102

1127

0.75

2.18

1.5

1.4

0.21

0.23

nmol/l

0.32

796

Seborrhoeic dermatitis

393

1.48

2.18

1.3

1.5

0.27

0.36

nmol/l

0.50

307

Retention of urine

117

753

1.32

2.16

1.6

1.4

0.25

0.33

nmol/l

1.27

595

Postpartum hemorraghe, parous women as controls

446

3411

1.15

2.16

1.4

0.56

0.50

nmol/l

0.39

374

2699

Pain in thoracic spine

132

1026

1.29

2.16

1.4

1.5

0.37

0.41

nmol/l

0.25

798

Vasomotor rhinitis (mode)

386

1.49

2.16

1.3

1.5

0.20

0.34

nmol/l

2.60

298

Undetermined asthma, excluding more controls

730

1.35

2.15

1.4

0.30

0.36

nmol/l

0.51

567

Recurring oral aphthae, including avohilmo

101

757

1.34

2.15

1.5

0.39

0.41

nmol/l

0.13

608

Glaucoma, exfoliation

101

1.98

2.15

1.9

1.5

0.23

0.20

nmol/l

0.14

Atrophic disorders of skin

102

766

1.34

2.14

1.4

0.29

0.38

nmol/l

0.60

566

Pulmonary heart disease

114

870

1.31

2.12

1.5

1.4

0.34

0.32

nmol/l

0.08

646

Other bacterial intestinal infections

715

1.35

2.12

1.6

1.4

0.22

0.38

nmol/l

3.52

550

Urticaria

319

2723

1.18

2.12

1.5

0.47

0.42

nmol/l

0.25

242

2151

Diseases of inner ear

294

2438

1.18

2.12

1.4

0.29

0.37

nmol/l

2.00

214

1811

Presbyopia

323

1.53

2.12

1.3

1.4

0.36

0.27

nmol/l

0.59

225

Renal tubulo-interstitial diseases

592

5095

0.89

2.11

1.4

1.5

0.35

0.41

nmol/l

1.24

449

4012

Benign neoplasm: Peripheral nerves and autonomic nervous system

2.48

2.11

1.9

1.3

0.15

0.32

nmol/l

—

Acne

161

1288

1.26

2.10

1.6

0.39

0.46

nmol/l

0.62

136

1077

Nontoxic goitre/thyroid nodule

172

1385

1.25

2.10

1.3

1.4

0.28

0.36

nmol/l

1.45

116

1012

Pulmonary embolism

114

872

1.31

2.09

1.5

1.4

0.34

0.32

nmol/l

0.08

647

Exposure to unspecified factor

897

6331

1.10

2.09

1.5

1.4

0.36

0.41

nmol/l

0.88

694

5024

Melanocytic naevi of lower limb, including hip

229

1.63

2.09

1.7

1.3

0.35

0.41

nmol/l

0.25

196

Other facial nerve disorders

131

1.85

2.09

1.4

1.5

0.41

0.36

nmol/l

0.10

106

Accidents

950

4328

1.10

2.09

1.5

1.4

0.38

0.45

nmol/l

1.60

737

3450

STROKE

230

1921

0.83

2.09

1.4

0.23

0.31

nmol/l

2.07

166

1390

Other disorders of eyelid

171

1330

1.24

2.08

1.4

0.24

0.29

nmol/l

1.14

119

950

Benign neoplasm: Brain, supratentorial

2.05

2.08

1.9

1.4

0.24

0.35

nmol/l

0.61

Mixed disorders of conduct and emotions, excluding more controls

230

1.63

2.07

1.2

1.5

0.27

0.49

nmol/l

1.80

199

Disorders of lens

211

1616

0.82

2.07

1.4

0.22

0.27

nmol/l

0.82

148

1151

Diseases of pulp and periapical tissues

248

2076

1.20

2.07

1.3

1.5

0.27

0.40

nmol/l

3.88

193

1614

Iron deficiency anaemia

268

2237

1.19

2.06

1.4

0.41

nmol/l

0.03

218

1705

Seminoma of testis, excluding all cancers (controls excluding all cancers)

3.55

2.06

1.3

1.5

0.16

0.17

nmol/l

—

Medical abortion

678

4106

0.90

2.06

1.4

0.45

0.43

nmol/l

0.16

513

3254

Other disorders of gingiva or/and edentulous alveolar ridge

230

1.62

2.05

1.5

0.20

0.43

nmol/l

1.91

176

Other female pelvic inflammatory diseases

157

1256

1.26

2.05

1.5

1.4

0.43

nmol/l

0.00

120

962

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

869

5365

1.10

2.05

1.4

0.35

0.42

nmol/l

1.60

678

4185

Other bacterial diseases

656

4063

1.12

2.03

1.5

1.4

0.26

0.38

nmol/l

3.98

477

3130

Autoimmune thyroiditis

140

1.81

2.03

1.5

1.4

0.42

0.39

nmol/l

0.08

120

Crohn's disease NAS

450

1.43

2.03

1.4

1.5

0.43

0.42

nmol/l

0.05

355

Benign neoplasm: Rectum

416

1.45

2.02

1.3

1.4

0.28

0.23

nmol/l

0.25

302

Benign neoplasm of bone and articular cartilage

517

1.40

2.02

1.5

1.4

0.34

0.37

nmol/l

0.19

406

Pregnancy with abortive outcome

875

4157

1.10

2.01

1.5

1.4

0.47

0.42

nmol/l

0.58

679

3300

Nontoxic diffuse goitre

133

1.82

2.00

1.2

1.4

0.38

0.29

nmol/l

0.61

103

Other and unspecified coagulation defects

369

1.48

1.99

1.6

1.4

0.72

0.39

nmol/l

0.40

297

Insulin, fast-acting (human)

1126

0.74

1.99

1.3

1.5

0.34

0.45

nmol/l

1.10

928

Fracture of rib(s), sternum and thoracic spine

125

976

1.28

1.99

1.5

1.4

0.23

0.31

nmol/l

1.38

748

Diffuse brain injury

148

1.77

1.99

1.3

1.5

0.16

0.43

nmol/l

4.57

129

Sudden idiopathic hearing loss

336

1.49

1.98

1.6

1.5

0.21

0.30

nmol/l

1.02

253

Other and unspecified myopathies

209

1.63

1.97

1.4

1.5

0.22

0.25

nmol/l

0.29

167

Benign neoplasm of breast

102

777

1.32

1.97

1.4

0.31

0.40

nmol/l

1.22

597

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

386

1.46

1.97

1.6

1.4

0.27

0.34

nmol/l

0.82

301

Benign neoplasm: Rectum, anus and anal canal

477

1.41

1.97

1.4

0.27

0.24

nmol/l

0.17

348

Other disorders of breast

134

1059

1.27

1.97

1.4

0.34

0.45

nmol/l

1.26

106

811

Erythema multiforme

105

1.93

1.97

1.5

1.4

0.82

0.31

nmol/l

0.41

Diseases of the digestive system

253

2128

1.19

1.96

1.4

1.5

0.33

0.38

nmol/l

0.68

193

1646

Intestinal adhesions without obstruction

225

1.61

1.96

1.2

1.5

0.27

0.30

nmol/l

0.12

165

Pulmonary heart disease, diseases of pulmonary circulation

120

934

1.29

1.96

1.5

1.4

0.33

0.32

nmol/l

0.05

694

Mixed and other personality disorders

666

1.35

1.96

1.3

1.5

0.39

0.42

nmol/l

0.22

542

Provisional assignment of new diseases of uncertain etiology

450

3965

1.14

1.95

1.5

0.42

0.43

nmol/l

0.02

359

3184

Melanocytic naevi of scalp and neck

157

1.74

1.94

1.9

1.5

0.33

0.35

nmol/l

0.07

135

Lymphangioma, anys site

2.62

1.94

2.6

1.5

0.35

0.53

nmol/l

—

Benign neoplasm of other and unspecified female genital organs

234

1.59

1.94

1.8

1.4

0.45

0.34

nmol/l

0.44

177

Erysipelas

244

1871

1.19

1.94

1.5

1.4

0.28

0.32

nmol/l

0.23

169

1406

Insulin, combination of fast acting with intermediate-acting or long-acting

269

2914

0.85

1.93

1.3

1.5

0.37

0.38

nmol/l

0.05

205

2273

Coronary atherosclerosis

150

1205

0.80

1.92

1.5

1.4

0.20

0.21

nmol/l

0.17

837

Abnormal spermatozoa

120

1.84

1.92

1.4

0.11

0.14

nmol/l

1.03

Malignant melanoma

421

1.43

1.92

1.3

1.5

0.27

0.25

nmol/l

0.13

317

Cerebrovascular diseases (FINNGEN)

143

1279

0.80

1.92

1.5

1.4

0.29

0.34

nmol/l

0.30

110

961

Codes for special purposes

450

3971

1.14

1.91

1.5

0.42

0.43

nmol/l

0.02

359

3190

Benign neoplasm: Conjunctiva

106

1.90

1.91

1.7

1.5

0.92

0.39

nmol/l

0.59

Vestibular neuronitis

331

1.49

1.91

1.7

1.5

0.27

0.31

nmol/l

0.29

251

Premature rupture of membranes

444

2876

1.14

1.90

1.4

0.46

nmol/l

0.06

355

2320

Cardiovascular diseases (excluding rheumatic etc)

927

4896

1.10

1.90

1.4

1.5

0.44

nmol/l

0.06

714

3971

Sarcoidosis

566

1.37

1.89

1.4

0.22

0.32

nmol/l

1.95

427

Subjective visual disturbances

187

1540

1.22

1.89

1.6

1.5

0.36

0.41

nmol/l

0.41

146

1211

Seminoma of testis

3.22

1.89

1.3

1.5

0.16

nmol/l

—

Cervicalgia

144

1154

1.25

1.88

1.3

1.5

0.29

0.38

nmol/l

1.07

107

887

Volume depletion

212

1.61

1.88

1.4

1.5

0.23

0.30

nmol/l

0.67

174

Nutritional anaemias

294

2452

1.17

1.87

1.4

0.40

nmol/l

0.06

239

1864

Congenital deformities of hip

159

1.72

1.87

1.4

1.5

0.30

0.33

nmol/l

0.10

132

Manic episode

174

1.68

1.87

1.3

1.4

0.29

0.36

nmol/l

0.52

136

Viral warts

680

1.33

1.86

1.5

0.46

0.40

nmol/l

0.21

545

Schizophrenia

941

0.73

1.85

1.3

1.5

0.21

0.35

nmol/l

2.75

749

Other embolism and thrombosis

500

1.38

1.85

1.4

0.44

0.34

nmol/l

0.35

392

Single spontaneous delivery

377

2300

0.87

1.85

1.5

0.43

0.38

nmol/l

0.32

305

1857

Rheumatism, unspecified

750

1.31

1.85

1.3

1.4

0.30

0.36

nmol/l

0.66

559

Other acute lower respiratory infections

397

3324

1.14

1.84

1.5

0.32

0.39

nmol/l

1.59

303

2639

Heartburn

561

1.36

1.83

1.3

1.4

0.39

nmol/l

0.01

447

Other specified/unspecified systemic involvement of connective tissue

343

1.47

1.83

1.5

1.4

0.33

0.34

nmol/l

0.03

258

Unequal limb length (acquired)

2.05

1.83

1.3

1.6

0.26

0.41

nmol/l

—

Abnormalities of gait and mobility

318

1.48

1.83

1.6

1.5

0.30

0.28

nmol/l

0.11

245

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

728

0.70

1.82

1.1

1.5

0.26

0.45

nmol/l

3.13

569

Benign neoplasm: Stomach

206

1.61

1.82

1.8

1.4

0.21

0.31

nmol/l

0.97

162

Dyspnoea

692

4801

1.11

1.81

1.4

0.31

0.40

nmol/l

2.48

506

3748

Convulsions, not elsewhere classified

187

1528

1.21

1.81

1.6

1.5

0.28

0.45

nmol/l

3.90

147

1246

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

722

4981

0.91

1.81

1.5

1.4

0.37

0.43

nmol/l

1.21

539

3973

722

4981

0.91

1.81

1.5

1.4

0.37

0.43

nmol/l

1.21

539

3973

Other complications of labour and delivery, not elsewhere classified

259

2131

1.18

1.81

1.5

0.63

0.47

nmol/l

1.70

237

1787

Viral hepatitis, IBD co-morbidity

377

1.44

1.80

1.4

1.5

0.22

0.42

nmol/l

4.04

308

Crohn disease

120

947

1.27

1.80

1.4

1.5

0.39

0.42

nmol/l

0.26

101

760

Supervision of normal pregnancy

389

1945

1.15

1.80

1.4

0.39

0.34

nmol/l

0.37

298

1461

Implicit Sepsis

431

2955

1.13

1.80

1.5

0.31

0.38

nmol/l

1.14

327

2292

Other viral diseases

320

2766

1.16

1.80

1.4

1.5

0.29

0.41

nmol/l

5.39

252

2224

Other inflammation of vagina/vulva

420

1.42

1.80

1.5

0.53

0.49

nmol/l

0.16

348

Sequelae of cerebrovascular disease

681

0.71

1.80

1.8

1.4

0.18

0.22

nmol/l

0.69

495

Other and unspecified visual disturbances

453

1.40

1.79

1.5

0.47

0.39

nmol/l

0.25

364

Benign neoplasm: Adrenal gland

223

1.58

1.79

1.6

1.4

0.34

0.25

nmol/l

0.60

156

Postpartum care and examination

291

1594

1.17

1.78

1.3

1.5

0.48

0.36

nmol/l

1.26

233

1235

Disorder of external ear, unspecified

131

1.77

1.78

1.5

1.4

0.34

nmol/l

0.00

101

Nontraumatic intracranial haemmorrhage

463

0.62

1.78

1.3

1.4

0.29

0.23

nmol/l

0.38

338

Hydrocephalus

161

1.68

1.78

1.8

1.5

0.23

0.29

nmol/l

0.45

123

Postpartum haemorrhage due to retained placenta

216

1819

1.20

1.78

1.4

0.48

0.50

nmol/l

0.09

181

1433

Poisoning by drugs, medicaments and biological substances

265

2269

1.17

1.76

1.5

0.37

0.43

nmol/l

0.31

207

1824

Toxic effect of corrosive substances

2.57

1.76

1.6

1.5

0.50

0.41

nmol/l

—

Other heart diseases, wide

768

5222

0.91

1.76

1.4

0.36

0.41

nmol/l

0.57

577

4090

Other specified disorders of kidney and ureter

117

1.81

1.75

1.2

1.5

0.34

0.32

nmol/l

0.07

Diseases of the myoneural junction and muscle

396

1.42

1.75

1.4

0.22

0.33

nmol/l

2.15

301

Injuries involving multiple body regions

209

1.59

1.74

1.2

1.5

0.44

0.34

nmol/l

0.53

172

Enthesopathies of lower limb, excluding foot

165

1355

1.22

1.74

1.5

1.4

0.38

0.36

nmol/l

0.13

115

1041

Focal epilepsy, strict definition

120

951

1.27

1.74

1.5

0.35

0.37

nmol/l

0.13

752

Congenital malformations of genital organs

141

1134

1.24

1.74

1.6

1.4

0.54

0.47

nmol/l

0.41

116

920

Traumatic subdural haemorrhage

167

1.65

1.73

1.3

1.4

0.13

0.27

nmol/l

2.42

136

Other disorders of central nervous system

2.17

1.73

1.2

1.5

0.17

0.33

nmol/l

—

Unspecified kidney failure

155

1.68

1.72

1.6

1.5

0.24

0.27

nmol/l

0.18

118

Collagenous colitis

398

1.41

1.71

1.7

1.5

0.34

0.35

nmol/l

0.06

310

Hypertrophic scar

441

1.39

1.71

1.4

1.5

0.40

0.43

nmol/l

0.14

355

Diabetic retinopathy, excluding more controls

610

0.76

1.70

1.3

1.6

0.28

0.43

nmol/l

1.21

468

Cervicocranial syndrome

638

1.32

1.70

1.6

1.4

0.67

0.35

nmol/l

0.56

487

Cholelithiasis, broad definition with cholecystitis

563

4282

0.90

1.70

1.4

0.37

0.40

nmol/l

0.42

443

3237

Other and unspecified iron deficiency

217

1833

1.19

1.70

1.5

1.4

0.40

0.43

nmol/l

0.23

175

1418

Coronary revascularization (ANGIO or CABG)

633

0.74

1.69

1.2

1.5

0.22

0.19

nmol/l

0.38

459

Other diseases of intestine

341

1.44

1.67

1.8

1.5

0.26

0.28

nmol/l

0.14

248

Osteoporosis with pathological fracture (FG)

104

1.83

1.67

2.3

1.3

0.21

0.19

nmol/l

—

Diseases of spleen

2.05

1.65

1.3

1.4

0.26

0.43

nmol/l

—

Other disorders of ear

528

3912

0.90

1.65

1.4

0.27

0.38

nmol/l

4.68

406

2965

Invasive ventilation

228

1.54

1.65

1.7

1.5

0.17

0.30

nmol/l

2.95

180

Carbimazole or st.post thyroidectomy, condition for graves disease

185

1547

1.20

1.65

1.5

1.4

0.39

0.41

nmol/l

0.16

140

1192

Acute sinusitis

556

4679

1.11

1.64

1.5

1.4

0.35

0.45

nmol/l

2.66

438

3734

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

1.93

1.64

1.1

1.3

0.14

0.19

nmol/l

—

Congenital malformations of the musculoskeletal system, not elsewhere classified

143

1.71

1.64

1.5

0.25

0.38

nmol/l

1.57

119

Other symptoms and signs involving the urinary system

335

1.44

1.63

1.8

1.5

0.34

0.30

nmol/l

0.15

267

Status epilepticus

120

1.76

1.62

1.3

1.5

0.23

0.36

nmol/l

1.54

101

Bacterial intestinal infections, IBD co-morbidities

739

1.29

1.62

1.6

1.5

0.23

0.37

nmol/l

2.68

580

Elevated blood glucose level

352

1.43

1.62

1.4

1.5

0.29

0.32

nmol/l

0.22

274

Thyrotoxicosis

203

1714

1.19

1.62

1.4

0.42

0.41

nmol/l

0.06

149

1299

Other bullous disorders

1.85

1.62

1.2

1.5

0.24

0.34

nmol/l

0.60

Hyperosmolality and hypernatraemia

3.60

1.62

1.6

1.2

0.13

0.19

nmol/l

—

Sequelae of tuberculosis

3.59

1.62

1.6

1.5

0.32

0.11

nmol/l

—

Anxious personality disorder

151

1.68

1.61

1.4

1.5

0.26

0.35

nmol/l

0.57

127

Combined immunodeficiencies

2.36

1.61

1.8

1.4

0.16

0.37

nmol/l

—

Other congenital malformations of circulatory system

113

1.79

1.61

1.4

1.5

0.25

0.37

nmol/l

0.70

Respiratory and cardiovascular disorders specific to the perinatal period

155

1.63

1.61

1.6

0.16

0.24

nmol/l

1.09

128

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

262

1.49

1.60

1.4

0.33

0.32

nmol/l

0.06

208

MS-disease / Multiple Sclerosis

674

0.71

1.60

1.4

0.44

nmol/l

0.01

546

Allergic asthma (mode)

299

2558

1.15

1.60

1.5

1.4

0.55

0.44

nmol/l

0.59

242

2089

Perineal laceration during delivery

260

2677

0.86

1.60

1.5

0.53

0.46

nmol/l

0.69

228

2213

Injury, poisoning and certain other consequences of external causes

673

3066

1.10

1.59

1.5

0.48

nmol/l

0.01

526

2455

Other inflammation of eyelid

645

1.31

1.59

1.4

1.5

0.32

0.38

nmol/l

0.33

503

Degenerative macular diseases

206

1.56

1.59

1.6

1.5

0.19

0.24

nmol/l

0.46

154

Allergic asthma (mode), excluding more controls

299

2560

1.15

1.58

1.5

0.55

0.44

nmol/l

0.60

242

2093

Disorders of vitreous body

192

1582

1.19

1.58

1.3

1.4

0.24

0.29

nmol/l

0.84

134

1098

Asthma and allergy

187

1555

1.19

1.57

1.6

1.5

0.59

0.43

nmol/l

0.65

156

1290

Diagnoses used for exclusion with ILD

116

930

1.25

1.56

1.4

0.27

0.32

nmol/l

0.46

690

Other and unspecified disorders of vitreous body

148

1212

1.22

1.55

1.3

1.4

0.22

0.25

nmol/l

0.44

103

805

Soft tissue disorders related to use, overuse and pressure

144

1183

1.22

1.55

1.3

1.4

0.29

0.34

nmol/l

0.53

112

896

Other benign neoplasms of connective and other soft tissue

398

1.39

1.54

1.3

1.4

0.46

0.38

nmol/l

0.40

332

Asthma and allergy, excluding more controls

187

1558

1.19

1.54

1.6

1.5

0.59

0.43

nmol/l

0.64

156

1289

Postmenopausal osteoporosis with pathological fracture

1.98

1.54

2.6

1.5

0.14

0.18

nmol/l

—

Sicca syndrome [Sjögren]

424

1.37

1.54

1.2

1.4

0.35

0.34

nmol/l

0.03

318

Chronic periodontitis

475

1.35

1.53

1.4

0.21

0.32

nmol/l

1.21

351

Demyelinating diseases of the central nervous system

783

0.74

1.53

1.4

0.45

0.44

nmol/l

0.01

634

Melanocytic naevi, other sites/unspecified

511

1.34

1.52

1.3

1.5

0.49

0.40

nmol/l

0.29

405

Chronic periapical parodontitis

117

943

1.24

1.51

1.3

1.4

0.25

0.38

nmol/l

1.79

711

Haemorrhage in early pregnancy

402

3502

1.12

1.51

1.4

0.62

0.45

nmol/l

1.25

323

2737

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

2.16

1.50

1.0

1.3

0.27

0.24

nmol/l

—

Explicit bacterial Sepsis

366

1.40

1.50

1.4

0.21

0.31

nmol/l

1.67

299

Type 1 diabetes, strict definition

869

0.75

1.50

1.2

1.5

0.35

0.45

nmol/l

0.71

718

Acute laryngitis and tracheitis

152

1242

1.21

1.50

1.5

1.6

0.33

0.45

nmol/l

1.25

123

1048

Type1 diabetes, definitions combined, early onset

730

0.73

1.49

1.3

1.5

0.35

0.44

nmol/l

0.47

614

conjunctival haemorrhage

178

1.58

1.48

2.0

1.4

0.30

0.29

nmol/l

0.05

132

Unspecified lump in breast

128

1046

1.23

1.47

1.4

0.24

0.42

nmol/l

4.83

781

Dental caries 3 and operation codes, only avohilmo

282

1625

0.87

1.47

1.4

1.5

0.33

0.40

nmol/l

1.27

221

1324

Acne vulgaris

124

1012

1.23

1.47

1.6

1.5

0.38

0.46

nmol/l

0.58

105

849

Atypical facial pain

293

1.44

1.46

1.7

1.5

0.29

0.33

nmol/l

0.17

216

Poisoning by medicine

240

2076

1.16

1.46

1.4

1.5

0.39

0.42

nmol/l

0.15

186

1672

Mental and behavioural disorders due to opioids

285

1.45

1.46

1.5

0.24

0.41

nmol/l

1.88

245

Hallux rigidus

411

1.37

1.45

1.1

1.4

0.27

nmol/l

0.02

276

Postpartum haemorrhage

446

3494

1.12

1.45

1.4

0.56

0.43

nmol/l

1.16

374

2731

Osteosarcoma, excluding all cancers (controls excluding all cancers)

3.20

1.45

1.2

1.4

0.12

0.76

nmol/l

—

Benign neoplasm: Connective and other soft tissue of head, face and neck

2.14

1.45

2.0

1.5

0.42

0.44

nmol/l

0.03

Bell's palsy

576

1.31

1.45

1.3

1.4

0.27

0.40

nmol/l

1.49

447

Malignant neoplasm of cervix uteri

110

1.75

1.44

1.4

0.42

0.37

nmol/l

0.12

Viral and other specified intestinal infections

252

2139

1.15

1.44

1.7

1.6

0.38

0.41

nmol/l

0.22

205

1789

Disorders of synovium and tendon

453

3674

1.11

1.44

1.4

1.5

0.32

0.41

nmol/l

2.94

327

2902

Certolizumab pegol

149

1.63

1.43

1.8

1.5

0.35

0.42

nmol/l

0.28

126

Inflammatory bowel disease treatment related agents

1116

5922

1.07

1.43

1.5

1.4

0.34

0.42

nmol/l

4.10

853

4709

Disorders of vitreous body and globe

196

1630

1.17

1.42

1.3

1.4

0.26

0.29

nmol/l

0.21

137

1136

Mental retardation, excluding more controls

193

1.54

1.42

1.7

1.4

0.29

0.32

nmol/l

0.17

158

Other diseases of oesophagus

278

1.44

1.42

1.4

1.5

0.23

0.28

nmol/l

0.55

209

Stomatitis and related lesions

500

1.33

1.41

1.5

0.44

0.45

nmol/l

0.03

398

Any dementia

309

0.66

1.41

1.6

1.4

0.15

0.20

nmol/l

0.85

225

Cholelithiasis

550

4236

0.91

1.41

1.4

0.37

0.40

nmol/l

0.36

433

3197

Gout

376

1.36

1.41

1.3

1.4

0.23

0.19

nmol/l

0.16

280

Type 1 diabetes, strict definition, subgroup 1

826

0.76

1.41

1.2

1.5

0.36

0.46

nmol/l

0.68

684

Aneurysms, operations, SAH

565

0.71

1.40

1.3

1.4

0.60

0.27

nmol/l

0.74

409

Other abnormal findings of blood chemistry

189

1.54

1.40

1.4

1.5

0.25

0.36

nmol/l

1.34

150

Congenital malformations of ovaries, fallopian tubes and broad ligaments

669

1.28

1.40

1.4

1.5

0.57

0.46

nmol/l

0.57

545

Follow-up care involving plastic surgery

230

1.49

1.39

1.4

0.33

0.35

nmol/l

0.12

172

Acute bronchitis

271

2325

1.14

1.39

1.4

1.5

0.34

0.41

nmol/l

1.14

200

1829

Effects of foreign body entering through natural orifice

154

1291

1.20

1.38

1.3

1.5

0.26

0.37

nmol/l

2.05

123

1040

Trigeminal neuralgia

297

1.42

1.37

1.3

1.4

0.45

0.35

nmol/l

0.30

224

Diabetic retinopathy

716

0.79

1.37

1.3

1.6

0.27

0.42

nmol/l

1.49

549

Calcific tendinitis of shoulder

297

1.42

1.37

1.2

1.4

0.22

0.29

nmol/l

0.62

220

Persons encountering health services for specific procedures, not carried out

494

1.32

1.37

1.4

1.5

0.65

0.38

nmol/l

0.39

385

Other diseases of stomach and duodenum

182

1.54

1.37

1.4

1.5

0.46

0.30

nmol/l

0.47

130

Carcinoma in situ of skin

1.80

1.37

1.4

1.3

0.16

0.31

nmol/l

1.32

Morphin

2.62

1.37

1.7

1.3

0.10

0.23

nmol/l

—

Hydrocephalus in other diseases

2.99

1.36

1.0

1.4

—

0.29

nmol/l

—

Hemiplegia

231

1.48

1.36

1.4

0.22

0.37

nmol/l

2.00

180

Oral corticosteroids

971

5474

1.07

1.36

1.5

1.4

0.34

0.43

nmol/l

3.82

742

4327

Foreign body on external eye

582

1.29

1.36

1.2

1.5

0.29

0.32

nmol/l

0.20

485

Urethral stricture

1.83

1.35

1.3

1.6

0.31

0.25

nmol/l

—

Insulin, intermediate and long-acting

230

2593

0.87

1.35

1.4

1.5

0.28

0.38

nmol/l

2.11

172

2021

Diplopia

583

1.29

1.34

1.4

0.45

0.36

nmol/l

0.38

466

Alcohol abuse, main dg, excluding more controls

752

1.25

1.34

1.4

0.31

0.40

nmol/l

0.95

611

Rotator cuff syndrome

346

2288

1.12

1.33

1.3

1.4

0.27

0.34

nmol/l

1.35

256

1718

Focal epilepsy, mode (most common among epilepsy diagnosis)

115

941

1.22

1.33

1.4

1.5

0.33

0.38

nmol/l

0.34

746

Other disorders of eye and adnexa

117

960

1.22

1.33

1.4

1.5

0.38

0.40

nmol/l

0.15

758

Dermatophytosis

453

1.33

1.6

1.4

0.23

0.29

nmol/l

0.97

345

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

238

2077

1.15

1.32

1.4

1.5

0.42

0.49

nmol/l

0.49

195

1676

Other keratitis

709

1.26

1.32

1.4

1.5

0.34

0.42

nmol/l

0.51

569

Other disorders of nervous system

192

1.52

1.32

1.3

1.5

0.27

0.29

nmol/l

0.08

145

Disorders of eyelid, lacrimal system and orbit

642

4632

1.09

1.31

1.4

0.34

0.39

nmol/l

0.90

479

3559

Mixed connective tissue disease

394

1.35

1.31

1.5

1.4

0.32

0.35

nmol/l

0.26

300

Complications of labour and delivery

797

4119

1.08

1.30

1.4

0.50

0.40

nmol/l

1.50

634

3183

Other vitreous opacities

129

1.64

1.30

1.9

1.4

0.31

0.34

nmol/l

0.07

Heart failure and coronary heart disease

302

0.67

1.29

1.1

1.4

0.18

0.14

nmol/l

0.38

231

Osteonecrosis

169

1.55

1.29

1.5

0.28

nmol/l

0.03

125

Bullous disorders

169

1.55

1.29

1.2

1.6

0.27

0.29

nmol/l

0.17

136

Hallux valgus (acquired)

170

1442

0.85

1.27

1.5

1.4

0.28

0.36

nmol/l

1.28

131

1045

Atherosclerosis, excluding cerebral and coronary sclerosis

527

0.74

1.27

1.2

1.4

0.16

0.18

nmol/l

0.39

386

Atopic dermatitis, strict definition with reimbursement

416

3649

1.11

1.27

1.6

1.5

0.37

0.45

nmol/l

1.27

327

2979

Trochanteric bursitis

642

1.27

1.26

1.3

1.4

0.22

0.34

nmol/l

2.00

485

Benign neoplasm of other and ill-defined parts of digestive system

633

1.27

1.26

1.5

1.4

0.27

0.31

nmol/l

0.27

469

Haemangioma and lymphangioma, any site

501

1.30

1.26

1.4

0.24

0.36

nmol/l

1.42

384

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

599

1.28

1.26

1.5

1.6

0.29

0.41

nmol/l

0.98

502

Other disorders of conjunctiva

431

1.33

1.26

1.8

1.4

0.38

0.26

nmol/l

0.78

321

Juvenile osteochondrosis

261

1.43

1.26

1.4

1.5

0.32

0.34

nmol/l

0.10

219

Hypertensive Heart Disease

295

1.36

1.25

1.2

1.4

0.22

0.19

nmol/l

0.20

220

Benign neoplasm: Skin of eyelid, including canthus

528

1.29

1.25

1.4

0.58

0.29

nmol/l

1.23

391

Unknown and unspecified causes of morbidity

363

1.36

1.24

1.7

1.4

0.23

0.47

nmol/l

3.36

300

Malignant neoplasm of thyroid gland

346

1.37

1.24

1.7

1.4

0.26

0.33

nmol/l

0.85

264

Other obstructed labour

800

0.77

1.24

1.3

1.4

0.47

0.41

nmol/l

0.18

606

Lumbar disc prolapse

488

3535

1.10

1.24

1.4

0.28

0.40

nmol/l

6.03

366

2757

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

188

1622

1.16

1.24

1.4

1.5

0.32

0.44

nmol/l

2.35

140

1300

Exclusion endpoint for clefts

155

1.57

1.24

1.3

1.5

0.45

0.37

nmol/l

0.14

127

Lymphangioma, anys site

2.08

1.23

2.6

1.5

0.35

0.46

nmol/l

—

Emergency coronary revascularization (for ACS)

698

0.79

1.23

1.2

1.4

0.20

0.18

nmol/l

0.22

515

Multiple delivery

987

0.80

1.22

2.3

1.4

0.38

0.44

nmol/l

0.38

763

Implicit parasitic Sepsis

2.68

1.22

2.6

1.2

0.32

0.37

nmol/l

—

Haemangioma, any site

460

1.31

1.22

1.4

1.5

0.22

0.33

nmol/l

1.92

353

Cellulitis

132

1107

1.20

1.22

1.3

1.5

0.27

0.39

nmol/l

1.98

109

873

Heart failure and hypertrophic cardiomyopathy

2.65

1.22

2.8

1.4

0.13

0.22

nmol/l

—

Benign neoplasm of male genital organs

2.64

1.22

3.0

1.3

0.16

0.19

nmol/l

—

Other specified congenital malformation syndromes affecting multiple systems

132

1.61

1.21

1.2

1.4

0.52

0.35

nmol/l

0.29

107

Benign neoplasm of other and unspecified sites

1.73

1.21

1.8

1.4

0.19

0.35

nmol/l

—

Pre-eclampsia or eclampsia

283

2517

1.13

1.20

1.4

1.5

0.55

0.48

nmol/l

0.28

227

1962

Retinal detachment with retinal break

314

1.37

1.20

1.2

1.4

0.21

0.25

nmol/l

0.43

235

Poisoning by narcotics and psychodysleptics [hallucinogens]

109

1.67

1.20

1.7

1.6

0.22

0.39

nmol/l

1.03

Rash and other nonspecific skin eruption

523

1.29

1.20

1.5

1.4

0.45

0.37

nmol/l

0.21

410

Other diseases of jaws

392

1.33

1.19

1.4

1.5

0.26

0.46

nmol/l

2.21

307

Entropion and trichiasis of eyelid

101

1.69

1.19

1.9

1.7

0.43

0.27

nmol/l

—

Cicatricial alopecia [scarring hair loss]

2.34

1.19

1.2

1.5

0.24

0.48

nmol/l

—

Peripheral artery disease

642

0.78

1.19

1.2

1.4

0.19

nmol/l

0.04

468

Other diseases of pancreas

189

1.49

1.18

1.5

1.6

0.24

0.26

nmol/l

0.13

141

Azathioprine

127

1065

1.20

1.18

1.5

0.41

0.43

nmol/l

0.09

841

Abnormal serum enzyme levels

701

1.24

1.18

1.5

1.4

0.21

0.28

nmol/l

1.09

552

Thyrotoxicosis with diffuse goitre

125

1047

1.20

1.18

1.5

1.4

0.46

0.44

nmol/l

0.08

819

Tooth agenesis EXCLUDE clefts and syndromes

402

1.33

1.18

1.4

1.6

0.40

0.35

nmol/l

0.23

338

ILD medications: azathioprine

127

1066

1.19

1.17

1.5

0.41

0.43

nmol/l

0.06

841

Pre-eclampsia

273

2428

1.13

1.17

1.4

1.5

0.55

0.49

nmol/l

0.24

220

1894

Secondary hypertension

304

1.37

1.17

1.6

1.5

0.25

0.31

nmol/l

0.28

246

Focal epilepsy

135

1139

1.19

1.17

1.5

0.33

0.39

nmol/l

0.49

106

899

Melanocytic naevi of other and unspecified parts of face

385

1.33

1.17

1.5

0.34

0.37

nmol/l

0.23

301

COPD, hospital admission 2, with asthma infections

524

0.75

1.17

1.2

1.4

0.21

0.20

nmol/l

0.02

384

Algoneurodystrophy

240

1.43

1.17

1.3

1.4

0.24

0.35

nmol/l

1.06

191

Myopia

149

1270

1.18

1.16

1.3

1.5

0.44

0.45

nmol/l

0.05

121

1024

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

623

1.26

1.16

1.3

1.4

0.55

0.34

nmol/l

0.37

475

Spontaneous rupture of synovium and tendon

265

1.40

1.16

1.2

1.5

0.18

0.27

nmol/l

1.30

204

Autoimmune hepatitis

0.00

1.16

0.0

1.5

—

0.32

—

Hypertrophic disorders of skin

491

1.29

1.16

1.4

1.5

0.39

0.43

nmol/l

0.17

395

Ascites

182

1.49

1.15

1.2

1.5

0.15

0.32

nmol/l

1.88

135

Episcleritis

334

1.36

1.15

1.2

1.5

0.30

0.33

nmol/l

0.14

262

Chronic myeloid leukaemia [CML], BCR/ABL-positive

2.52

1.15

2.2

1.7

0.26

0.23

nmol/l

—

Other neurotic disorders

174

1.50

1.15

1.7

1.5

0.20

0.31

nmol/l

1.25

136

Artificial joint re-operation

110

1.64

1.15

1.4

0.24

0.18

nmol/l

0.17

152

1771

0.85

1.15

1.5

0.58

0.53

nmol/l

0.15

128

1463

Type of accident

158

1839

0.86

1.15

1.4

1.5

0.30

0.40

nmol/l

1.71

123

1447

Pneumonia due to other infectious organisms, not elsewhere classified

118

1.62

1.15

1.5

0.44

0.31

nmol/l

0.35

Disorder of lipoprotein metabolism, unspecified

257

1.40

1.15

1.3

1.4

0.20

0.21

nmol/l

0.06

191

Other diseases of pleura

138

1035

1.18

1.14

1.4

0.22

0.29

nmol/l

1.03

101

766

Injuries to the head

913

6336

0.94

1.14

1.5

1.4

0.29

0.42

nmol/l

9.96

712

5027

Fracture of skull and facial bones

135

1143

1.18

1.14

1.4

1.5

0.26

0.39

nmol/l

2.68

105

895

Other obstetric trauma

821

0.79

1.14

1.4

1.5

0.81

0.44

nmol/l

1.23

647

Obesity due to excess calories

450

4116

1.10

1.13

1.4

1.5

0.30

0.44

nmol/l

4.14

352

3235

Herpesviral [herpes simplex] infections

716

1.23

1.13

1.4

0.27

0.40

nmol/l

2.41

569

Ocular pain

555

1.27

1.12

1.2

1.5

0.42

0.43

nmol/l

0.04

438

Polyarthritis, unspecified

167

1.51

1.12

2.3

1.4

0.52

0.33

nmol/l

0.48

132

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

103

1.65

1.12

1.3

1.4

0.27

0.22

nmol/l

—

Type 1 diabetes, wide definition

145

1693

0.85

1.12

1.3

1.5

0.35

0.43

nmol/l

0.92

115

1368

Postprocedural disorders of digestive system, not elsewhere classified

111

1.63

1.12

1.2

1.6

0.26

0.36

nmol/l

0.71

Other disorders of white blood cells

225

1.43

1.12

1.5

1.4

0.20

0.31

nmol/l

1.64

179

Lichen simplex chronicus

127

1.58

1.11

2.3

1.5

0.15

0.34

nmol/l

2.11

Internal derangement of knee

283

2523

1.12

1.11

1.6

1.4

0.35

0.41

nmol/l

0.53

213

1962

Cardiomyopathy, other and unspecified

192

1.46

1.11

1.3

1.5

0.21

0.26

nmol/l

0.39

155

Etanercept

458

0.72

1.11

1.3

1.4

0.45

0.38

nmol/l

0.27

359

Hypertensive heart and/or renal disease

333

1.30

1.11

1.2

1.4

0.21

0.20

nmol/l

0.06

247

Disorders of gallbladder, biliary tract and pancreas

664

4604

0.93

1.11

1.4

0.37

0.40

nmol/l

0.49

516

3522

Cutaneous abscess, furuncle and carbuncle

195

1704

1.15

1.10

1.4

1.5

0.39

0.42

nmol/l

0.14

153

1363

Puerperal sepsis

886

0.80

1.10

1.4

0.34

0.41

nmol/l

0.49

646

Substance abuse, excluding more controls

377

2994

1.10

1.4

0.31

0.40

nmol/l

2.50

285

2381

Other meningitis

1.74

1.09

1.6

1.5

0.26

0.36

nmol/l

—

Other follicular disorders

513

1.27

1.09

1.4

1.5

0.29

0.44

nmol/l

1.74

413

Dental pulpitis 3

230

1462

1.14

1.09

1.7

1.6

0.36

0.38

nmol/l

0.06

196

1247

Scleritis and episcleritis

381

1.32

1.09

1.2

1.5

0.30

0.37

nmol/l

0.50

303

Falls/tendency to fall

1195

5660

1.06

1.09

1.5

1.4

0.34

0.43

nmol/l

3.21

921

4529

Nerve, nerve root and plexus disorders

880

5186

1.07

1.09

1.4

0.33

0.42

nmol/l

3.19

658

4067

COPD, early/later onset

832

0.81

1.09

1.4

0.19

0.21

nmol/l

0.37

600

Type 1 diabetes, wide definition, subgroup 1

140

1633

0.85

1.08

1.3

1.5

0.35

0.42

nmol/l

0.77

110

1325

Other disorders of bone

167

1446

1.16

1.08

1.6

1.5

0.29

0.42

nmol/l

2.69

138

1132

Delivery

399

2319

0.91

1.08

1.5

0.49

0.38

nmol/l

0.79

327

1872

Adverse effects, not elsewhere classified

196

1718

1.14

1.07

1.6

1.5

0.50

0.44

nmol/l

0.19

142

1371

Type 1 diabetes, strict (exclude DM2)

957

0.81

1.07

1.3

1.5

0.45

0.43

nmol/l

0.06

788

Scoliosis

739

1.22

1.07

1.7

1.6

0.35

0.39

nmol/l

0.35

612

Recurring oral aphthae

219

1.42

1.07

1.5

0.49

0.31

nmol/l

0.55

175

Non-invasive ventilation

115

1280

0.84

1.06

1.4

0.50

0.44

nmol/l

0.14

994

Unstable angina pectoris

547

0.77

1.05

1.2

1.4

0.17

0.15

nmol/l

0.15

398

Cardiac arrhythmias

574

4093

0.93

1.05

1.4

0.35

0.41

nmol/l

0.65

441

3207

COPD, hospital admissions

830

0.81

1.05

1.4

0.19

0.21

nmol/l

0.38

598

Visual impairment including blindness (binocular or monocular)

220

1.41

1.04

1.5

0.26

0.32

nmol/l

0.41

182

Any dementia, excluding more controls

284

0.71

1.04

1.6

1.4

0.15

0.19

nmol/l

0.64

206

Other disorders starting during childhood or adolescence

566

1.25

1.04

1.6

0.22

0.42

nmol/l

3.25

479

DVT of lower extremities and pulmonary embolism

169

1464

1.15

1.04

1.4

0.41

0.33

nmol/l

0.40

120

1081

Strabismus

239

2123

1.13

1.04

1.4

1.5

0.37

0.43

nmol/l

0.34

176

1692

Mixed disorders of conduct and emotions

272

1.37

1.04

1.2

1.6

0.27

0.39

nmol/l

0.93

237

Intracranial injury

417

3689

1.09

1.04

1.5

0.27

0.39

nmol/l

5.71

314

2922

Benign neoplasm of mouth and pharynx

437

1.29

1.03

1.3

1.5

0.47

0.29

nmol/l

0.80

334

Thrombocytopenia, unspecified

246

1.39

1.03

1.8

1.5

0.94

0.34

nmol/l

0.41

196

Injury of nerves at wrist and hand level

179

1.46

1.03

2.0

1.4

0.19

0.32

nmol/l

1.99

144

Benign neoplasm of urinary organs

1.64

1.03

1.3

1.4

0.16

0.37

nmol/l

2.57

Other and unspecified mononeuropathies, also in other diseases

106

1.61

1.03

1.9

1.4

0.32

0.33

nmol/l

0.05

Mucosal proctocolitis

108

907

1.19

1.03

1.5

0.45

0.42

nmol/l

0.13

740

Familial hypercholesterolemia, with ischemic heart disease

1.64

1.03

1.1

1.6

0.10

0.13

nmol/l

1.11

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

292

1.32

1.03

1.4

0.38

0.21

nmol/l

0.54

226

Blepharochalasis

797

1.21

1.02

1.4

0.19

0.23

nmol/l

0.54

526

Other disorders of patella

175

1529

1.15

1.02

1.5

1.4

0.37

0.46

nmol/l

0.50

145

1190

Sub-endpoint used in defining T1D endpoints

168

1893

0.87

1.02

1.4

1.5

0.39

0.43

nmol/l

0.24

132

1536

Papillary adenocarcinoma of thyroid gland

264

1.37

1.02

1.7

1.4

0.24

0.33

nmol/l

0.79

198

Diseases of oesophagus, stomach and duodenum

824

5327

0.94

1.01

1.5

1.4

0.39

0.40

nmol/l

0.11

640

4155

Dental operations

469

2211

1.09

1.00

1.4

1.5

0.33

0.38

nmol/l

0.91

360

1733

Malignant melanoma of skin

325

1.33

1.00

1.4

1.5

0.25

0.27

nmol/l

0.12

241

Benign neoplasm: Liver

115

1.58

1.00

1.1

1.4

0.26

0.38

nmol/l

0.88

Primary coxarthrosis, bilateral

546

1.25

1.00

1.3

1.4

0.19

nmol/l

0.00

357

Other retinal disorders

221

1998

0.89

1.00

1.6

1.4

0.32

0.38

nmol/l

0.58

163

1513

Spinal stenosis

162

1102

1.15

1.00

1.4

0.27

0.23

nmol/l

0.36

106

773

Motorcycle rider injured in other and unspecified transport accidents

352

1.31

0.99

1.4

1.6

0.24

0.30

nmol/l

0.53

290

Other diseases of arteries and capillaries

317

1.33

0.99

1.5

1.4

0.22

0.31

nmol/l

1.35

241

Other juvenile arthritis

423

1.29

0.99

1.7

1.5

0.33

0.43

nmol/l

0.79

354

Injury of nerves at lower leg level

1.86

0.99

1.3

1.6

0.15

0.30

nmol/l

—

Sacroiliitis, not elsewhere classified

441

1.28

0.98

1.5

0.39

0.41

nmol/l

0.08

363

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

415

2868

0.92

0.98

1.3

1.4

0.43

0.41

nmol/l

0.13

306

2226

Supplementary factors related to causes of morbidity and mortality classified elsewhere

181

2057

0.88

0.98

1.5

0.30

0.40

nmol/l

1.93

143

1628

Other respiratory disorders and diseases

467

1.27

0.98

1.6

1.5

0.17

0.24

nmol/l

1.85

350

Other diseases of the respiratory system

467

1.27

0.98

1.6

1.5

0.17

0.24

nmol/l

1.85

350

Other disorders affecting eyelid function

0.00

0.98

0.0

1.6

—

0.29

—

Ulcerative ileocolitis

275

1.35

0.97

1.8

1.4

0.47

0.36

nmol/l

0.45

218

Impingement syndrome of shoulder

113

958

1.18

0.97

1.4

0.25

0.28

nmol/l

0.40

696

Other disorders of kidney and ureter

388

1.29

0.97

1.3

1.5

0.27

nmol/l

0.04

289

Mandibular retrognathia

636

0.78

0.97

1.4

1.5

0.35

0.38

nmol/l

0.17

507

Other retinal artery occlusion

0.00

0.97

0.0

1.3

—

0.16

—

Varicose veins of other sites

173

1.45

0.97

1.5

1.6

0.20

0.24

nmol/l

0.31

137

Aortic valve malfunction, age under 60 years

362

1.30

0.97

1.3

1.5

0.73

0.26

nmol/l

0.91

275

ILD, hospital admission 2, with pulmonary infections

173

1.45

0.97

1.7

1.6

0.16

0.23

nmol/l

1.10

132

Congenital malformations of uterus and cervix

276

1.36

0.97

1.3

1.5

0.58

0.42

nmol/l

0.58

243

Insulin, fast-acting or short human

187

2117

0.88

0.97

1.3

1.5

0.31

0.41

nmol/l

1.54

144

1685

Degenerative diseases of the nervous system

259

0.70

0.97

1.3

1.4

0.15

nmol/l

0.02

183

Other strabismus

213

1889

1.13

0.96

1.4

1.5

0.39

0.43

nmol/l

0.19

155

1507

Colorectal adenocarcinoma

342

0.70

0.96

1.4

1.5

0.40

0.20

nmol/l

0.30

253

Retained placenta and membranes, without haemorrhage

1163

0.84

0.96

1.7

1.4

0.51

0.42

nmol/l

0.28

878

Fracture of foot, except ankle

163

1861

0.87

0.96

1.5

0.32

0.43

nmol/l

1.19

125

1482

Presence of cardiac and vascular implants and grafts

660

0.81

0.96

1.1

1.5

0.29

0.20

nmol/l

0.30

482

Other deformities of toe(s)

149

1.48

0.95

1.5

1.4

0.41

0.34

nmol/l

0.22

120

Non-allergic asthma (mode), excluding more controls

130

1107

1.17

0.95

1.5

1.4

0.31

0.36

nmol/l

0.71

870

Coronary angioplasty

533

0.79

0.95

1.2

1.4

0.18

0.19

nmol/l

0.12

394

5-aminosalicylic acid

186

1642

1.14

0.95

1.5

0.41

0.44

nmol/l

0.21

150

1312

Other viral diseases, not elsewhere classified

169

1479

1.14

0.94

1.4

1.5

0.28

0.41

nmol/l

3.30

132

1176

Substance use, excluding alcohol

158

1380

1.15

0.94

1.5

0.26

0.42

nmol/l

4.02

115

1110

Neuromuscular dysfunction of bladder

355

1.30

0.94

1.8

1.4

0.23

0.34

nmol/l

1.30

277

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

359

3287

1.09

0.94

1.4

1.5

0.43

0.44

nmol/l

0.05

277

2666

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

1.78

0.94

1.7

1.3

0.29

0.23

nmol/l

—

Muscular dystrophy

2.25

0.94

1.3

1.4

0.15

0.28

nmol/l

—

Other infectious diseases

303

1.32

0.93

1.3

1.5

0.21

0.34

nmol/l

1.87

245

Benign neoplasm: Choroid

117

1.54

0.93

1.4

0.28

0.34

nmol/l

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

209

1.34

0.93

1.8

1.5

0.16

0.30

nmol/l

2.61

150

Artificial joint operation, meniscal resection

414

2992

0.92

0.93

1.4

0.21

0.31

nmol/l

4.69

302

2202

Other demyelinating diseases of the central nervous system

350

0.71

0.93

1.3

1.4

0.43

0.46

nmol/l

0.10

283

Symptoms and signs involving cognition, perception, emotional state and behaviour

794

5241

1.06

0.92

1.5

1.4

0.30

0.40

nmol/l

5.19

613

4080

Shoulder lesions

522

2966

1.08

0.92

1.3

1.4

0.32

0.38

nmol/l

0.60

381

2283

Melanocytic naevi of lower limb, including hip

278

1.34

0.92

1.7

1.4

0.35

0.39

nmol/l

0.14

227

Alzheimer disease, including avohilmo

212

0.68

0.92

1.4

0.14

0.13

nmol/l

0.11

152

Infections, IBD-co-morbidities

117

727

1.17

0.92

1.7

1.4

0.24

0.43

nmol/l

4.00

101

570

Allergic urticaria

635

1.22

0.92

1.7

1.4

0.58

0.42

nmol/l

0.23

511

Embedded and impacted teeth

410

3212

1.09

0.92

1.7

1.5

0.40

0.46

nmol/l

0.76

351

2705

Hyperkinetic disorders (excl. ADHD)

133

1.50

0.92

1.6

1.5

0.24

0.37

nmol/l

1.00

113

Postzoster neuralgia

2.16

0.91

1.5

1.4

0.29

0.30

nmol/l

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

508

1.24

0.91

1.2

1.4

0.25

0.24

nmol/l

0.05

358

Injuries to the knee and lower leg

1029

6204

0.95

0.91

1.4

1.5

0.30

0.42

nmol/l

8.13

805

4917

Benign mammary dysplasia

699

1.20

0.91

1.6

1.4

0.44

0.40

nmol/l

0.18

509

Car occupant injured in noncollision transport accident

255

0.66

0.91

1.3

1.5

0.36

0.37

nmol/l

0.05

212

Infective dermatitis

531

0.77

0.90

1.5

0.17

0.38

nmol/l

4.21

424

Non-allergic asthma (mode)

130

1114

1.16

0.90

1.5

1.4

0.31

0.36

nmol/l

0.69

875

Other autoimmune haemolytic anaemias

2.08

0.89

1.2

1.3

0.28

0.38

nmol/l

—

Benign neoplasm: Conjunctiva

135

1.49

0.89

1.7

1.5

0.92

0.33

nmol/l

0.68

103

Colectomy operation

474

1.25

0.89

1.4

1.5

0.36

0.26

nmol/l

0.65

357

Familial hypercholesterolemia

288

1.32

0.89

1.2

1.5

0.20

0.22

nmol/l

0.12

223

Hypoglycaemia, other or unspecified

341

1.29

0.89

1.4

1.5

0.19

0.36

nmol/l

3.82

272

Seropositive rheumatoid arthritis, strict definition

729

0.81

0.88

1.7

1.4

0.25

0.36

nmol/l

1.44

548

Other specified/unspecified spondylopathies

1.91

0.88

1.4

1.7

0.16

0.24

nmol/l

—

Other and unspecified psoriasis

254

1.34

0.88

1.6

1.5

0.21

0.32

nmol/l

1.15

191

Dental pulpitis 4

1071

5287

1.05

0.88

1.4

1.5

0.42

0.41

nmol/l

0.10

841

4237

Superficial injury of hip and thigh

592

1.22

0.88

1.3

1.5

0.23

0.38

nmol/l

2.27

473

Exposure to other and unspecified animate mechanical forces

220

1.37

0.88

1.1

1.5

0.59

0.36

nmol/l

0.30

184

Insulin, fast-acting

187

2100

0.89

0.88

1.3

1.5

0.31

0.41

nmol/l

1.52

144

1671

Allergic rhinitis

369

3363

1.09

0.88

1.5

0.39

0.42

nmol/l

0.21

303

2684

Disorders of choroid and retina

339

2694

0.92

0.87

1.5

1.4

0.30

0.37

nmol/l

0.88

249

2026

Ptosis of eyelid

289

1.32

0.87

1.3

1.5

0.22

0.27

nmol/l

0.44

218

Other enthesopathies

210

1879

1.12

0.87

1.3

1.4

0.25

0.38

nmol/l

4.51

160

1427

Disorders of orbit

220

1.37

0.87

1.6

1.5

0.39

0.34

nmol/l

0.28

171

Excessive vomiting in pregnancy

124

1073

1.16

0.87

1.3

1.5

0.39

0.48

nmol/l

0.89

100

871

Delirium, not induced by alcohol and other psychoactive substances

177

1.41

0.87

1.3

1.4

0.36

0.25

nmol/l

0.28

137

Benign neoplasm: Skin of other and unspecified parts of face

413

1.26

0.87

1.6

1.4

0.22

0.36

nmol/l

1.83

317

Hypotension

298

1.31

0.87

1.3

1.5

0.28

0.26

nmol/l

0.13

237

Spinal instabilities

136

1.48

0.87

1.0

1.4

0.32

0.35

nmol/l

0.09

Dislocation, sprain and strain of joints and ligaments of thorax

161

1.44

0.87

1.3

1.5

0.54

0.32

nmol/l

0.27

129

Anorexia

120

1.52

0.86

1.6

1.4

0.38

0.36

nmol/l

0.02

Abscess of anal and rectal regions

396

1.27

0.86

1.2

1.5

0.26

0.39

nmol/l

0.87

309

Fentanyl

212

1.37

0.86

1.4

1.5

0.19

0.29

nmol/l

1.39

153

Enteropathic arthropathies

145

1.46

0.85

1.3

1.4

0.35

0.39

nmol/l

0.15

121

AV-block

279

1.30

0.85

1.2

1.5

0.18

0.25

nmol/l

1.08

226

Glucagon-like peptide-1 (GLP-1) analogues

141

1325

0.87

0.85

1.4

0.19

0.24

nmol/l

1.68

942

Other specified and unspecified disorders of eyelid

1.79

0.84

1.1

1.5

0.19

0.24

nmol/l

—

Nontoxic single thyroid nodule

344

1.28

0.84

1.4

0.32

0.38

nmol/l

0.36

258

Use of fingolimod

114

0.52

0.84

2.0

1.4

0.48

0.38

nmol/l

—

Primary open-angle glaucoma

483

1.23

0.84

1.6

1.4

0.17

0.20

nmol/l

0.28

331

Other shoulder lesions

569

1.22

0.84

1.4

0.62

0.40

nmol/l

0.26

451

Other blood glucose lowering drugs, excl. Insulins

378

0.74

0.84

1.1

1.5

0.16

0.23

nmol/l

1.49

268

Impacted teeth

294

2500

1.10

0.83

1.7

1.5

0.38

0.45

nmol/l

0.71

257

2126

Impacted cerumen

274

1.32

0.83

1.4

1.5

0.26

0.30

nmol/l

0.34

209

Birth trauma

1.77

0.83

1.3

1.7

0.19

0.38

nmol/l

—

Carcinoma in situ of cervix uteri

127

1106

1.15

0.83

1.3

1.5

0.52

0.54

nmol/l

0.09

946

Diabetes mellitus in pregnancy

660

4028

1.06

0.83

1.4

0.56

0.44

nmol/l

1.31

536

3218

Hypertensive diseases (excluding secondary)

550

2987

1.07

0.83

1.5

1.4

0.32

0.40

nmol/l

1.47

386

2323

Superficial injury of wrist and hand

151

1711

0.88

0.83

1.5

0.31

0.43

nmol/l

1.08

122

1378

Benign neoplasm: Liver/bile ducts

121

1.50

0.83

1.1

1.4

0.26

0.37

nmol/l

0.78

104

Other inflammatory liver diseases

292

1.31

0.83

1.3

1.5

0.23

0.35

nmol/l

1.42

221

Umbilical hernia

149

1311

1.14

0.83

1.6

1.4

0.30

0.38

nmol/l

0.85

122

1029

COPD, hospital admissions 3, with asthma pneumonia sepsis

360

0.76

0.83

1.2

1.4

0.24

0.21

nmol/l

0.25

267

Paralytic strabismus

231

1.35

0.83

1.7

1.5

0.23

0.31

nmol/l

0.83

181

Other peripheral vascular diseases

417

1.25

0.82

1.6

1.4

0.22

0.39

nmol/l

2.41

335

Purpura and other haemorrhagic conditions

662

1.20

0.82

1.8

1.5

0.60

0.38

nmol/l

0.33

527

Complications of the puerperium, not elsewhere classified

563

1.22

0.82

1.4

0.52

0.47

nmol/l

0.26

457

Diseases of pulp and periapical tissues, including avohilmo

1068

5286

1.05

0.81

1.4

1.5

0.42

0.41

nmol/l

0.11

838

4236

Dental pulpitis 3, only avohilmo

208

1364

1.12

0.81

1.7

1.6

0.36

0.37

nmol/l

0.04

176

1162

Maternal care for known or suspected malpresentation of fetus

332

2689

0.92

0.81

1.4

0.59

0.48

nmol/l

0.56

268

2166

Pacemaker

519

1.22

0.81

1.3

1.4

0.18

0.21

nmol/l

0.59

386

Inflammatory disorders of breast

730

0.82

0.81

1.4

1.5

0.35

0.52

nmol/l

1.61

590

Atopic dermatitis, strict definition

396

3598

1.08

0.81

1.6

1.5

0.36

0.44

nmol/l

1.22

310

2935

Preterm labour and delivery

293

2682

1.09

0.81

1.6

1.4

0.55

0.40

nmol/l

0.94

225

1997

Type 1 diabetes, definitions combined

956

0.84

0.81

1.3

1.5

0.45

0.43

nmol/l

0.03

786

Cyst of kidney

130

1.47

0.80

1.1

1.5

0.17

0.27

nmol/l

0.73

101

Dental pulpitis 1

1068

5289

1.05

0.80

1.4

1.5

0.42

0.41

nmol/l

0.12

838

4239

Disorders of continuity of bone

545

1.21

0.80

1.7

1.4

0.26

0.39

nmol/l

1.86

423

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

527

1.22

0.80

1.6

1.5

0.25

0.37

nmol/l

2.27

441

Gout, FINNGEN

454

1.23

0.80

1.3

1.4

0.23

0.18

nmol/l

0.21

345

Crohn's disease of large intestine

356

1.27

0.80

1.3

1.4

0.40

0.43

nmol/l

0.10

286

Other chronic obstructive pulmonary disease

789

0.84

0.80

1.4

0.19

0.20

nmol/l

0.24

563

Occupant of pick-up truck or van injured in other and unspecified transport accidents

0.00

0.79

0.0

1.6

—

0.26

—

Use of disulfiram, acamprosate or naltrexone

383

1.26

0.79

1.3

1.5

0.29

0.27

nmol/l

0.13

295

Dislocation, sprain and strain of joints and ligaments at neck level

164

1458

1.13

0.79

1.4

1.5

0.40

0.45

nmol/l

0.26

127

1176

Specific development disorders of scholastic skills

415

1.25

0.79

2.0

1.6

0.39

0.35

nmol/l

0.12

344

Dental pulpitis 4, only avohilmo

1076

5360

1.05

0.79

1.4

1.5

0.42

0.41

nmol/l

0.15

837

4297

Rheumatoid arthritis

155

1588

0.89

0.78

1.5

1.4

0.30

0.41

nmol/l

1.69

114

1189

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

173

1.39

0.78

1.2

1.5

0.24

0.31

nmol/l

0.54

145

Conductive and sensorineural hearing loss

337

2532

0.92

0.78

1.4

0.23

0.34

nmol/l

4.55

259

1869

ILD, hospital admissions 1, main diag only

251

1.32

0.78

1.8

1.5

0.17

0.25

nmol/l

1.53

189

Other disorders of the genitourinary system

438

1.24

0.78

1.4

0.23

0.30

nmol/l

0.95

308

Persistent delusional disorders

304

1.29

0.78

1.5

0.52

0.29

nmol/l

0.88

232

Adjustment and management of implanted device

375

1.25

0.78

1.4

1.5

0.20

0.24

nmol/l

0.55

283

COPD, hospital admissions 1, only main diagnosis

555

0.81

0.77

1.4

0.16

0.21

nmol/l

1.44

401

Gonarthrosis,primary

374

2541

0.92

0.77

1.3

0.24

0.27

nmol/l

0.41

268

1786

Bruxism

174

1.39

0.77

1.6

1.4

0.33

0.35

nmol/l

0.11

140

Gestational [pregnancy-induced] hypertension

347

3740

0.92

0.77

1.4

0.50

0.48

nmol/l

0.07

272

2978

Dental pulpitis 1, only avohilmo

1077

5371

1.05

0.76

1.4

1.5

0.42

0.41

nmol/l

0.12

837

4306

Unspecified acute lower respiratory infection

732

1.18

0.76

1.6

1.5

0.34

0.39

nmol/l

0.39

604

Dental operations, only avohilmo

490

2344

1.07

0.76

1.4

0.33

0.38

nmol/l

0.83

369

1837

Allergic colitis

209

1.35

0.76

1.8

1.6

0.18

0.34

nmol/l

1.84

166

Chronic laryngitis and laryngotracheitis

613

1.19

0.75

1.5

1.3

0.31

0.37

nmol/l

0.45

456

Benign neoplasm of eye and adnexa

368

1.25

0.75

1.5

0.64

0.29

nmol/l

0.95

278

Left ventricular outflow tract obstruction (LVOTO), broad definition

422

1.24

0.75

1.3

1.5

0.67

0.27

nmol/l

0.85

320

Dislocation, sprain and strain of joint and ligaments of hip

1.54

0.75

1.6

1.5

0.53

0.33

nmol/l

0.29

Adalimumab

680

0.82

0.75

1.4

1.5

0.25

0.42

nmol/l

3.01

539

Fissure and fistula of anal and rectal regions

146

1294

1.13

0.75

1.2

1.4

0.32

0.38

nmol/l

0.79

110

990

Cardiac murmurs and other cardiac sounds

707

1.18

0.75

1.6

1.5

0.36

0.37

nmol/l

0.04

577

Mental disorders, not otherwise specified

790

1.17

0.74

1.3

1.5

0.43

0.46

nmol/l

0.17

645

Functional dyspepsia

188

1693

1.11

0.74

1.4

0.38

0.40

nmol/l

0.16

147

1296

Hernia of abdominal wall

237

2160

1.10

0.73

1.6

1.4

0.28

0.37

nmol/l

1.45

182

1655

Paroxysmal tachycardia

171

1294

1.12

0.73

1.3

1.4

0.34

0.39

nmol/l

0.27

137

1003

Foreign body or object entering through skin

325

1.27

0.73

1.3

1.6

0.45

0.34

nmol/l

0.16

268

Injury of muscle and tendon at hip and thigh level

451

1.22

0.73

1.5

1.4

0.26

0.32

nmol/l

0.45

333

Other disorders of glucose regulation and pancreatic internal secretion

415

1.23

0.73

1.4

0.27

0.38

nmol/l

0.77

331

Oral lichen ruber planus, including avohilmo

228

1.32

0.73

1.4

1.5

0.31

0.30

nmol/l

0.03

169

Inflammatory bowel disease

258

2363

1.09

0.73

1.4

1.5

0.38

0.42

nmol/l

0.44

212

1868

Benign neoplasm of male genital organs

2.01

0.72

3.0

1.2

0.16

0.17

nmol/l

—

Other intracranial haemorrhages

1.80

0.72

1.1

1.3

0.16

0.21

nmol/l

—

Cyst of Bartholin Gland

335

1.26

0.72

1.3

1.4

0.52

0.43

nmol/l

0.46

266

Meniscus derangement

294

2185

0.92

0.72

1.3

1.4

0.28

0.36

nmol/l

1.16

212

1632

Acute nasopharyngitis (common cold)

558

1.20

0.72

1.2

1.5

0.49

0.35

nmol/l

0.54

465

Fibroblastic disorders

820

1.16

0.72

1.2

1.4

0.30

0.33

nmol/l

0.19

620

Injuries to the thorax

225

2048

1.10

0.72

1.3

1.5

0.34

0.37

nmol/l

0.15

164

1599

Other specified/unspecified inflammatory spondylopathies

380

1.24

0.72

1.3

1.5

0.39

0.40

nmol/l

0.07

299

Conduction disorders

101

727

1.16

0.72

1.4

0.27

0.30

nmol/l

0.35

561

Pathological resorption of teeth

168

1.38

0.72

1.2

1.5

0.22

0.39

nmol/l

1.69

132

Prolonged pregnancy

257

2554

0.92

0.71

1.4

1.5

0.59

0.48

nmol/l

0.76

206

2089

Ankylosing spondylitis, strict definition

287

0.73

0.71

1.5

0.19

0.32

nmol/l

2.29

229

Lesion of radial nerve

134

1.42

0.71

1.7

1.4

0.19

0.35

nmol/l

—

102

Pregnancy hypertension

578

4919

1.06

0.71

1.4

0.48

0.47

nmol/l

0.11

459

3844

Lactose intolerance

203

1.34

0.71

1.7

1.5

0.57

0.38

nmol/l

0.41

168

Caught, crushed, jammed or pinched in or between objects

275

0.72

0.70

1.5

1.6

0.24

0.32

nmol/l

0.34

224

Other and unspecified effects of external causes

267

2454

1.09

0.70

1.5

0.47

0.43

nmol/l

0.17

188

1980

Injuries to the ankle and foot

710

6142

1.05

0.70

1.5

0.33

0.42

nmol/l

4.04

561

4894

Diseases of arteries, arterioles and capillaries

204

1678

0.91

0.70

1.4

0.21

0.31

nmol/l

3.91

161

1239

Impacted maxillary molar

758

1.17

0.70

1.9

1.5

0.42

0.47

nmol/l

0.25

641

Cholecystectomy

489

4061

1.07

0.70

1.3

1.4

0.35

0.40

nmol/l

0.67

381

3030

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

327

1.26

0.70

1.5

0.26

0.22

nmol/l

0.25

244

Graves disease, strict definition

842

1.16

0.70

1.6

1.4

0.51

0.43

nmol/l

0.45

673

Mental and behavioural disorders due to sedatives or hypnotics

427

1.22

0.69

1.6

1.5

0.21

0.36

nmol/l

3.19

342

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

121

1068

1.14

0.69

1.3

1.4

0.30

0.48

nmol/l

3.70

841

Presence of other devices

637

1.18

0.69

1.3

1.4

0.24

0.36

nmol/l

1.92

484

Other disorders of cornea

382

1.23

0.69

1.4

1.5

0.66

0.33

nmol/l

0.54

292

Spirochaetal infections, other/unspecified

337

1.25

0.69

1.5

1.4

0.27

0.31

nmol/l

0.33

253

Fall on and from ladder

169

0.65

0.69

1.6

1.5

0.14

0.26

nmol/l

—

141

Infections of genitourinary tract in pregnancy

1102

0.87

0.69

1.4

1.6

0.72

0.49

nmol/l

0.73

906

Achilles tendinitis

455

1.21

0.68

1.6

1.4

0.43

0.30

nmol/l

0.69

330

Disorders of sclera, cornea, iris and ciliary body

393

3673

1.07

0.68

1.4

1.5

0.35

0.40

nmol/l

0.61

304

2849

Lesion of ulnar nerve

639

1.18

0.68

1.6

1.4

0.41

0.34

nmol/l

0.26

488

Injuries to the hip and thigh

217

1811

1.10

0.67

1.5

1.4

0.29

0.36

nmol/l

0.86

173

1377

Other mental disorders due to brain damage and dysfunction and to physical disease

231

1.30

0.67

2.0

1.5

0.30

0.27

nmol/l

0.14

182

Other diseases of anus and rectum

140

1247

1.12

0.67

1.4

0.38

0.37

nmol/l

0.06

113

945

Benign lipomatous neoplasm

152

1362

1.12

0.67

1.4

0.44

0.35

nmol/l

0.29

106

1012

Other pleural conditions

170

1.35

0.67

1.1

1.4

0.10

0.24

nmol/l

3.15

132

Other condition

811

0.85

0.67

1.3

1.5

0.28

0.37

nmol/l

0.80

643

Overexertion and strenuous or repetitive movements

576

1.18

0.66

1.2

1.5

0.26

0.37

nmol/l

1.76

457

Convergence insufficiency and excess

128

1.42

0.66

1.5

0.17

0.39

nmol/l

3.31

107

Other infective otitis externa

312

1.25

0.66

1.5

1.4

0.45

0.34

nmol/l

0.65

245

Certain conditions originating in the perinatal period

111

866

1.14

0.66

1.6

0.26

0.35

nmol/l

1.27

716

Injuries to the neck

206

1879

1.10

0.66

1.4

1.5

0.36

0.44

nmol/l

0.72

159

1518

Superficial injury of lower leg

167

1848

0.90

0.66

1.5

0.28

0.42

nmol/l

4.10

133

1472

Benign neoplasm: Connective and other soft tissue of head, face and neck

1.58

0.65

2.0

1.5

0.42

0.35

nmol/l

0.14

Speech and linguistic disorders

768

1.15

0.65

1.8

1.6

0.33

0.38

nmol/l

0.31

640

Deep bite

105

806

1.14

0.65

1.5

0.45

0.33

nmol/l

0.49

645

Tumor necrosis factor alpha inhibitors

104

1182

0.88

0.65

1.4

1.5

0.31

0.43

nmol/l

1.80

934

Anogenital herpesviral [herpes simplex] infection

736

1.16

0.65

1.4

1.5

0.47

0.50

nmol/l

0.16

607

Alzheimer disease

179

0.72

0.65

1.4

0.11

0.13

nmol/l

—

129

Other enthesopathy of foot (+metatarsalgia)

624

1.17

0.65

1.3

1.4

0.28

0.40

nmol/l

1.64

487

Acute suppurative otitis media

350

3050

1.07

0.64

1.6

1.5

0.32

0.44

nmol/l

4.41

288

2555

Ulcerative colitis, NAS

107

942

1.14

0.64

1.4

1.5

0.39

0.40

nmol/l

0.06

757

Lichen simplex chronicus and prurigo

233

1.29

0.64

1.9

1.5

0.16

0.30

nmol/l

2.03

176

Acute renal failure

431

1.21

0.64

1.7

1.5

0.23

0.24

nmol/l

0.04

334

Other and unspecified nerve root and plexus disorders, also in other diseases

117

1036

1.13

0.64

1.5

1.4

0.34

0.37

nmol/l

0.20

788

Mental retardation

233

1.29

0.64

1.7

1.5

0.29

0.32

nmol/l

0.16

184

Mental retardation, wide definition

242

1.29

0.64

1.7

1.5

0.29

0.33

nmol/l

0.24

190

Adenocarcinoma and ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

1.73

0.64

1.4

1.2

0.07

0.24

nmol/l

—

Keratitis

246

2266

1.09

0.64

1.4

1.5

0.40

0.41

nmol/l

0.07

192

1787

Dental caries 1 and operation codes, only avohilmo

239

1309

0.92

0.64

1.5

0.32

0.36

nmol/l

0.75

188

1059

Juvenile arthritis (FINNGEN)

478

1.20

0.64

1.7

1.5

0.32

0.44

nmol/l

1.01

396

Concussion

448

3648

1.06

0.64

1.5

0.28

0.43

nmol/l

8.21

329

2934

Other contact dermatitis

525

0.82

0.64

1.2

1.5

0.34

0.40

nmol/l

0.23

420

Ventral hernia

108

952

1.14

0.63

1.7

1.4

0.27

0.36

nmol/l

0.94

702

Other disorders of binocular movement

190

1.33

0.63

1.4

1.5

0.19

0.40

nmol/l

3.88

162

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

287

1.26

0.63

1.4

0.19

0.24

nmol/l

0.45

219

Problems related to lifestyle

766

1.15

0.63

1.4

1.5

0.32

0.46

nmol/l

1.36

623

Transient global amnesia

155

1.36

0.63

1.3

1.6

0.13

0.17

nmol/l

0.67

113

Hidradenitis suppurativa

315

1.24

0.62

1.4

0.28

0.45

nmol/l

1.40

263

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

262

2424

1.08

0.62

1.4

1.5

0.39

0.41

nmol/l

0.12

209

1919

Other and unspecified mood [affective] disorders

730

1.15

0.62

1.6

1.5

0.26

0.47

nmol/l

3.48

595

Chronic Coagulation defects

182

1.33

0.62

1.8

1.5

0.31

0.37

nmol/l

0.34

150

Benign neoplasm: Pharynx, unspecified

1.68

0.61

1.0

1.5

0.54

0.49

nmol/l

—

Metatarsalgia

572

1.17

0.61

1.4

0.27

0.38

nmol/l

1.38

448

Acute pancreatitis (for exclusion)

674

1.16

0.61

1.6

1.4

0.25

0.32

nmol/l

0.79

519

Conjunctivitis (acute, non atopic)

236

2168

1.09

0.61

1.5

0.34

0.41

nmol/l

1.08

189

1709

Injuries to the elbow and forearm

498

4756

0.95

0.61

1.4

1.5

0.35

0.38

nmol/l

0.39

385

3720

Use of ropinirole

1.60

0.61

1.0

1.4

0.25

0.16

nmol/l

—

Atopic conjunctivitis

325

1.24

0.61

1.7

1.4

0.32

0.33

nmol/l

0.07

255

Oral leukoplakia and related diseases, including avohilmo

271

1.26

0.61

1.4

1.5

0.34

0.28

nmol/l

0.25

200

Benign neoplasm: salivary glands, exclude unknown (D119)

312

0.77

0.60

1.3

1.5

0.12

0.28

nmol/l

5.10

231

Benign lipomatous neoplasm of other sites/unspecified

267

0.75

0.60

1.3

1.5

0.16

0.29

nmol/l

1.51

202

Folate deficiency anaemia

0.00

0.60

0.0

1.4

—

0.20

—

Cerebral aneurysm, nonruptured

334

0.78

0.60

1.3

1.4

0.65

0.26

nmol/l

0.55

244

Hypotension due to drugs

0.00

0.60

0.0

1.5

—

0.19

—

Operations for atrial fibrillation

0.00

0.60

0.0

1.4

—

0.13

—

Malignant neoplasm of oesophagus

0.00

0.60

0.0

1.4

—

0.13

—

Mixed conductive and sensorineural hearing loss

362

1.22

0.60

1.3

1.5

0.30

nmol/l

0.00

272

Combinations of oral blood glucose lowering drugs

748

0.85

0.60

1.2

1.4

0.13

0.22

nmol/l

3.49

539

Opening and dilatation of root channel of tooth

454

1.19

0.59

1.4

1.5

0.32

0.36

nmol/l

0.33

366

Complications of anaesthesia during labour and delivery

1.54

0.59

1.1

1.5

0.31

0.39

nmol/l

—

Panniculitis affecting regions of neck and back

192

1.31

0.59

1.6

0.36

0.35

nmol/l

0.04

149

Paranoid personality disorder

114

1.41

0.59

1.1

1.4

0.47

0.39

nmol/l

0.12

Acute pancreatitis

677

1.15

0.58

1.6

1.4

0.25

0.32

nmol/l

0.82

523

Postpartum hemorraghe, all women as controls

446

4197

1.06

0.58

1.4

1.5

0.56

0.48

nmol/l

0.56

374

3362

Other, unspecified and serous retinal detachments

1.57

0.58

2.4

1.4

0.23

0.28

nmol/l

—

Dyshidrosis [pompholyx]

113

0.61

0.58

1.0

1.4

0.11

0.39

nmol/l

—

Colitis due to radiation

0.00

0.58

0.0

1.5

—

0.23

—

Pedal cyclist injured in noncollision transport accidents

692

0.85

0.58

2.1

1.5

0.29

0.38

nmol/l

0.96

550

Chronic suppurative otitis media

343

0.79

0.58

1.6

1.5

0.24

0.37

nmol/l

1.86

284

Other aneurysm

1.46

0.58

1.2

1.6

0.20

0.21

nmol/l

—

ILD, hospital admissions

291

1.24

0.58

1.8

1.5

0.16

0.26

nmol/l

2.00

217

Eustachian salpingitis and obstruction

726

1.15

0.57

1.6

1.4

0.59

0.46

nmol/l

0.19

613

Pain in throat and chest

760

4446

1.05

0.57

1.3

1.5

0.34

0.42

nmol/l

1.42

558

3534

COPD

834

0.88

0.57

1.4

0.18

0.20

nmol/l

0.41

597

Finngen Rheumatological endpoints

922

5465

0.96

0.56

1.5

0.33

0.43

nmol/l

3.84

714

4348

Other/unspecified enthesopathies of lower limb, excluding foot

439

1.19

0.56

1.4

0.31

0.39

nmol/l

0.79

342

Rheumatoid arthritis, including avohilmo

184

2005

0.92

0.56

1.4

0.30

0.39

nmol/l

1.43

136

1479

Dermatitis due to substances taken internally

302

1.23

0.55

1.5

0.24

0.38

nmol/l

1.83

241

Dental caries 1 and operation codes

699

3426

1.05

0.55

1.4

1.5

0.39

0.38

nmol/l

0.10

530

2721

Faecal incontinence

311

1.22

0.55

1.4

0.32

0.33

nmol/l

0.06

230

Striking against or struck by other objects

251

2331

1.08

0.55

1.5

0.25

0.39

nmol/l

5.98

191

1877

Dermatitis due to ingested food

335

1.21

0.55

1.5

1.6

0.23

0.30

nmol/l

0.85

266

Interstitial lung disease endpoints

293

1.23

0.55

1.8

1.4

0.16

0.26

nmol/l

1.98

218

Interstitial lung disease

293

1.23

0.55

1.8

1.4

0.16

0.26

nmol/l

1.98

218

Other respiratory diseases principally affecting the interstitium

375

1.20

0.55

1.7

1.4

0.16

0.25

nmol/l

2.58

280

Abnormal findings on antenatal screening of mother

143

1573

0.91

0.55

1.4

1.5

0.64

0.50

nmol/l

0.68

122

1330

Condition for Implicit Sepsis (Organ dysfunction codes)

559

3865

1.05

0.55

1.5

0.31

0.38

nmol/l

1.97

429

2991

Contusion of toe(s) without damage to nail

195

1.29

0.54

1.2

1.5

0.37

0.36

nmol/l

0.05

162

Specific development disorders of speech and language

397

1.19

0.54

1.6

0.24

0.40

nmol/l

1.60

325

Polyhydramnios

707

0.86

0.54

1.3

1.5

0.60

0.47

nmol/l

0.34

577

Squamous cell neoplasms and carcinomas of the skin

116

1.38

0.54

1.1

1.5

0.14

0.16

nmol/l

—

Non-ischemic cardiomyopathy

513

1.15

0.54

1.4

1.5

0.26

0.21

nmol/l

0.43

376

Childhood asthma (age<16)

234

1722

1.08

0.54

1.5

0.46

0.47

nmol/l

0.01

202

1472

Other interstitial pulmonary diseases

294

1.23

0.54

1.8

1.4

0.16

0.26

nmol/l

1.96

219

Arthropod-borne viral fevers and viral haemorrhagic fevers

404

1.19

0.53

1.3

1.5

0.49

0.37

nmol/l

0.21

311

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

601

5022

1.05

0.53

1.4

0.47

0.46

nmol/l

0.05

480

3918

Birth asphyxia

1.55

0.53

2.0

1.7

0.17

0.22

nmol/l

—

Other disorders of pigmentation

169

1.31

0.53

1.2

1.5

0.37

0.30

nmol/l

0.17

129

Leisure time condition

1057

0.89

0.53

1.5

0.31

0.39

nmol/l

0.87

845

Childhood asthma (age<16), excluding more controls

234

1723

1.08

0.53

1.5

0.46

0.47

nmol/l

0.01

202

1474

Type 1 diabetes

170

1850

0.92

0.53

1.4

1.5

0.39

0.42

nmol/l

0.23

134

1485

Coeliac disease

788

1.13

0.52

1.7

1.5

0.40

nmol/l

0.01

626

Open wound of ankle and foot

563

1.16

0.52

1.4

1.5

0.24

0.41

nmol/l

3.14

451

Renal failure

116

953

1.11

0.52

1.5

1.4

0.22

0.29

nmol/l

1.28

718

Benign neoplasm of other and unspecified sites

117

1.37

0.52

1.8

1.5

0.19

0.32

nmol/l

—

Hydrocele

143

1.33

0.52

1.8

1.4

0.13

0.12

nmol/l

0.11

119

Smoking dependency

425

0.82

0.52

1.2

1.4

0.26

0.35

nmol/l

0.59

323

Exclusion endpoint for supernumerary teeth

100

0.59

0.52

1.7

1.5

0.48

0.37

nmol/l

—

Chronic gastritis

826

1.13

0.52

1.4

0.34

0.28

nmol/l

0.42

589

Benign neoplasm: Parotid gland

282

0.78

0.52

1.2

1.4

0.11

0.29

nmol/l

6.66

211

Maxillary prognathism

1.52

0.52

1.2

1.7

1.60

0.22

nmol/l

—

Lung cancer and mesothelioma

270

0.79

0.52

1.2

1.4

0.22

0.17

nmol/l

0.65

198

Benign neoplasm: Long bones of lower limb

179

1.29

0.51

1.7

1.4

0.27

0.39

nmol/l

0.95

158

Other disorders of veins

247

2302

1.07

0.51

1.3

1.4

0.41

0.38

nmol/l

0.08

191

1684

Benign neoplasm of middle ear and respiratory system

206

1.26

0.51

1.2

1.4

0.41

0.30

nmol/l

0.26

169

Heart failure, not strict

269

1982

0.93

0.50

1.5

1.4

0.22

0.29

nmol/l

2.49

202

1435

Toxic effects of substances chiefly nonmedicinal as to source

735

1.13

0.50

1.5

0.45

0.39

nmol/l

0.17

590

Oral leukoplakia, including avohilmo

1.50

0.50

1.6

1.4

0.16

0.26

nmol/l

—

Pregnancy, childbirth and the puerperium

296

1651

0.94

0.49

1.4

1.5

0.48

0.35

nmol/l

0.94

250

1339

Other and/or unspecified nontoxic goitre

325

1.20

0.49

1.2

1.4

0.25

0.30

nmol/l

0.52

236

Mental and behavioural disorders due to tobacco

422

0.83

0.49

1.2

1.4

0.26

0.35

nmol/l

0.60

320

Other malignant neoplasms of skin (=non-melanoma skin cancer)

133

954

1.10

0.49

1.3

1.4

0.26

0.22

nmol/l

0.75

101

645

Metabolic disorders

662

3942

1.04

0.49

1.5

1.4

0.29

0.36

nmol/l

2.30

486

2999

Meralgia paraesthetica

145

1.32

0.49

1.2

1.4

0.46

0.34

nmol/l

—

116

Basal cell carcinoma

137

994

1.10

0.49

1.3

1.4

0.26

0.22

nmol/l

0.51

104

672

Nummular dermatitis

289

1.21

0.49

1.8

1.5

0.20

0.31

nmol/l

0.97

227

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

233

0.79

0.48

1.3

0.22

0.18

nmol/l

0.38

173

Schizotypal disorder

166

0.72

0.48

1.1

1.5

0.59

0.35

nmol/l

—

140

Medial epicondylitis

199

1.26

0.48

1.3

1.4

0.20

0.31

nmol/l

1.03

149

Chalazion

662

1.14

0.48

1.5

0.39

0.38

nmol/l

0.03

523

Dementia

366

0.85

0.48

1.6

1.5

0.15

0.19

nmol/l

0.84

264

Other disorders of amniotic fluid and membranes

219

2325

0.93

0.47

1.3

1.5

0.45

0.50

nmol/l

0.36

182

1885

Viral haemorrhagic fevers, not elsewhere classified/unspecified

336

1.19

0.47

1.3

1.5

0.55

0.32

nmol/l

0.33

253

Mandibular retrognathia AND surgery (BSSRO)

233

0.77

0.47

1.3

1.4

0.34

0.36

nmol/l

0.07

186

Impetigo

327

1.20

0.47

1.5

0.37

0.34

nmol/l

0.13

263

Colorectal cancer, excluding all cancers (controls excluding all cancers)

450

1.16

0.47

1.4

1.3

0.29

0.22

nmol/l

0.27

334

Other diseases of spinal cord

111

1.36

0.46

1.5

1.4

0.29

0.35

nmol/l

—

Other specified/unspecified hearing loss

245

1.23

0.46

1.4

1.5

0.27

0.29

nmol/l

0.14

187

Ulcerative enterocolitis

200

1.26

0.46

1.3

1.4

0.32

0.34

nmol/l

0.09

162

Parodontitis, under 40 years

129

1411

0.91

0.46

1.7

1.6

0.66

0.53

nmol/l

0.31

111

1225

Carcinoma in situ of skin

120

1.34

0.46

1.4

1.5

0.16

0.26

nmol/l

1.09

Conductive hearing loss, unspecified

430

1.17

0.46

1.3

1.5

0.28

0.36

nmol/l

0.78

333

Diseases of external ear

200

1861

1.08

0.46

1.3

1.4

0.44

0.39

nmol/l

0.22

149

1448

Psoriasis (vulgaris), strict definition

138

1.31

0.45

1.1

1.6

0.25

0.33

nmol/l

0.31

113

Basal cell carcinoma, including avohilmo

144

1040

1.09

0.45

1.3

1.4

0.27

0.22

nmol/l

0.71

107

709

Other and unspecified corneal deformities and disorders

147

1.30

0.45

1.5

1.4

0.26

0.35

nmol/l

0.66

121

Coronary artery bypass grafting

269

0.82

0.45

1.1

1.4

0.20

0.14

nmol/l

0.63

206

Unspecified privation

543

1.14

0.45

1.6

1.5

0.32

0.39

nmol/l

0.59

437

Sequelae of injuries of upper limb

487

1.15

0.45

1.5

0.43

0.33

nmol/l

0.22

379

Infectious mononucleosis

114

1037

1.10

0.45

1.4

1.5

0.29

0.47

nmol/l

3.79

851

Macular pucker

210

1.24

0.45

1.7

1.5

0.20

0.17

nmol/l

0.25

145

Other obstructive and reflux uropathy

311

1.19

0.44

1.5

1.4

0.31

0.40

nmol/l

0.79

262

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

397

3738

1.05

0.44

1.4

1.5

0.43

0.47

nmol/l

0.25

316

3046

Other congenital malformations of tongue, mouth and pharynx

103

1.36

0.44

1.4

1.6

0.36

0.38

nmol/l

0.05

Alcohol abuse, main dg

847

1.11

0.44

1.4

1.5

0.31

0.37

nmol/l

0.55

682

Other CVD (FINNGEN)

237

1.20

0.44

1.3

1.5

0.29

0.28

nmol/l

0.04

197

Allergic contact dermatitis

109

1198

0.91

0.44

1.4

1.5

0.42

0.44

nmol/l

0.11

937

Other/unspecified seropositive rheumatoid arthritis

108

1188

0.91

0.44

1.5

1.4

0.28

0.37

nmol/l

1.07

879

Other/unspecified rheumatoid arthritis

416

0.84

0.44

1.3

1.5

0.28

0.30

nmol/l

0.07

308

Benign neoplasm: Liver

139

1.30

0.44

1.1

1.4

0.26

0.35

nmol/l

0.65

111

Pollen allergy

240

2230

1.07

0.43

1.5

0.43

0.42

nmol/l

0.05

204

1811

Delivery, wide proxy

358

2007

0.95

0.43

1.4

1.5

0.51

0.37

nmol/l

1.03

308

1627

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

274

1.16

0.43

1.5

1.4

0.12

nmol/l

0.05

223

Event of undetermined intent

377

1.17

0.43

1.6

1.5

0.37

0.35

nmol/l

0.06

306

Arthropathic psoriasis

565

0.87

0.43

1.4

0.33

nmol/l

0.01

430

Female pelvic inflammatory disorders in diseases classified elsewhere

1.43

0.43

1.4

1.6

0.40

0.48

nmol/l

—

Chondropathies

116

1059

1.10

0.43

1.6

1.5

0.32

0.41

nmol/l

1.11

837

Benign neoplasm of major salivary glands

339

0.82

0.43

1.3

1.5

0.14

0.27

nmol/l

3.83

249

Parodontitis, under 40 years, or operation codes

130

1414

0.92

0.43

1.7

1.6

0.66

0.53

nmol/l

0.32

111

1227

Ulcerative colitis (strict definition, require KELA)

113

1237

0.91

0.42

1.4

1.5

0.42

0.41

nmol/l

0.04

994

Other and unspecified disorders of skin and subcutaneous tissue

284

0.81

0.42

2.6

1.5

0.18

0.32

nmol/l

2.62

216

Peritonsillar abscess

204

1908

1.07

0.42

1.4

1.5

0.36

0.44

nmol/l

0.76

158

1548

Agoraphobia

341

1.18

0.42

1.8

1.5

0.28

0.46

nmol/l

1.82

287

Other benign neoplasms of skin

197

1840

1.07

0.42

1.5

1.4

0.37

0.36

nmol/l

0.01

147

1379

Eclampsia

1.54

0.42

1.4

1.6

0.45

0.35

nmol/l

—

Autoimmune hyperthyroidism

453

1.15

0.42

1.8

1.4

0.43

nmol/l

0.01

367

Dental caries 3

678

3338

1.04

0.42

1.4

1.5

0.35

0.39

nmol/l

0.66

511

2665

Crohn's disease of small intestine

500

1.14

0.42

1.4

1.5

0.43

0.41

nmol/l

0.10

399

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

149

1.28

0.42

1.2

1.5

0.50

0.35

nmol/l

0.41

116

Somnolence, stupor and coma

176

1.25

0.42

1.5

0.24

0.35

nmol/l

1.08

148

Suggestive for eosinophilic asthma

327

0.82

0.41

1.4

1.5

0.17

0.30

nmol/l

2.63

254

Hereditary motor and sensory neuropathy

1.52

0.41

1.8

1.4

0.13

0.42

nmol/l

—

Epileptic seizures related to alcohol

0.00

0.41

0.0

1.3

—

0.19

—

Open bite

567

1.13

0.41

1.5

0.56

0.43

nmol/l

0.27

469

Vascular dementia (subcortical)

0.00

0.41

0.0

1.6

—

0.09

—

Chronic periodontitis, complicated

286

1.19

0.41

1.2

1.5

0.18

0.28

nmol/l

1.09

216

Crystalline deposits in vitreous body

0.00

0.41

0.0

1.5

—

0.15

—

Pre-eclampsia or poor fetal growth

455

4347

1.05

0.41

1.5

1.4

0.51

0.48

nmol/l

0.14

366

3463

Overjet

221

1.22

0.41

1.4

1.7

0.24

0.30

nmol/l

0.80

188

Pedal cyclist injured in other and unspecified transport accidents

633

1.12

0.41

1.8

1.5

0.42

0.38

nmol/l

0.13

505

Dialysis, with operation codes

407

1.16

0.41

1.5

0.21

0.26

nmol/l

0.86

313

Nasal polyp

721

0.89

0.41

1.3

1.4

0.38

0.34

nmol/l

0.12

542

Other bursitis of hip

1.40

0.41

1.5

1.3

0.42

0.34

nmol/l

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

644

4349

0.96

0.41

1.4

0.38

0.39

nmol/l

0.11

479

3323

Complications peculiar to reattachment and amputation

0.00

0.41

0.0

1.5

—

0.17

—

Atlantoaxial subluxation

0.00

0.41

0.0

1.4

—

0.28

—

Perioral dermatitis

186

1.24

0.40

1.2

1.4

0.44

0.40

nmol/l

0.12

155

Other superficial mycoses

123

1.31

0.40

1.0

1.5

0.54

0.37

nmol/l

0.46

102

Dental caries 3, only avohilmo

687

3388

1.04

0.40

1.4

1.5

0.35

0.39

nmol/l

0.61

520

2700

Seropositive rheumatoid arthritis, wide

110

1202

0.91

0.40

1.5

1.4

0.29

0.37

nmol/l

1.06

888

Adenocarcinoma and ductal carcinoma of pancreas

1.47

0.40

1.4

0.07

0.17

nmol/l

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

108

1181

0.91

0.40

1.5

1.4

0.28

0.37

nmol/l

1.10

875

Parodontitis, under 40 years and operation codes

123

1336

0.92

0.40

1.7

1.6

0.68

0.54

nmol/l

0.33

106

1158

Injury of nerves and spinal cord at thorax level

0.00

0.40

0.0

1.7

—

0.20

—

Aortic aneurysm

346

1.16

0.39

1.3

1.4

0.15

0.19

nmol/l

0.44

275

Congenital malformations of eye, ear, face and neck

550

1.13

0.39

1.4

1.5

0.35

0.40

nmol/l

0.27

458

Gonarthrosis [arthrosis of knee](FG)

401

2471

0.95

0.39

1.4

1.3

0.27

0.31

nmol/l

0.64

287

1799

Viral hepatitis

484

1.14

0.39

1.4

1.5

0.22

0.41

nmol/l

3.45

392

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

335

0.83

0.39

1.5

1.4

0.21

0.44

nmol/l

3.04

246

Other congenital malformations of urinary system

0.00

0.39

0.0

1.7

—

0.54

—

Other and unspecified mononeuropathies of lower limb

106

0.66

0.39

1.3

0.29

0.32

nmol/l

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

205

1.22

0.39

1.2

1.4

0.26

0.29

nmol/l

0.25

159

Carcinoma in situ of skin of lower limb, including hip

0.00

0.39

0.0

1.4

—

0.16

—

Spondylolisthesis/Spondylolysis

826

1.10

0.39

1.3

1.4

0.45

0.32

nmol/l

0.33

610

Other diseases of lip and oral mucosa

674

1.11

0.38

1.3

1.4

0.28

0.40

nmol/l

1.04

502

Ulcerative colitis (strict definition, all Crohn cases excluded)

1021

0.91

0.38

1.5

0.41

0.42

nmol/l

0.04

831

Oesophagitis

151

1.26

0.38

1.2

1.5

0.22

0.33

nmol/l

0.72

122

Contact with hypodermic needle

1.34

0.38

2.0

1.7

0.26

0.42

nmol/l

—

Fracture of femur

477

1.13

0.38

1.5

0.35

0.26

nmol/l

0.48

350

Sequelae of injuries of lower limb

526

0.87

0.38

1.9

1.5

0.29

0.37

nmol/l

0.78

410

Allergic purpura

188

1.23

0.37

2.3

1.4

0.36

0.35

nmol/l

0.02

152

Other injuries of spine and trunk, level unspecified

1.36

0.37

1.0

1.5

0.33

0.44

nmol/l

—

Parodontitis, operation under 40 years and operation codes

124

1340

0.92

0.37

1.7

1.6

0.68

0.54

nmol/l

0.33

106

1163

Colorectal neuroendocrine tumor and carcinoma, excluding all cancers (controls excluding all cancers)

1.35

0.37

2.0

1.6

0.36

0.47

nmol/l

—

Coxarthrosis [arthrosis of hip](FG)

174

1345

0.94

0.37

1.4

0.20

0.26

nmol/l

1.08

125

943

LeFortI or BSSRO operation

386

0.85

0.37

1.3

1.5

0.48

0.40

nmol/l

0.22

312

Inflammatory diseases of the central nervous system

440

1.14

0.36

1.6

1.4

0.31

0.35

nmol/l

0.19

344

Pre-eclampsia superimposed on chronic hypertension

0.64

0.36

2.0

1.3

0.52

0.35

nmol/l

—

Fracture of shoulder and upper arm

174

1629

1.07

0.36

1.5

0.33

0.36

nmol/l

0.20

129

1236

Speech therapy

115

1246

0.92

0.36

1.4

0.23

0.35

nmol/l

3.02

927

Dementia, including avohilmo

399

0.88

0.36

1.6

1.5

0.15

0.19

nmol/l

0.91

290

Other and specified injuries of hip and thigh

1.27

0.36

1.4

1.5

0.14

0.38

nmol/l

—

Hereditary deficiency of other clotting factors

0.65

0.36

3.6

1.4

0.14

0.39

nmol/l

—

Congenital malformations of the circulatory system

100

888

1.09

0.36

1.6

1.5

0.41

0.35

nmol/l

0.20

712

Pilonidal cyst

640

1.11

0.36

1.4

1.5

0.41

0.44

nmol/l

0.08

524

Lateral epicondylitis

812

1.10

0.35

1.3

1.4

0.22

0.34

nmol/l

2.60

608

Maxillary retrognathism

153

1.25

0.35

1.6

0.22

0.33

nmol/l

1.41

125

Biological medication for rheuma

118

1275

0.92

0.35

1.4

1.5

0.32

0.43

nmol/l

1.70

1003

Sequelae of infectious and parasitic diseases

385

1.14

0.35

1.3

1.4

0.25

0.42

nmol/l

2.04

301

Olecranon bursitis

117

1.28

0.35

1.3

1.5

0.22

nmol/l

0.00

Malignant neoplasm of respiratory system and intrathoracic organs

285

1.16

0.35

1.4

1.5

0.41

0.20

nmol/l

0.62

211

Radial styloid tenosynovitis [de Quervain]

423

1.14

0.35

1.7

1.4

0.34

0.39

nmol/l

0.19

347

Budesonide

100

919

1.09

0.35

1.5

0.50

0.42

nmol/l

0.38

722

Exposure to other specified factors

635

5765

1.03

0.35

1.4

1.5

0.32

0.40

nmol/l

1.93

514

4541

All dysplastic lesions of the vulva

330

0.85

0.34

1.3

1.4

0.24

0.33

nmol/l

1.00

246

Rosacea

718

1.10

0.34

1.4

0.34

0.40

nmol/l

0.51

555

Malignant neoplasm of prostate

297

0.87

0.34

1.1

1.4

0.11

0.12

nmol/l

0.38

246

Benign neoplasm: Skin of lip

1.37

0.34

1.3

1.4

0.16

0.31

nmol/l

—

Personality and behavioural disorders due to brain disease, damage and dysfunction

1.37

0.34

1.2

1.4

0.38

0.40

nmol/l

—

Bacterial, viral and other infectious agents

528

1.12

0.34

1.4

1.5

0.79

0.40

nmol/l

0.65

420

Laparoscopic right hemicolectomy

1.34

0.34

1.5

1.4

0.14

0.21

nmol/l

—

Other and unspecified nonorganic psychotic disorders

178

1675

1.06

0.34

1.4

1.5

0.26

0.42

nmol/l

5.09

138

1355

Disorders of muscles

519

1.12

0.33

1.6

1.5

0.30

0.38

nmol/l

0.42

421

Psoriatic arthropathies

531

0.88

0.33

1.3

1.4

0.33

0.39

nmol/l

0.24

406

Other puerperal infections

137

1279

1.07

0.33

1.3

1.5

0.57

0.55

nmol/l

0.06

115

1085

Additional codes for the location of defect, injury or illness

286

0.84

0.33

1.1

1.5

0.29

0.35

nmol/l

0.29

226

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

100

1.30

0.33

1.3

1.4

0.28

0.35

nmol/l

—

Bicuspidal aortic valve syndrome

118

1.27

0.33

1.2

1.5

0.34

0.32

nmol/l

—

Meningitis

265

1.17

0.33

1.5

0.32

nmol/l

0.01

213

Suicide or other Intentional self-harm

227

2153

1.06

0.33

1.4

1.5

0.36

0.42

nmol/l

0.50

166

1718

Intracranial trauma

498

3855

0.96

0.33

1.5

0.29

0.44

nmol/l

4.82

368

3096

Congenital malformations of spine and bony thorax

1.31

0.33

2.2

1.6

0.26

0.31

nmol/l

—

Malignant neoplasm of colon

264

0.83

0.33

1.5

0.22

0.23

nmol/l

0.03

198

Family history of certain disabilities and chronic diseases leading to disablement

435

1.13

0.33

1.8

1.5

0.37

0.47

nmol/l

0.47

358

Acute and transient psychotic disorders

740

1.10

0.32

1.5

0.36

0.37

nmol/l

0.01

584

Diverticular disease of intestine

306

1941

1.05

0.32

1.4

0.26

0.28

nmol/l

0.18

222

1355

Other arrhythmias

440

3496

0.96

0.32

1.5

1.4

0.35

0.40

nmol/l

0.38

326

2686

Streptococcal septicaemia

247

1.18

0.32

1.4

1.5

0.16

0.28

nmol/l

1.95

205

Other and unspecified rosacea

473

1.12

0.32

1.5

1.4

0.30

0.37

nmol/l

0.44

363

Acute pharyngitis

130

1383

0.93

0.32

1.5

1.6

0.31

0.44

nmol/l

1.85

1166

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

110

1186

0.93

0.32

1.4

1.5

0.42

0.41

nmol/l

0.04

957

Intestinal malabsorption

238

1.18

0.32

1.5

0.47

0.31

nmol/l

0.60

191

Chronic ulcer of skin, not elsewhere classified

164

1.22

0.32

1.3

1.5

0.30

0.28

nmol/l

0.09

126

Lichen ruber planus, wide definition including periferal and oral lichen planus

817

1.09

0.32

1.4

0.26

0.31

nmol/l

0.41

595

Seropositive rheumatoid arthritis

110

1183

0.93

0.32

1.5

1.4

0.29

0.38

nmol/l

1.14

876

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

704

1.09

0.32

1.4

1.3

0.29

0.23

nmol/l

0.40

526

Corns and callosities

263

0.84

0.32

1.4

1.5

0.14

0.32

nmol/l

4.54

196

Later onset COPD

190

0.83

0.32

1.5

1.3

0.12

0.11

nmol/l

0.20

146

Pneumococcal septicemia

128

1.25

0.32

1.2

1.5

0.24

0.32

nmol/l

0.55

105

Convergent concomitant strabismus

475

0.88

0.31

1.6

1.5

0.30

0.42

nmol/l

0.90

380

Inflammatory disease of uterus

180

1701

1.06

0.31

1.4

1.5

0.40

0.50

nmol/l

0.90

147

1358

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

174

1.21

0.31

1.5

1.4

0.42

0.21

nmol/l

0.37

138

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

124

1328

0.93

0.31

1.4

1.5

0.41

nmol/l

0.03

100

1059

Congenital malformations of aortic and mitral valves

165

1.21

0.31

1.3

1.6

0.29

nmol/l

0.02

130

Single delivery by forceps and vacuum extractor

318

1855

1.05

0.31

1.5

0.44

0.42

nmol/l

0.15

264

1536

Sensorineural hearing loss

295

2158

0.96

0.31

1.4

0.21

0.32

nmol/l

4.29

224

1576

Glomerulonephritis

437

1.12

0.31

1.5

0.44

0.33

nmol/l

0.27

336

Other/unspecified synovitis and tenosynovitis

647

1.10

0.31

1.3

1.4

0.31

0.38

nmol/l

0.40

512

L04AX Other immunosuppressants

379

3935

0.96

0.31

1.5

1.4

0.34

0.39

nmol/l

0.63

281

3029

Gastroduodenal ulcer

588

1.10

0.30

1.5

1.4

0.63

0.24

nmol/l

0.54

427

Schizophrenia, schizotypal and delusional disorders

251

2395

1.05

0.30

1.5

0.31

0.40

nmol/l

1.73

185

1895

Other disorders of skin and subcutaneous tissue, not elsewhere classified

571

1.10

0.30

1.8

1.5

0.21

0.37

nmol/l

3.07

443

Colonic or urogenital fistula

153

1440

1.06

0.30

1.3

1.4

0.31

0.37

nmol/l

0.97

117

1107

Pyogenic arthritis

212

1.18

0.30

1.4

1.5

0.14

0.34

nmol/l

4.79

171

Lung diseases due to external agents

315

1.14

0.30

1.5

0.46

0.26

nmol/l

0.58

242

Rubella [German measles]

1.27

0.30

2.1

1.4

0.14

0.15

nmol/l

—

Bacterial pneumoniae

190

1774

0.95

0.30

1.6

1.5

0.32

0.36

nmol/l

0.51

147

1383

Maternal care for known or suspected abnormality of pelvic organs

416

2973

0.96

0.29

1.5

1.4

0.57

0.46

nmol/l

0.73

346

2357

Heart failure and antihypertensive medication

459

1.09

0.29

1.5

1.4

0.22

0.24

nmol/l

0.23

319

Psoriatic arthropathies, ICD10

525

0.89

0.29

1.3

1.4

0.33

0.36

nmol/l

0.10

399

Optic neuritis

377

0.87

0.29

1.6

1.4

0.71

0.46

nmol/l

0.51

306

Glucosamine medication

114

848

1.07

0.29

1.5

1.4

0.23

0.20

nmol/l

0.22

558

Ankylosing spondylitis, ICD10

535

0.90

0.29

1.4

0.24

0.35

nmol/l

1.90

421

Gluteal tendinitis

185

1.19

0.29

1.2

1.5

0.48

0.35

nmol/l

0.16

130

Single delivery by caesarean section

353

1964

1.04

0.29

1.4

1.5

0.59

0.41

nmol/l

1.24

297

1609

Benign neoplasm: Stomach

288

1.15

0.29

1.8

1.5

0.21

0.29

nmol/l

0.77

206

Pneumonia derived septicemia

130

1.23

0.28

1.2

1.5

0.24

0.30

nmol/l

0.38

107

LSIL lesion of the cervix uteri

146

1548

0.94

0.28

1.5

0.38

0.50

nmol/l

1.89

119

1251

Benign neoplasm of urinary organs

130

1.23

0.28

1.3

1.5

0.16

0.30

nmol/l

1.97

102

Mental and behavioural disorders due to use of other stimulants, including caffeine

227

0.83

0.28

1.4

1.5

0.17

0.36

nmol/l

2.99

188

Schizophrenia or delusion

251

2401

1.05

0.28

1.5

0.31

0.40

nmol/l

1.72

185

1899

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

507

1.11

0.28

1.5

0.23

0.38

nmol/l

2.81

413

Nephropathy related operations

402

1.12

0.28

1.6

1.5

0.21

0.26

nmol/l

0.95

310

Other viral hepatitis

450

1.11

0.28

1.3

1.5

0.21

0.41

nmol/l

3.41

367

Failed attempted abortion

194

0.82

0.28

1.3

1.4

0.32

0.44

nmol/l

0.68

164

Car occupant injured in other and unspecified transport accidents

156

1650

0.94

0.28

1.3

1.5

0.46

0.43

nmol/l

0.11

125

1338

Chronic suppurative otitis media, including avohilmo

418

0.88

0.28

1.9

1.5

0.23

0.39

nmol/l

2.33

343

Other appendicitis

481

0.89

0.28

1.5

1.4

0.38

0.34

nmol/l

0.15

373

Other and unspecified injuries of head

270

1.15

0.28

1.8

1.4

0.28

0.31

nmol/l

0.22

209

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

158

1.20

0.28

1.4

1.2

0.20

0.30

nmol/l

0.78

111

Perforation of tympanic membrane

517

1.10

0.28

1.4

1.5

0.26

0.40

nmol/l

1.83

412

Early lumbar disc prolapse operation

1042

0.93

0.28

1.8

1.5

0.38

0.44

nmol/l

0.46

843

Benign neoplasm: Liver/bile ducts

149

1.21

0.28

1.1

1.4

0.26

0.34

nmol/l

0.56

118

Maternal care for cervical incompetence

327

1.13

0.28

2.4

1.5

0.60

0.43

nmol/l

0.30

272

Other Crohn's disease

508

1.10

0.27

1.4

1.5

0.49

0.43

nmol/l

0.28

410

Ménière disease

327

1.13

0.27

1.7

1.5

0.26

0.29

nmol/l

0.14

238

Superficial injury of neck

161

0.80

0.27

1.2

1.5

0.21

0.38

nmol/l

—

135

Injury of muscle and tendon at ankle and foot level

131

1.23

0.27

1.5

0.22

0.32

nmol/l

0.70

107

Other disorders of urethra and urinary system

584

4498

0.97

0.27

1.4

0.39

0.42

nmol/l

0.22

449

3495

Dental caries 3 and operation codes

750

3752

1.03

0.27

1.4

1.5

0.42

0.39

nmol/l

0.19

567

2994

Use of other anti-dementia drugs

146

1.19

0.27

1.4

0.12

0.11

nmol/l

0.10

106

Use of memantine

146

1.19

0.27

1.4

0.12

0.11

nmol/l

0.10

106

Early onset COPD

657

0.91

0.27

1.4

0.21

0.23

nmol/l

0.33

473

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

347

1.13

0.26

1.4

0.33

0.30

nmol/l

0.20

254

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

310

0.87

0.26

1.2

1.4

0.34

0.30

nmol/l

0.26

226

Lactose intolerance, other/unspecified

178

1.18

0.26

1.6

0.70

0.35

nmol/l

0.60

147

Dipeptidyl peptidase 4 (DPP-4) inhibitors

234

1.15

0.26

1.4

1.5

0.14

0.21

nmol/l

1.35

174

Glaucoma suspect

120

1128

1.06

0.26

1.3

1.4

0.21

0.30

nmol/l

2.78

794

Impacted maxillary canine

0.67

0.26

2.2

1.7

0.19

0.30

nmol/l

—

Injury of muscle and tendon at lower leg level

614

0.91

0.26

1.3

1.5

0.30

0.33

nmol/l

0.27

484

Other and unspecified injuries of shoulder and upper arm

141

1.21

0.26

1.6

1.5

0.45

0.31

nmol/l

—

115

Sequelae of injuries, of poisoning and of other consequences of external causes

127

1347

0.94

0.26

1.5

1.4

0.34

0.38

nmol/l

0.19

102

1049

Assault

106

993

1.07

0.26

1.3

1.5

0.24

0.42

nmol/l

3.70

814

Injury of eye and orbit

809

1.08

0.26

1.3

1.5

0.22

0.39

nmol/l

4.35

645

malignant neoplasm of male genital organs

323

1.10

0.26

1.4

0.11

0.12

nmol/l

0.32

267

Otalgia

501

1.10

0.25

1.3

1.5

0.27

0.40

nmol/l

1.58

396

Maltreatment syndromes

482

1.10

0.25

1.2

1.5

0.47

0.38

nmol/l

0.18

400

Other benign neoplasms of connective and other soft tissue

501

1.10

0.25

1.3

1.4

0.46

0.35

nmol/l

0.62

386

Paraplegia, diplegia of upper limbs

1.25

0.25

1.1

1.4

0.24

0.38

nmol/l

—

Sequelae of injuries of neck and trunk

127

0.79

0.25

1.5

1.4

0.23

0.34

nmol/l

—

102

Hypertension, essential

573

3358

0.97

0.25

1.4

0.30

0.35

nmol/l

0.85

404

2547

Malignant neoplasm of skin

176

1261

1.05

0.25

1.3

1.4

0.26

nmol/l

0.04

136

876

Ulcerative colitis

186

1775

1.05

0.25

1.4

1.5

0.39

0.42

nmol/l

0.22

150

1412

Hyperlipidaemia, other/unspecified

813

1.07

0.24

1.4

0.24

0.20

nmol/l

0.18

569

Fracture of forearm

349

3378

0.97

0.24

1.4

1.5

0.35

0.38

nmol/l

0.31

264

2573

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

321

1.12

0.24

1.2

1.5

0.28

0.42

nmol/l

1.05

260

Obstructed labour due to malposition and malpresentation of fetus

340

3311

0.97

0.24

1.4

0.61

0.42

nmol/l

1.22

277

2557

Superficial injury of abdomen, lower back and pelvis

1045

0.94

0.24

1.4

1.5

0.25

0.44

nmol/l

3.19

855

Acute alcohol intoxication ICD-9

1.28

0.24

1.0

1.5

0.20

0.21

nmol/l

—

Heart failure and bmi 25plus

452

1.08

0.24

1.4

0.19

0.18

nmol/l

0.07

312

Tubulo-interstitial nephritis, not specified as acute or chronic

339

0.88

0.24

1.3

1.4

0.33

0.37

nmol/l

0.23

266

Substance abuse

377

3491

1.03

0.24

1.4

1.5

0.31

0.38

nmol/l

1.52

285

2766

Other symptoms and signs involving general sensations and perceptions

152

1.19

0.23

1.9

1.5

0.23

0.39

nmol/l

1.75

121

Myocardial infarction, without ST-elevation

563

0.92

0.23

1.2

1.4

0.17

0.16

nmol/l

0.04

411

Nonsuppurative otitis media

263

2358

0.96

0.23

1.6

0.40

0.45

nmol/l

0.21

224

1988

Complex cardiac defects

1.32

0.23

2.4

1.5

0.18

0.29

nmol/l

—

Frostbite

1.32

0.23

1.4

1.5

1.63

0.36

nmol/l

—

Pedal cyclist injured in transport accident

146

1535

0.95

0.23

1.8

1.5

0.35

0.40

nmol/l

0.33

118

1214

Other otitis externa (chronic)

338

0.89

0.23

1.4

1.5

0.36

0.35

nmol/l

0.00

262

Placenta praevia

698

1.08

0.23

1.5

1.4

0.55

0.50

nmol/l

0.23

570

Foreign body in respiratory tract

294

1.12

0.23

1.5

0.22

0.37

nmol/l

1.47

232

Other and unspecified tonsillitis

414

3411

1.03

0.23

1.5

0.33

0.48

nmol/l

4.98

325

2871

Cardiodefibrillation

600

1.08

0.23

1.2

1.5

0.16

0.18

nmol/l

0.36

437

Late syphilis

1.29

0.23

1.0

1.6

0.18

0.37

nmol/l

—

Chronic iridocyclitis

247

1.14

0.22

1.4

1.5

0.27

0.32

nmol/l

0.34

196

False labour

530

3414

0.97

0.22

1.4

0.54

0.44

nmol/l

0.78

432

2704

Injury of unspecified body region

358

0.89

0.22

1.4

1.5

0.35

0.34

nmol/l

0.07

290

Other assisted single delivery

305

0.88

0.22

1.6

1.5

1.26

0.47

nmol/l

0.41

250

Spondylopathies

475

2963

0.97

0.22

1.4

0.29

0.37

nmol/l

1.81

326

2258

Inflammatory disease of cervix uteri

333

1.11

0.22

1.6

1.4

0.29

0.39

nmol/l

0.48

246

Galactorrhea

116

1.21

0.22

1.3

1.5

0.24

0.39

nmol/l

—

100

Methotrexate

825

1.07

0.22

1.3

1.4

0.29

0.37

nmol/l

0.99

624

Viral pneumonia (unknown virus, not influenza)

333

1.11

0.22

1.7

1.5

0.34

nmol/l

0.03

272

L01XX Other antineoplastic agents

1.27

0.22

1.2

1.4

0.27

0.22

nmol/l

—

Postpartum haemorrhage due to anatomy

172

1797

0.96

0.22

1.4

1.5

0.69

0.56

nmol/l

0.40

146

1503

Toxic effect of ethanol

276

1.13

0.22

1.5

0.38

nmol/l

0.02

230

Other congenital malformations of heart

1.22

0.22

1.6

0.32

nmol/l

—

Mental and behavioural disorders due to psychoactive substance use

394

3612

1.03

0.22

1.4

1.5

0.30

0.38

nmol/l

1.89

295

2867

Infections with a predominantly sexual mode of transmission

389

3777

1.03

0.22

1.4

1.5

0.41

0.47

nmol/l

1.20

333

3055

Special screening examination for other diseases and disorders

506

1.09

0.22

1.5

0.54

0.44

nmol/l

0.19

408

Autoimmune diseases excluding thyroid diseases, strict definition

840

4773

0.98

0.22

1.4

0.37

0.40

nmol/l

0.54

638

3824

COPD related to multimorbidity

581

0.93

0.22

1.5

1.4

0.15

0.19

nmol/l

1.36

416

Organic, including symptomatic, mental disorders

729

0.94

0.22

1.6

1.4

0.26

0.24

nmol/l

0.20

530

Synovial cyst of popliteal space [Baker]

231

0.86

0.22

1.1

1.5

0.64

0.29

nmol/l

0.68

173

Mental and behavioural disorders due to cannabinoids

229

1.14

0.21

1.3

1.5

0.32

0.35

nmol/l

0.13

196

Intentional self-harm by jumping or lying before moving object

0.00

0.21

0.0

1.3

—

0.30

—

Reimbursement for rheumatic diseases

375

3850

0.97

0.21

1.5

1.4

0.35

0.39

nmol/l

0.48

273

2951

Contusion of other and unspecified parts of foot

401

1.10

0.21

1.5

0.39

0.38

nmol/l

0.04

325

Other psoriatic arthropathies

513

0.92

0.21

1.3

1.4

0.33

0.35

nmol/l

0.06

391

Adhesive capsulitis of shoulder

681

1.07

0.21

1.3

1.4

0.30

nmol/l

0.01

507

Pediculosis and phthiriasis

0.00

0.21

0.0

1.9

—

0.34

—

Injury of other and unspecified intrathoracic organs

182

1.16

0.21

1.2

1.6

0.21

0.31

nmol/l

0.88

140

Other (seronegative) rheumatoid arthritis, wide

833

0.94

0.21

1.4

0.29

0.36

nmol/l

0.52

624

Other chondrocalcinosis

0.00

0.21

0.0

1.1

—

0.20

—

Arthrosis

502

2691

1.03

0.21

1.4

0.31

0.38

nmol/l

1.33

375

2036

Colorectal cancer

450

0.91

0.21

1.4

0.33

0.22

nmol/l

0.37

327

Follicular cysts of skin and subcutaneous tissue

925

1.06

0.21

1.5

1.4

0.46

0.38

nmol/l

0.35

712

Poor fetal growth

208

2159

0.96

0.20

1.5

0.45

0.52

nmol/l

0.52

173

1783

Other congenital malformations of face and neck

219

0.87

0.20

1.3

1.5

0.30

0.38

nmol/l

0.52

184

LSIL lesion of the cervix uteri, vagina or vulva

174

1813

0.96

0.20

1.6

1.5

0.35

0.48

nmol/l

2.54

141

1439

Asthma/COPD (KELA code 203)

864

5978

1.02

0.20

1.4

1.5

0.41

0.40

nmol/l

0.08

673

4752

Other and unspecified iridocyclitis

219

0.87

0.20

1.6

1.5

0.19

0.33

nmol/l

1.67

180

Bitten or struck by other mammals

975

0.94

0.20

1.4

1.5

0.27

0.44

nmol/l

2.93

782

Sequelae of injuries of head

240

0.87

0.20

1.0

1.5

0.28

0.31

nmol/l

0.17

194

Other maltreatment syndromes

183

1.15

0.20

1.6

1.5

0.29

0.31

nmol/l

0.07

141

Ulcerative rectosigmoiditis

538

1.08

0.20

1.5

1.4

0.30

0.41

nmol/l

0.78

426

Peripheral arterial reconstruction

183

1.15

0.20

1.0

1.4

0.12

0.17

nmol/l

1.50

136

Lichen sclerosus et atrophicus

403

1.09

0.20

1.5

1.4

0.21

0.31

nmol/l

1.81

292

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

519

1.08

0.20

1.4

1.5

0.48

0.43

nmol/l

0.24

419

Benign neoplasm: Skin of trunk

155

1.16

0.20

1.8

1.5

0.43

0.38

nmol/l

0.16

133

Chorioretinal inflammation

127

1.18

0.19

1.3

1.5

0.37

0.32

nmol/l

—

106

Maternal care for other conditions predominantly related to pregnancy

342

3282

1.03

0.19

1.3

1.4

0.44

0.46

nmol/l

0.16

281

2614

327

3089

0.97

0.19

1.3

1.5

0.31

0.37

nmol/l

1.00

254

2441

Diseases of peritoneum

394

1.09

0.19

1.4

1.5

0.42

0.30

nmol/l

0.49

293

Alcohol use disorder, Swedish definition

309

2785

1.03

0.19

1.3

1.5

0.32

0.37

nmol/l

0.63

236

2196

Foreign body in alimentary tract

241

1.12

0.19

1.7

1.5

0.35

0.30

nmol/l

0.14

190

Alcohol dependence

1044

0.95

0.19

1.3

1.4

0.33

0.32

nmol/l

0.08

805

Exposure to other and unspecified inanimate mechanical forces

385

1.09

0.19

1.4

1.5

0.29

0.37

nmol/l

0.56

308

severe traumatic brain injury, does not include concussion

588

1.07

0.19

1.3

1.5

0.35

0.29

nmol/l

0.11

459

Sulfasalazine

187

1941

0.96

0.19

1.5

0.34

0.42

nmol/l

1.15

131

1510

Fitting and adjustment of other devices

885

0.95

0.19

1.5

1.4

0.19

0.29

nmol/l

2.28

650

DVT of lower extremities

666

1.07

0.19

1.4

0.48

0.35

nmol/l

0.33

505

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

260

1.12

0.19

1.3

1.5

0.51

0.37

nmol/l

0.32

216

Other arthritis (FG)

203

1959

1.04

0.18

1.5

1.4

0.34

0.41

nmol/l

0.84

145

1506

Long labour

389

3312

1.03

0.18

1.4

0.62

0.43

nmol/l

1.51

321

2597

Fall on same level involving ice and snow

379

3696

1.03

0.18

1.4

1.5

0.37

0.38

nmol/l

0.10

288

2831

Unspecified fall

293

2824

1.03

0.18

1.6

1.4

0.27

0.37

nmol/l

2.90

225

2191

Injuries to the shoulder and upper arm

519

4258

1.02

0.18

1.4

1.5

0.28

0.36

nmol/l

2.11

395

3287

Wegener granulomatosis

1.21

0.18

2.0

1.4

0.35

0.38

nmol/l

—

Valvular operations

242

1.12

0.18

1.1

1.5

0.12

0.22

nmol/l

2.78

196

Spondyloarthritis

119

1136

1.05

0.18

1.4

0.34

0.42

nmol/l

0.73

899

Ulcer of lower limb, not elsewhere classified

290

1.10

0.18

1.1

1.5

0.22

0.25

nmol/l

0.34

223

Unspecific neurodegenerative disorder

272

0.91

0.18

1.5

1.4

0.14

0.16

nmol/l

0.40

199

Otitis media, unspecified

116

1019

1.05

0.18

1.8

1.5

0.24

0.36

nmol/l

3.11

839

Acute generalized exanthematous pustulosis

237

0.88

0.17

1.5

0.20

0.33

nmol/l

1.54

187

Pleural effusion

300

1.10

0.17

1.2

1.5

0.22

0.24

nmol/l

0.23

232

Injuries to the abdomen, lower back, lumbar spine and pelvis

221

2266

0.97

0.17

1.4

1.5

0.35

0.42

nmol/l

0.61

173

1790

Nonspecific lymphadenitis

403

0.92

0.17

1.4

1.5

0.24

0.34

nmol/l

1.48

305

Vitreous haemorrhage

320

0.91

0.17

1.1

1.5

0.23

0.30

nmol/l

0.63

252

Calcific aortic valvular stenosis

364

0.91

0.17

1.3

1.4

0.68

0.16

nmol/l

0.72

271

Calcific aortic valvular stenosis, operated

364

0.91

0.17

1.3

1.4

0.68

0.16

nmol/l

0.72

271

Pedestrian injured in transport accident

351

0.91

0.17

1.9

1.5

0.26

0.35

nmol/l

0.73

281

Alcoholic liver disease

205

1.12

0.17

1.6

1.5

0.22

0.23

nmol/l

0.01

160

Congenital malformations of the respiratory system

0.72

0.17

1.4

1.5

0.15

0.27

nmol/l

—

Persons encountering health services for specific procedures and health care

965

5889

1.01

0.16

1.5

1.4

0.33

0.41

nmol/l

1.84

738

4658

Diseases of arteries, arterioles and capillaries (FINNGEN)

562

0.94

0.16

1.3

1.4

0.19

0.24

nmol/l

1.02

414

Atrial fibrillation and flutter with reimbursement

466

1.06

0.16

1.4

0.18

0.21

nmol/l

0.37

329

All-cause Heart Failure

108

815

0.95

0.16

1.3

1.4

0.23

0.19

nmol/l

0.55

574

Left ventricular outflow tract obstruction, narrow definition

215

1.12

0.16

1.4

1.6

0.27

0.28

nmol/l

0.03

170

Golimumab

244

1.11

0.16

1.7

1.5

0.29

0.36

nmol/l

0.42

197

Complications following abortion and ectopic and molar pregnancy

183

0.87

0.16

1.2

1.5

0.32

0.29

nmol/l

0.17

132

Postprocedural musculoskeletal disorders, not elsewhere classified

183

0.87

0.16

1.3

1.4

0.25

0.28

nmol/l

0.17

134

Second line medication for Crohn's disease

402

4107

0.98

0.16

1.5

1.4

0.35

0.39

nmol/l

0.50

299

3170

Calcific aortic valvular stenosis, including rheumatic fever

362

0.92

0.16

1.3

1.4

0.68

0.16

nmol/l

0.72

271

Major anomalies of jaw size

187

1.13

0.16

1.7

1.5

0.61

0.30

nmol/l

0.69

149

D07AA Corticosteroids, weak (group I)

139

1442

0.96

0.16

1.5

0.34

0.45

nmol/l

1.56

111

1156

Cellulitis of external ear

1.10

0.16

1.7

1.5

0.39

0.37

nmol/l

—

361

3307

0.98

0.16

1.3

1.5

0.31

0.37

nmol/l

1.23

275

2619

Diabetic retinopathy, strict definition

614

0.94

0.15

1.3

1.6

0.28

0.46

nmol/l

1.81

476

Other/unspecified enthesopathies, not elsewhere classified

370

1.08

0.15

1.1

1.5

0.29

0.30

nmol/l

0.07

287

Thoracic aortic aneurysm

235

1.11

0.15

1.5

0.19

0.21

nmol/l

0.14

187

Coxarthrosis

171

1200

0.97

0.15

1.4

0.20

0.27

nmol/l

1.26

122

842

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

105

1061

0.96

0.15

1.7

1.5

0.39

0.40

nmol/l

0.03

851

Need for other prophylactic measures

245

1.10

0.15

1.3

1.4

0.19

0.31

nmol/l

1.41

184

Bacterial pneumonia, not elsewhere classified

179

1636

0.97

0.15

1.6

1.5

0.32

0.37

nmol/l

0.50

140

1284

Anterior Iridocyclitis

110

1147

0.96

0.15

1.4

0.23

0.38

nmol/l

4.42

886

Polymyalgia rheumatica

182

0.88

0.15

1.2

1.5

0.19

0.18

nmol/l

—

133

Gout, strict definition

226

1.11

0.15

1.2

1.4

0.14

0.15

nmol/l

0.34

176

Injuries to the wrist and hand

887

6339

1.01

0.15

1.5

1.4

0.34

0.41

nmol/l

1.82

705

5022

Trigger finger

728

0.95

0.15

1.3

1.4

0.22

0.35

nmol/l

2.20

559

Reactive arthropathies, FINNGEN

410

1.07

0.15

1.4

0.36

0.41

nmol/l

0.19

320

Reactive arthropathies

488

1.07

0.14

1.5

1.4

0.34

0.40

nmol/l

0.28

390

Coxarthrosis, primary

148

1330

0.97

0.14

1.3

1.4

0.20

0.22

nmol/l

0.31

110

903

Intermittent heterotropia

512

0.94

0.14

1.4

1.5

0.49

0.46

nmol/l

0.04

426

Alcohol use disorder, ICD-based

220

2140

1.03

0.14

1.3

1.5

0.33

0.37

nmol/l

0.32

171

1682

Use of donepezil

135

1.14

0.14

1.6

1.4

0.10

0.13

nmol/l

—

All influenza (not pneumonia)

762

1.05

0.14

1.5

0.30

0.35

nmol/l

0.48

634

Benign neoplasm: Long bones of lower limb

208

1.11

0.14

1.7

1.5

0.27

0.36

nmol/l

0.64

174

Other cataract

131

1051

0.96

0.13

1.4

0.24

0.27

nmol/l

0.25

735

Biomechanical lesions, not elsewhere classified

189

1.11

0.13

1.3

1.5

0.29

0.32

nmol/l

0.14

146

Early lumbar disc prolapse, operated

970

0.96

0.13

1.8

1.5

0.38

0.43

nmol/l

0.32

794

Contact with sharp glass

276

1.09

0.13

1.3

1.5

0.22

0.35

nmol/l

1.92

230

Other disorders of the musculoskeletal system and connective tissue

572

0.94

0.13

1.3

1.4

0.25

0.35

nmol/l

1.05

435

Other intervertebral disc disorders

658

3969

1.01

0.13

1.4

0.29

0.43

nmol/l

8.11

500

3121

Crohn disease (strict definition, require KELA)

481

1.06

0.13

1.5

0.52

0.43

nmol/l

0.41

393

Calcific aortic valvular stenosis, diagnosis (helper)

358

0.93

0.13

1.3

1.4

0.68

0.16

nmol/l

0.72

267

Operations 2 for CAVS

358

0.93

0.13

1.3

1.4

0.68

0.16

nmol/l

0.72

267

Pedal cyclist injured in collision with motor vehicle

190

0.89

0.13

1.4

1.5

0.26

0.37

nmol/l

0.78

156

L04AA Selective immunosuppressants

139

1346

1.03

0.12

1.4

0.29

0.36

nmol/l

1.10

111

1034

Otitis externa

148

1435

1.03

0.12

1.3

1.4

0.49

0.41

nmol/l

0.27

112

1128

Myocardial infarction, unclassifiable

234

0.91

0.12

1.1

1.4

0.16

nmol/l

0.01

178

Benign neoplasm: Skin of trunk

200

0.90

0.12

1.8

1.5

0.43

0.35

nmol/l

0.28

158

Intrahepatic Cholestasis of Pregnancy (ICP)

1028

0.96

0.12

1.4

1.5

0.38

0.47

nmol/l

0.90

833

Superficial injury of thorax

723

0.95

0.12

1.3

1.5

0.47

0.35

nmol/l

0.36

576

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

262

0.92

0.12

1.4

0.40

0.21

nmol/l

0.28

200

Other specified/unspecified disorders of bone/cartilage

104

1.16

0.12

2.3

1.4

0.22

0.25

nmol/l

0.21

Acute alcohol intoxication

125

1209

1.03

0.12

1.4

1.5

0.29

0.37

nmol/l

0.96

953

Acute alcohol intoxication, ICD10

112

1081

1.04

0.12

1.4

1.5

0.30

0.38

nmol/l

0.81

862

ILD medications: immunosuppressive drugs

489

4616

1.02

0.12

1.5

1.4

0.32

0.40

nmol/l

1.79

378

3599

Twin gestation

131

1352

0.97

0.12

1.9

1.4

0.47

0.48

nmol/l

0.01

106

1060

Spondylopathies (FG)

110

1062

1.04

0.12

1.5

1.4

0.35

0.43

nmol/l

0.63

842

HSIL lesion of the cervix uteri

276

2704

1.02

0.12

1.5

0.54

0.49

nmol/l

0.32

223

2188

Scabies

249

1.09

0.12

1.6

0.28

0.32

nmol/l

0.24

211

Benign neoplasm: Choroid

162

1.11

0.11

1.4

0.28

0.30

nmol/l

—

117

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

220

1.09

0.11

1.2

1.4

0.24

0.29

nmol/l

0.32

168

Pyogenic granuloma

1.16

0.11

1.6

1.5

0.17

0.36

nmol/l

1.67

All dysplastic lesions of the cervix uteri

384

3897

0.98

0.11

1.5

1.4

0.49

0.50

nmol/l

0.04

310

3121

FESS (DNB20)

699

1.04

0.11

1.3

1.4

0.33

0.39

nmol/l

0.38

557

Gastric ulcer

405

1.06

0.11

1.5

1.4

0.87

0.26

nmol/l

0.53

298

Anomalies of pupillary function

143

1.12

0.11

1.8

1.6

0.38

0.33

nmol/l

—

116

Congenital malformations of cardiac septa

431

0.94

0.11

1.7

1.5

0.53

0.32

nmol/l

0.42

343

Contact with other sharp object(s)

466

0.94

0.11

1.6

1.5

0.29

0.40

nmol/l

0.91

382

Embedded teeth, including avohilmo

108

1117

0.97

0.11

1.6

1.5

0.45

0.48

nmol/l

0.09

933

Non-allergic asthma

386

1.06

0.11

1.9

1.5

0.41

0.36

nmol/l

0.22

302

Recurrent dislocation of patella

661

1.05

0.11

1.4

1.5

0.37

0.52

nmol/l

0.90

552

Fracture of lower leg, including ankle

339

3318

1.02

0.11

1.5

0.25

0.38

nmol/l

5.25

248

2537

Labour and delivery complicated by umbilical cord complications

577

0.95

0.11

1.3

1.4

0.80

0.41

nmol/l

1.10

446

Erythema nodosum

163

1.11

0.10

1.4

0.22

0.34

nmol/l

0.92

136

Artrosis, including avohilmo

632

3511

0.99

0.10

1.4

0.32

0.39

nmol/l

1.68

475

2683

Presence of other functional implants

154

1120

0.97

0.10

1.4

0.23

0.27

nmol/l

0.34

779

Muscle strain

198

0.91

0.10

1.1

1.7

0.23

0.37

nmol/l

1.55

161

Inflammatory bowel disease, strict (require KELA)

183

1874

0.98

0.10

1.4

1.5

0.43

nmol/l

0.04

150

1503

Atrial fibrillation and flutter

135

907

0.97

0.10

1.4

0.19

0.27

nmol/l

2.01

100

666

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

309

1.07

0.10

1.4

0.34

0.37

nmol/l

0.11

262

Injuries to unspecified part of trunk, limb or body region

495

0.95

0.10

1.4

1.5

0.41

0.37

nmol/l

0.20

395

Primary open-angle glaucoma, strict

396

1.06

0.10

1.7

1.5

0.15

0.20

nmol/l

0.65

274

Primary gonarthrosis, bilateral

132

1188

0.97

0.10

1.3

1.4

0.16

0.22

nmol/l

2.97

796

Otosclerosis

280

0.93

0.10

1.4

1.5

0.27

0.31

nmol/l

0.23

204

Covid-19 suspected case

206

2105

0.98

0.10

1.5

0.56

0.45

nmol/l

0.43

174

1688

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

236

0.94

0.10

1.2

1.4

0.12

nmol/l

0.10

195

Gout, unspecified

290

1.07

0.10

1.2

1.4

0.17

0.18

nmol/l

0.04

223

Other peripheral vertigo

341

0.94

0.10

1.4

1.5

0.33

0.30

nmol/l

0.12

258

Open wound of wrist and hand

317

3087

1.02

0.10

1.4

1.5

0.31

0.39

nmol/l

1.73

242

2470

Crohn disease (strict definition, all UC cases excluded)

349

1.06

0.10

1.4

1.5

0.39

0.36

nmol/l

0.11

287

Toxic effect of other and unspecified substances

106

1.14

0.10

1.4

1.6

0.18

0.36

nmol/l

—

Open wound of head

261

2524

1.02

0.09

1.5

0.33

0.36

nmol/l

0.36

199

1960

Tobacco use

320

0.94

0.09

1.3

1.5

0.44

0.40

nmol/l

0.10

268

Struck by thrown, projected or falling objec

238

0.92

0.09

1.4

1.5

0.51

0.30

nmol/l

0.55

195

Respiratory tuberculosis, not confirmed

1.09

0.09

1.4

1.5

0.29

0.15

nmol/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

1021

0.97

0.09

1.4

0.38

0.53

nmol/l

1.64

831

Dental caries, including avohilmo

588

2970

1.01

0.09

1.4

1.5

0.32

0.38

nmol/l

0.97

439

2356

Other arthrosis

260

1826

1.02

0.09

1.3

1.4

0.29

0.31

nmol/l

0.17

181

1329

Other abnormal findings in urine

1.04

0.09

1.8

1.5

0.46

0.42

nmol/l

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

116

1.12

0.09

1.3

1.5

0.28

0.33

nmol/l

—

Acute bronchiolitis

491

1.04

0.09

1.6

0.24

0.32

nmol/l

0.76

400

Dislocation, sprain and strain of joints and ligaments of elbow

452

0.95

0.09

1.7

1.5

0.27

0.36

nmol/l

0.82

365

Other spirochaetal diseases

129

1257

1.03

0.09

1.6

1.4

0.24

0.35

nmol/l

2.93

936

Septal defects

400

1.05

0.09

1.7

1.5

0.52

0.32

nmol/l

0.41

325

Speech disturbances, not elsewhere classified

268

0.93

0.09

1.8

1.4

0.20

0.30

nmol/l

1.52

208

Dental caries 1

588

2971

1.01

0.09

1.4

1.5

0.32

0.38

nmol/l

0.97

439

2357

Acute tubulo-interstitial nephritis

449

4032

0.99

0.09

1.5

0.38

0.41

nmol/l

0.33

336

3168

Chronic pancreatitis

311

1.06

0.09

1.5

0.33

0.24

nmol/l

0.34

238

Other predominantly sexually transmitted diseases, not elsewhere classified

207

2110

0.98

0.09

1.4

1.5

0.42

0.49

nmol/l

0.79

178

1715

Polymorphous light eruption

1.11

0.09

1.5

1.4

0.29

0.34

nmol/l

—

Myeloproliferative diseases (CML excluded)

196

0.92

0.09

1.5

0.24

0.28

nmol/l

0.24

150

Superficial injury of head

127

1302

0.97

0.09

1.5

1.4

0.34

0.41

nmol/l

0.64

1019

Viral infections of the central nervous system

441

0.95

0.09

1.8

1.4

0.33

0.41

nmol/l

0.38

345

Polyarthrosis

515

1.04

0.08

1.4

0.24

nmol/l

0.01

331

Other fall from one level to another

144

1473

0.98

0.08

1.4

1.5

0.35

0.39

nmol/l

0.31

114

1198

Burns and corrosions

826

0.97

0.08

1.4

1.5

0.37

0.38

nmol/l

0.04

665

Labour and delivery complicated by fetal stress [distress]

481

3246

0.99

0.08

1.5

1.4

0.55

0.44

nmol/l

1.28

408

2618

Autoimmune diseases excluding thyroid diseases

907

4991

1.01

0.08

1.5

1.4

0.36

0.40

nmol/l

0.62

694

3987

Acute lymphadenitis

420

1.05

0.08

1.7

1.5

0.28

0.43

nmol/l

1.69

339

COPD (mode)

527

0.96

0.08

1.5

1.4

0.19

nmol/l

0.05

378

Psoriasis

150

1533

0.98

0.08

1.4

0.26

0.37

nmol/l

2.03

106

1161

Mental and behavioural disorders due to alcohol, excluding acute intoxication

233

2289

1.02

0.08

1.3

1.5

0.32

0.37

nmol/l

0.50

181

1814

Suppurative and unspecified otitis media

433

3793

1.01

0.08

1.6

1.5

0.33

0.46

nmol/l

4.27

350

3152

Bronchiectasis

156

1.09

0.08

1.4

0.36

0.26

nmol/l

0.24

118

Disorders resulting from impaired renal tubular function

1.12

0.07

1.5

0.15

0.32

nmol/l

—

Other sexually transmitted chlamydial diseases

915

0.97

0.07

1.5

0.31

0.51

nmol/l

3.71

776

Cholecystitis

421

1.05

0.07

1.4

0.51

0.31

nmol/l

0.66

325

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

166

1.08

0.07

1.4

0.15

0.25

nmol/l

1.16

135

Other specified/unspecified arthritis

170

1668

1.02

0.07

1.4

1.5

0.32

0.44

nmol/l

1.65

120

1287

Corneal ulcer

116

1133

1.02

0.07

1.3

1.5

0.33

0.41

nmol/l

0.90

902

Alcohol-induced chronic pancreatitis

137

1.10

0.07

1.5

1.6

0.13

0.20

nmol/l

—

104

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

143

0.91

0.07

1.5

1.6

0.31

0.36

nmol/l

0.19

122

Hordeolum and other deep inflammation of eyelid

337

0.95

0.07

1.7

1.4

0.65

0.40

nmol/l

0.26

270

Fracture of lumbar spine and pelvis

687

1.03

0.07

1.3

1.5

0.45

0.36

nmol/l

0.39

541

Crohn disease (strict definition, require KELA, min 2 HDR)

471

1.04

0.07

1.4

1.5

0.52

0.43

nmol/l

0.39

385

IBD patients in KELA-register

183

1862

0.98

0.07

1.4

1.5

0.43

nmol/l

0.04

150

1493

Glaucoma

170

1519

0.98

0.07

1.4

0.21

0.29

nmol/l

2.63

122

1093

Other and unspecified nail disorders

1.03

0.07

1.8

1.5

0.36

0.37

nmol/l

—

Lyme disease

126

1234

1.02

0.07

1.5

1.4

0.24

0.36

nmol/l

2.94

919

Childhood allergy (age < 16)

248

2014

1.01

0.07

1.8

1.6

0.40

0.44

nmol/l

0.26

219

1724

Open wound of shoulder and upper arm

0.87

0.06

1.6

1.5

0.27

0.35

nmol/l

—

Valvular heart disease excluding rheumatic fever

154

1146

0.98

0.06

1.4

0.39

0.29

nmol/l

0.47

108

858

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

630

1.03

0.06

1.3

1.4

0.28

0.41

nmol/l

2.16

506

Superficial injury of forearm

739

1.03

0.06

1.3

1.5

0.42

nmol/l

0.02

599

Burns and corrosions of external body surface, specified by site

650

0.97

0.06

1.3

1.5

0.33

0.37

nmol/l

0.30

518

Maternal care for other known or suspected fetal problems

490

3114

1.01

0.06

1.4

0.47

0.45

nmol/l

0.13

398

2513

Other and unspecified urticaria

171

1682

1.02

0.06

1.4

1.5

0.40

0.43

nmol/l

0.30

131

1328

Otitis externa, unspecified

710

0.97

0.06

1.3

1.5

0.57

0.41

nmol/l

0.24

569

Bursitis of shoulder

105

0.86

0.06

1.2

1.4

0.25

0.36

nmol/l

—

Early onset COPD, excluding more controls

581

1.03

0.06

1.4

1.3

0.21

0.22

nmol/l

0.13

419

Other symptoms and signs involving the circulatory and respiratory systems

305

1.05

0.06

1.5

0.24

0.35

nmol/l

1.61

248

Stenosis and insufficiency of lacrimal passages

386

0.96

0.06

1.5

0.43

0.31

nmol/l

0.27

299

Other secondary gonarthrosis

148

1.08

0.06

1.5

1.4

0.79

0.29

nmol/l

—

111

Malignant neoplasm of rectum

162

0.93

0.06

1.3

1.5

0.57

0.23

nmol/l

—

119

Tooth eruption problems

194

1893

1.01

0.06

1.7

1.6

0.43

0.44

nmol/l

0.01

154

1597

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

131

0.91

0.06

1.3

1.5

0.25

0.30

nmol/l

—

101

Unspecified abortion

434

1.04

0.06

1.4

1.3

0.41

0.32

nmol/l

0.35

301

Open wound of lower leg

711

1.03

0.06

1.5

0.23

0.37

nmol/l

2.52

574

Acute appendicitis

604

5655

1.01

0.06

1.5

1.4

0.44

0.42

nmol/l

0.21

477

4427

Bicipital tendinitis

178

1.07

0.05

1.1

1.5

0.41

0.31

nmol/l

0.60

136

236

1.05

0.05

1.5

0.19

0.13

nmol/l

0.55

150

Desensitization to allergens

587

0.97

0.05

1.6

1.5

0.51

0.42

nmol/l

0.20

478

Chronic kidney disease

600

1.03

0.05

1.4

0.19

0.25

nmol/l

1.36

449

Gonarthrosis

373

2119

1.01

0.05

1.4

0.28

0.34

nmol/l

0.98

270

1556

Degeneration of macula and posterior pole

675

0.98

0.05

1.6

1.4

0.31

0.20

nmol/l

0.37

452

Papulosquamous disorders

202

2046

0.99

0.05

1.4

0.26

0.36

nmol/l

2.10

146

1530

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

103

1050

0.98

0.05

1.3

1.4

0.38

0.52

nmol/l

1.63

846

Arthropathies in other diseases classified elsewhere

151

0.93

0.05

1.4

0.36

0.33

nmol/l

—

120

Other diseases of biliary tract

208

1.06

0.05

1.0

1.5

0.25

0.30

nmol/l

0.26

156

Lichen planus, including avohilmo

667

0.97

0.05

1.5

1.4

0.24

0.32

nmol/l

0.80

485

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

400

3960

1.01

0.05

1.5

0.37

0.43

nmol/l

0.87

320

3194

Bleeding

394

2890

0.99

0.05

1.4

0.24

0.36

nmol/l

5.55

299

2191

Heart failure, strict

113

828

0.98

0.05

1.4

0.22

0.19

nmol/l

0.50

584

208

1.06

0.05

1.5

1.7

0.19

0.22

nmol/l

0.35

173

Glomerular diseases

737

0.98

0.05

1.5

1.4

0.43

0.37

nmol/l

0.19

578

Dental pulpitis 2

533

2710

1.01

0.05

1.4

1.5

0.29

0.38

nmol/l

3.04

414

2155

Carcinoma in situ of cervix uteri

127

1290

0.98

0.05

1.3

1.5

0.52

0.51

nmol/l

0.02

1075

Benign neoplasm of major salivary glands

268

1.05

0.04

1.3

1.4

0.14

0.29

nmol/l

4.10

216

Ethmoidectomy

714

1.02

0.04

1.3

1.4

0.33

0.39

nmol/l

0.37

568

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

103

1048

0.98

0.04

1.3

1.5

0.38

0.47

nmol/l

0.91

845

Dental caries 1, only avohilmo

596

3029

1.01

0.04

1.4

1.5

0.32

0.37

nmol/l

0.93

446

2398

Bacterial meningitis

150

1.07

0.04

1.4

1.5

0.41

0.35

nmol/l

0.19

123

Malignant neoplasm of corpus uteri

160

0.94

0.04

1.5

0.19

0.20

nmol/l

—

109

Granulomatous disorders of skin and subcutaneous tissue

160

1.06

0.04

1.4

0.34

0.37

nmol/l

0.14

129

Other specified/unspecified bacterial intestinal infections

241

0.95

0.04

1.4

1.5

0.21

0.32

nmol/l

1.61

191

Other hammer toe(s) (acquired)

419

1.03

0.04

1.6

1.4

0.20

0.27

nmol/l

0.62

277

Psoriasis vulgaris

936

0.98

0.04

1.5

1.4

0.26

0.35

nmol/l

1.08

715

All dysplastic lesions of the cervix uteri, vagina or vulva

417

4170

0.99

0.04

1.5

1.4

0.47

0.49

nmol/l

0.14

336

3315

Carpal tunnel syndrome

391

3505

1.01

0.04

1.3

1.4

0.32

0.38

nmol/l

1.40

277

2619

HSIL lesion of the cervix uteri, vagina or vulva

287

2847

1.01

0.04

1.5

0.53

0.49

nmol/l

0.27

232

2292

Transient ischemic attack

146

1195

1.01

0.03

1.3

1.4

0.24

0.27

nmol/l

0.41

852

Antepartum haemorrhage, not elsewhere classified

144

1423

1.01

0.03

1.4

1.5

0.54

0.51

nmol/l

0.09

116

1142

Flat foot [pes planus] (acquired)

472

0.97

0.03

1.5

1.4

0.21

0.37

nmol/l

2.51

349

Generalized epilepsy

351

0.97

0.03

1.3

1.5

0.31

0.43

nmol/l

0.45

289

Pneumonitis due to solids and liquids

141

1.06

0.03

1.7

1.5

0.51

0.29

nmol/l

—

114

Other ulcerative colitis

379

1.03

0.03

1.3

1.5

0.38

0.41

nmol/l

0.11

301

Gout, idiopatic and unspecified

389

1.03

0.03

1.2

1.4

0.15

0.18

nmol/l

0.61

300

Chronic viral hepatitis

399

1.03

0.03

1.4

1.5

0.20

0.38

nmol/l

4.95

329

Malignant neoplasm of digestive organs

745

1.02

0.03

1.4

0.30

0.20

nmol/l

0.59

529

Other heart diseases

458

3009

1.01

0.03

1.4

0.35

0.38

nmol/l

0.29

342

2348

Superficial injury of ankle and foot

103

1044

0.99

0.03

1.4

1.5

0.32

0.43

nmol/l

1.12

845

Vulvovaginal ulceration/inflammation in other diseases

718

1.02

0.03

1.5

0.48

0.47

nmol/l

0.04

592

Focal brain injury

201

1.04

0.03

1.2

1.5

0.85

0.32

nmol/l

0.35

165

Bacterial pneumonia (organism specified)

209

1888

1.01

0.03

1.6

1.5

0.33

0.37

nmol/l

0.42

160

1464

All influenza

127

1256

1.01

0.03

1.4

1.5

0.29

0.38

nmol/l

1.39

1015

Monoarthritis, not elsewhere classified

231

1.04

0.02

1.3

1.4

0.24

0.35

nmol/l

1.28

186

Other and unspecified injuries of wrist and hand

241

1.04

0.02

1.8

1.5

0.58

0.36

nmol/l

0.31

195

Crowding of teeth, including avohilmo

113

922

1.01

0.02

1.6

1.5

0.30

0.38

nmol/l

0.91

761

Other and unspecified injuries of lower leg

530

0.98

0.02

1.3

1.5

0.36

0.38

nmol/l

0.16

425

Mental and behavioural disorders due to alcohol

295

2855

1.01

0.02

1.3

1.5

0.31

0.37

nmol/l

1.00

227

2267

Other gastritis (incl. Duodenitis)

809

1.01

0.02

1.5

1.4

0.33

0.29

nmol/l

0.14

599

Dental pulpitis 2, only avohilmo

535

2748

1.00

0.02

1.4

1.5

0.29

0.38

nmol/l

3.20

411

2188

Personal history of certain other diseases

192

1.04

0.02

1.5

0.26

0.46

nmol/l

1.87

168

Benign lipomatous neoplasm of other sites/unspecified

208

0.96

0.02

1.3

1.4

0.16

0.31

nmol/l

1.88

172

Congenital malformations of heart and great arteries

803

1.01

0.02

1.6

1.5

0.41

0.36

nmol/l

0.15

642

Lichen planus

419

0.98

0.02

1.4

1.5

0.25

0.27

nmol/l

0.18

305

Hypertension

632

3564

1.00

0.02

1.5

1.4

0.31

0.36

nmol/l

1.10

441

2722

Pustular psoriasis

222

1.04

0.02

1.6

1.5

0.17

0.32

nmol/l

2.04

162

Cardiomyopathy

451

1.02

0.02

1.4

0.17

0.24

nmol/l

1.24

349

Other orthopaedic follow-up care

262

1.03

0.02

2.1

1.4

0.27

0.33

nmol/l

0.32

204

Divergent concomitant strabismus

541

1.02

0.02

1.3

1.5

0.62

0.41

nmol/l

0.33

425

Gonarthrosis, primary, with knee surgery

138

1118

1.01

0.02

1.4

0.15

0.19

nmol/l

1.10

731

Infections of breast associated with childbirth

498

0.98

0.01

1.3

1.5

0.64

0.52

nmol/l

0.42

407

Acute appendicitis, with complications

103

1039

0.99

0.01

1.5

1.4

0.36

0.37

nmol/l

0.03

783

Hypertensive diseases

632

3568

1.00

0.01

1.5

1.4

0.31

0.36

nmol/l

1.10

441

2726

Pediculosis, acariasis and other infestations

313

1.02

0.01

1.6

0.29

0.35

nmol/l

0.49

258

Other and unspecified injuries of ankle and foot

333

1.02

0.01

1.3

1.5

0.23

0.39

nmol/l

2.11

269

Hydronephrosis

423

1.02

0.01

1.3

1.4

0.18

0.30

nmol/l

3.02

335

Other osteochondropathies

433

1.02

0.01

1.6

1.4

0.32

0.40

nmol/l

0.35

340

Use of anticholinesterases

224

0.98

0.01

1.5

1.4

0.13

nmol/l

0.07

158

N06DA Anticholinesterases

224

0.98

0.01

1.5

1.4

0.13

nmol/l

0.07

158

Abnormalities of forces of labour

134

1348

0.99

0.01

1.2

1.4

0.48

0.42

nmol/l

0.18

108

996

Open wound of forearm

487

0.99

0.01

1.5

0.28

0.38

nmol/l

1.06

399

Fall on and from stairs and steps

139

1398

0.99

0.01

1.4

0.26

0.38

nmol/l

2.48

105

1076

Seronegative rheumatoid arthritis

517

0.99

0.01

1.4

0.27

0.39

nmol/l

1.03

380

Superficial injury of shoulder and upper arm

607

0.99

0.01

1.1

1.5

0.26

0.36

nmol/l

1.01

484

Special screening examination for neoplasms

116

0.95

0.00

1.1

1.6

0.67

0.30

nmol/l

0.74

Later onset COPD, excluding more controls

153

0.97

0.00

1.5

1.4

0.12

0.11

nmol/l

0.39

116

Oral leukoplakia and related diseases

144

1.04

0.00

1.3

1.5

0.46

0.22

nmol/l

—

105

Non-rheumatic valve diseases

155

1126

1.00

0.00

1.4

0.39

0.29

nmol/l

0.47

108

841

L04AC Interleukin inhibitors

314

1.02

0.00

1.3

1.5

0.28

0.37

nmol/l

0.54

254

Appendicitis, broad definition

634

5788

1.00

0.00

1.5

1.4

0.44

0.42

nmol/l

0.23

498

4539

Ulcerative proctitis

446

0.99

0.00

1.3

1.5

0.31

0.42

nmol/l

0.68

365

Acute appendicitis, no complications

501

4989

1.00

0.00

1.4

0.46

0.41

nmol/l

0.46

395

3911

Heart failure,strict

111

796

1.01

0.00

1.4

0.22

0.19

nmol/l

0.41

564

Crushed, pushed or stepped on by crowd or human stampede

556

0.99

0.00

1.5

0.22

0.38

nmol/l

3.00

455

Ankyloglossia

124

1.05

0.00

1.6

0.37

0.36

nmol/l

0.03

107

Coxarthrosis, primary, with hip surgery

929

1.00

0.00

1.3

1.4

0.18

0.19

nmol/l

0.37

611

Acute and subacute iridocyclitis

108

1076

1.00

0.00

1.4

0.23

0.38

nmol/l

4.23

838

Diseases of appendix

636

5794

1.00

0.00

1.5

1.4

0.44

0.42

nmol/l

0.22

500

4544

Other bursopathies

468

1.00

0.00

1.1

1.4

0.41

0.28

nmol/l

0.62

356

Benign neoplasm of middle ear and respiratory system

255

1.02

0.00

1.2

1.5

0.41

0.28

nmol/l

0.33

195

Complications predominantly related to the puerperium

331

3314

1.00

0.00

1.3

1.5

0.51

0.49

nmol/l

0.08

269

2638

Viral pneumonia

585

1.01

0.00

1.5

0.28

0.39

nmol/l

0.92

478

Psoriatic and enteropathic arthropathies

665

1.01

0.00

1.3

1.4

0.34

0.39

nmol/l

0.24

504

Recurrent dislocation and subluxation of joint

570

1.00

0.00

1.3

1.4

0.27

0.41

nmol/l

2.01

466

Fracture at wrist and hand level

222

2214

1.00

0.00

1.6

1.5

0.26

0.38

nmol/l

3.14

176

1741

Thyrotoxicosis with toxic multinodular goitre

176

1.02

0.00

1.3

1.4

0.37

0.25

nmol/l

—

129

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

285

1.02

0.00

1.4

0.56

0.41

nmol/l

0.28

236

Pustulosis palmaris et plantaris

204

0.98

0.00

1.7

1.5

0.20

0.33

nmol/l

1.36

149

Myeloproliferative diseases

226

1.02

0.00

1.7

1.5

0.25

0.28

nmol/l

0.23

169

Right hemicolectomy

112

0.98

0.00

1.4

1.5

0.37

0.28

nmol/l

0.16

Injury of muscle and tendon at wrist and hand level

616

1.01

0.00

1.6

1.4

0.28

0.32

nmol/l

0.23

486

Polypectomy (DHB20)

218

1.01

0.00

1.4

1.5

0.45

0.29

nmol/l

0.27

174

Generalized skin eruption due to drugs and medicaments

212

0.99

0.00

1.5

0.20

0.32

nmol/l

1.44

170

Viral meningitis

278

1.01

0.00

2.1

1.5

0.33

0.37

nmol/l

0.12

230

Other and unspecified disease of Bartholin gland

141

0.99

0.00

1.4

1.5

0.31

0.30

nmol/l

—

111

Unspecified urinary incontinence

339

1.00

0.00

1.3

1.5

0.29

0.31

nmol/l

0.15

256

Chondrocostal junction syndrome [Tietze]

211

1.00

0.00

1.7

1.5

0.22

0.31

nmol/l

0.93

169

Asthma mixed form (mode), excluding more controls

275

0.98

0.00

1.4

0.28

0.31

nmol/l

0.18

223

Ankylosing spondylitis

494

0.99

0.00

1.4

1.5

0.24

0.38

nmol/l

2.34

396

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

114

1139

1.00

0.00

1.4

1.3

0.23

0.32

nmol/l

1.12

831

Iridocyclitis

127

1271

1.00

0.00

1.4

1.5

0.22

0.39

nmol/l

6.64

988

Dislocation, sprain and strain of joints and ligaments of knee

545

5065

1.00

0.00

1.4

1.5

0.33

0.42

nmol/l

2.25

446

3974

Transport accidents

428

3790

1.00

0.00

1.6

1.5

0.38

0.46

nmol/l

0.87

352

3050

Bilateral sagittal split ramus osteotomy operation

303

0.99

0.00

1.3

1.5

0.47

0.37

nmol/l

0.26

244

Failed induction of labour

973

1.00

0.00

1.4

1.5

0.49

0.48

nmol/l

0.04

803

Assault by bodily force

573

0.99

0.00

1.3

1.5

0.25

0.39

nmol/l

1.96

468

Alcohol withdrawal state with delirium

143

0.98

0.00

1.1

1.5

0.13

0.24

nmol/l

—

112

Multiple gestation

139

1393

1.00

0.00

1.9

1.4

0.46

0.47

nmol/l

0.06

113

1089

Asthma mixed form (mode)

274

0.98

0.00

1.4

0.28

0.32

nmol/l

0.19

222

Distal bite

363

0.98

0.00

1.2

1.6

0.19

0.30

nmol/l

2.90

297

Exposure to other specified electric current

0.96

0.00

2.0

1.6

0.13

0.36

nmol/l

—

Disorders of conjunctiva in diseases classified elsewhere

0.00

0.0

1.7

—

0.14

—

Injury of nerves at forearm level

0.97

0.00

1.3

1.5

0.14

0.36

nmol/l

—

COPD-related respiratory insufficiency

160

1.00

0.00

1.0

1.4

0.19

0.24

nmol/l

0.45

122

Vitamin deficiency, wide

230

1.00

0.00

1.3

1.5

0.27

0.34

nmol/l

0.42

183

Sequelae of complication of pregnancy, childbirth and the puerperium

0.00

0.0

1.4

—

0.40

—

Benign neoplasm: Parotid gland

220

1.00

0.00

1.2

1.4

0.11

0.31

nmol/l

6.63

177

Erythema annulare centrifugum

0.00

0.0

2.6

—

0.33

—

Schizoaffective disorder

560

1.00

0.00

1.4

1.5

0.20

0.41

nmol/l

3.62

446

Tympanosclerosis

0.00

0.0

1.5

—

0.32

—

Intentional self-harm by crashing of motor vehicle

0.00

0.0

1.4

—

0.27

—

Colorectal neuroendocrine tumor and carcinoma

0.93

0.00

2.0

1.5

0.36

0.38

nmol/l

—

Mononeuritis multiplex

0.00

0.0

1.2

—

0.26

—

Genetic anomalies of leukocytes

0.00

0.0

1.7

—

0.17

—

Vitamin deficiency

230

1.00

0.00

1.3

1.5

0.27

0.34

nmol/l

0.42

183

Disorders of synovium and tendon in diseases classified elsewhere

0.88

0.00

1.3

1.4

0.17

0.33

nmol/l

—

Erythema ab igne [dermatitis ab igne]

0.00

0.0

1.2

—

1.05

—

Iliac crest spur

0.00

0.0

1.6

—

0.25

—

Contracture of joint

1.02

0.00

1.2

1.3

0.09

0.45

nmol/l

—

Plantar fascial fibromatosis

570

1.00

0.00

1.2

1.4

0.39

0.35

nmol/l

0.15

432

conjunctival degenerations and deposits

0.98

0.00

1.7

1.3

0.21

0.38

nmol/l

—

Sequelae of other and unspecified infectious and parasitic diseases

360

1.00

0.00

1.3

1.4

0.24

0.43

nmol/l

2.15

281

Diphtheria

0.00

0.0

1.4

—

0.25

—

Polydactyly

0.00

0.0

1.6

—

0.22

—

Thoracic root disorders

0.00

0.0

1.7

—

0.32

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Estradiol (E2) [Moles/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS